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TABLE 2. Taken from Reference 1./ 
Table 1. Stable changes in enzyme and carrier activityJollowing short term exposure of tissues to insulin 
Enzyme or carrier 
Glucose uptake 
Glucose transport 
Cyclic AMP metabolism 
Phosphodiesterase (low Km) 
Protein kinase (Cyclic AMP dep.) 
Glycogen metabolism 
. Glycogen synthase 
PhosphoryJase kinase 
Phosphorylase 
















Change in activity Possible mechanism 
increase (V*) ? translocation 
increase (V*) ? (W); phosphorylation (l) 
decrease association of Rand C subunits 
(V+ in W; Ka* in SM) 
increase (Ka *) dephosphorylation 
decrease (V+) dephosphorylation 
decrease (Ka +) dephosphorylation 
increase dephosphorylation (l); ? (W) 
(Ks + in L; Ks* in W) 
















Column 2 and elsewhere: W. white fat; B. brown fat; H. heart muscle; SM. skeletal muscle; L.liver; MG. mammary gland. Column 3: ":1 
change in V max; Ks. change in Km for substrate; Ka change in sensitivity to appropriate activator; * change in activity most marked in absence: 
of other hormones; + 9 change in activity most marked under conditions of increased cell cyclic AMP concentrations .:;.~ 
~- }~ 
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CHARLES F. BURANT. The Role of the Insulin Receptor in Skeletal Muscle 
Insulin Resistance: Evaluation of Two Animal Models. (Under the 
direction of MARIA G. BUSE.) 
The role of the insulin receptor in muscle insulin resistance was 
studied. Denervation of skeletal muscle resulted in the rapid appear-
ance of a decrease in basal and insulin stimulated glucose transport, 
glycogen synthesis and a defect in the activation of glycogen synthase 
which was independent of levels of glycogen in the muscle. The effect 
was seen in both predominantly red and predominantly white muscle. 
There was no change in the denervated muscles' sensitivity to epinephrine-
mediated decrease in glycogen synthesis or glycogen content, nor was 
there a major change in the insulin binding capacity of denervated 
muscles. 
A technique was developed to investigate the properties of the 
insulin receptor solubilized from skeletal muscle. Freezing hindlimb 
muscles with subsequent powdering and homogenization with buffered 
Triton X-100 produced a fraction with specific insulin binding. Further 
purification on agarose-bound wheat germ agglutinin yielded insulin 
receptors with intact insulin binding, as well as insulin stimulatable 
autophosphorylation and exogenous substrate kinase activity. The autophos-
phorylation of the insulin receptor ~-subunit in intact tissues was also 
demonstrated. 
The binding and kinase domains of insulin receptors solubilized 
from denervated skeletal muscle were identical to that from contra-
lateral controls. No significant changes were seen in the autophos-
phorylation of the ~-subunit in intact, denervated solei. Injection of 
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insulin in the rat and subsequent partial purification of insulin re-
ceptors in the presence of phosphatase inhibitors allowed the demonstra-
tion of an increased kinase activity towards histone H2b as compared to 
saline treated rats. The increase was due to an increase in tyrosine 
phosphorylation attributed to the activation of the insulin receptor 
kinase. Again, no change in the insulin receptors from denervated 
muscles was observed. 
Streptozotocin diabetes resulted in an increase in specific insulin 
binding but a decrease in insulin-stimulatable autophosphorylation and 
tyrosine kinase activity. Structural analysis showed no change in the 
a-subunit but the ~-subunit attained a component with a slower migration 
on electrophoresis. The ~-subunit change was shown to be, in part, due 
to increased sialic acid content of the receptor subunit. The kinetic 
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CHAPTER I: INTRODUCTION & LITERATURE REVIEW 
Insulin has varied and profound effects upon its target tissue. 
Even with the immense amount of effort to elucidate the mode of action 
of insulin, the exact pathway leading from insulin binding to the 
changes in intracellular metabolism remain a mystery. Many theories on 
the mechanism by which insulin acts upon the cell, including searches 
for tsecond messengers' analogous to cAMP have been proposed (Table 1). 
Most, however, have not withstood the test of time (1). 
INSULIN MEDIATORS: Two areas of investigation into the mode of 
action of insulin have recently received much attention: the generation 
of small peptide mediators and the recently discovered kinase activity 
of the insulin receptor. This latter aspect is discussed in detail 
below. By taking extracts of cells treated with insulin, several investi-
gators have been able to demonstrate insulin-like effects on certain 
enzyme systems in broken cell preparations (2,3,4,5). Two commonly used 
end point assays are the activation of pyruvate dehydrogenase and the 
inhibition of cAMP dependent protein kinase (6). Since the insulin-like 
activity of the substance is eliminated by protease treatment, the 
mediator is thought to be a protein. Gel filtration has shown that the 
molecular weight of the substance to be small - "" 1000-2000 daltons (5). 
Further data revealed that some of the 'mediator' effects could be 
abolished by treatment with glycosidases (6), suggesting a glycoprotein 
nature of the substance. 
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Because cells treated with low concentrations of trypsin show 
insulin-like responses, and this same treatment can reproduce the genera-
tion of the small peptide 'mediators', Larner has proposed that insulin 
acts to produce these mediators by the initiation of a proteolytic event 
(6). However, due to complications such as mUltiple peaks of activity 
when the mediator extract is separated by chromatography, the nonspeci-
ficity of the end point assays and the fact that the exact chemical 
nature of the peptide has not been determined, it is difficult to assess 
at this time the merits of the mediator theory in insulin action. 
GLUCOSE TRANSPORT: Upon exposure of a cell to insulin, one wit-
nesses an increase in the influx of glucose. Glucose enters the cell by 
facilitated diffusion and the effect of insulin is to increase the Vmax 
of the transport reaction. In independent observations Suzuki and Kono 
(7) and Cushman and Wardzala (8) have provided a mechanism for the 
increase in glucose transport. By isolating plasma membranes from 
insulin treated cells they showed there is an increase in the ability of 
the membranes to transport glucose and bind [3H]cytochalsain B, which 
tightly binds hexose transporters. In parallel to the observed increase 
in glucose transporters on the surface membranes there was a concommit-
tant decrease in glucose transporters in the low density microsome 
fraction of these cells. These results suggested that insulin causes 
the translocation of the glucose transporters from the interior of the 
cell to the cell surface. 
This redistribution theory has been elegantly confirmed by Oka and 
Czech (9). Cytochalasin B binds to the "inside tt hexose binding site of 
the glucose transporter while the non-transportable glucose analogue 
ethylidene glucose binds to the "outside tt hexose binding site and 
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changes the transporters conformation such that the "inside" site now 
• loses its ability to bind the cytochalasin. Incubation of control cells 
with ethylidene glucose along with Cytochalasin B (which can be photo-
crosslinked to the glucose transporter) allowed the demonstration of 
labeling of only the low density microsomal fraction of the glucose 
transporters. Furthe"rmore, upon stimulation of the cells with insulin 
there was an increase in the number of photo-crosslinked transporters 
isolated from the plasma membrane. 
In addition to increasing glucose transport insulin also causes the 
stimulation of intracellular glucose metabolism such as increases in 
glucose oxidation and glycogen synthesis as well as an increase in 
pentose shunt activity. The immediate effects of insulin on the intra-
cellular metabolism of glucose occur primarily through the increase in 
activity of certain sets of enzymes and inhibition of others. For 
example, the increase in glycogen accumulation seen in cells after 
insulin treatment is due to the activation of the enzyme glycogen syn-
thase which incorporates glucose into glycogen. Dephosphorylation of 
certain sites on the enzyme increases its affinity for glucose-6-phos-
phate which is an allosteric activator of the enzyme (10). The Concen-
tration of glucose-6-phosphate also increases in the cell as a result of 
the insulin stimulation of glucose transport. The enzyme phosphorylase, 
which breaks down glycogen into glucose monomers is inactivated in cells 
treated with insulin also by the dephosphorylation of sites on the 
enzyme (11). This cycle of phospborylationderhospporylation is repeated 
on numerous other metabolic pathways that are modulateq by insulin 
(Table 2). 
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In addition to the effects on glucose metabolism, insulin also has 
effects on transport of amino acids, ion fluxes across cell membranes, 
the synthesis and degradation of protein and triglycerides and influ-
ences RNA synthesis (1). These effects of insulin are also seen rela-
tively rapidly after insulin exposure and occurs at relatively low 
concentrations of insulin. This is in contrast to the growth promoting 
effects of insulin which require higher concentrations of insulin and 
occurs in a time frame of hours to days. This growth promoting effect 
of insulin may be mediated through a pathway distinct from that asso-
ciated with the well-characterized changes in intermediary metabolism 
(see below). 
INSULIN BINDING: Although the results of insulin exposure to cells 
are well-characterized, the mechanism by which insulin causes changes in 
the metabolic state of the target tissues are unknown. The initial 
event in insulin action is binding to specific cell surface receptors. 
The binding of insulin to this receptor is specific and saturable with a 
dissociation constant of approximately lO-1 2M. The number of these high 
affinity receptors is low on most cells and in the most abundant case 
represents only 0.01% of the protein in plasma membrane preparations 
(12).. Even with this small number of receptors it has been observed in 
a number of cell types that the maximal biological response can be 
elicited when only a fraction of the high affinity receptors are occu-
pied (13). Binding isotherms of insulin to receptors on intact cells, 
on membranes and to receptors solubilized by the use of non-ionic deter-
gents are non-linear when plotted by the method of Scatchard. Debate 
exists for the reason behind this curvilinearity, which may be due on 
one hand to the existence of two different classes of receptor molecules 
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that differ in their affinity for insulin or to a negative cooperativity 
in insulin binding where the bivalent receptor, after binding one in-
sulin molecule, has a reduced affinity for the second. The negative 
cooperativity model was given strong experimental support by the experi-
ments of DeMeyts (14) who showed that the dissociation of previously 
bound [1251]insulin was increased in the presence of unlabeled insulin. 
EVidence also exists for the first model however. Pollet et al. (15) 
have demonstrated that the increase in the dissociation of labeled 
insulin from its receptor induced by added insulin to the media occurs 
at the same rate regardless of the degree of receptor occupancy_ He 
also points out that univalent receptors such as the prolactin receptor 
also show curvilinear Scatchard binding profiles. 
BINDING INDUCED CONFORMATIONAL CHANGES: The binding of insulin to 
its receptor appears to result in change in the conformation of the 
receptor. By the use of radiation inactivation it was shown that the 
occupied receptor was altered in rat liver membranes (16). The occupied 
receptor is more susceptible to the digestive actions of trypsin (17) 
suggesting a conformational change upon insulin binding that exposes 
trypsin sensitive sites. In a series of reports, Donner and co-workers 
have demonstrated a time and temperature dependent increase in insulin 
receptor affinity. They suggest that the receptor exists in two affi-
nity states and that binding of insulin shifts the equilibrium towards 
the higher affinity conformation (18,19,20,21). In a recent report, 
this group used affinity cross-linking techniques to show that a bi-
phasic pattern of trypsin sensitivity of the receptor occurred upon in-
sulin binding. After an initial increase in trypsin sensitivity, com-
ponents of the receptor became less trypsin labile. This shift in 
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protease sensitivity was correlated to an increase in the amount of 
insulin receptor in the higher affinity state (22). 
LIGAND INDUCED AGGREGATION AND INTERNALIZATION: In an analogous 
fashion to that seen with surface immunoglobulin molecules which are 
exposed to antigen, the insulin receptor, upon binding insulin, aggre-
gates to form patches and caps on the cell surface. This has been 
directly observed using fluorescent microscope techniques (23). The 
importance of microaggregation in the signalling of the receptor was 
demonstrated by the use of fragments of antibodies directed towards the 
insulin receptor. It was shown that bivalent Fab fragments of these 
antibodies were insulinomimetic in that they could stimulate the uptake 
of glucose into the target cells (in this case lymphocytes) but the 
monovalent Fab did not change glucose flux. The addition of bivalent 
antibodies towards the monovalent antibodies resulted in aggregation and 
an increase in glucose transport. Bivalent antibodies directed towards 
insulin were synergistic with insulin in eliciting a metabolic response 
(23,25). 
Several morphological and biochemical studies have shown that the 
aggregated insulin receptor and associated insulin are internalized and 
the insulin subsequently degraded in a time and temperature dependent 
fashion. This is known as receptor mediated endocytosis and is common 
to many cell surface receptors. For low density lipoproteins, trans-
ferrin and certain toxins (i.e .. tetanus toxin) this endocytotic event is 
required for these substances to alter cellular metabolism (26). The 
receptors for these substances are seemingly the shuttle for transfer of 
the ligands to the interior of the cell. In most cells the endosomes 
fuse with lysosome like vesicles (receptosomes) and the bound insulin is 
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rapidly degraded. The unoccupied receptor is then either degraded or 
recycled back to the surface of the cell (27,28). The exact role of the 
endocytotic event in peptide hormone action remains unclear. It has 
been suggested that some of insulin's effects may be mediated through 
binding of intracellular insulin receptors which reside on various 
organelles (29). This is unlikely in that substances which interfere 
with the internalization of insulin have little effect on insulin's 
biological effects (30). Furthermore, microinjected insulin had no 
insulin-like effects on the cells treated. 
STRUCTURE OF THE INSULIN RECEPTOR: Various methodologies that have 
evolved over the last IS years have allowed the determination of the 
structure of the insulin receptor. By using affinity chromatography 
after solubilizing membrane components in non-ionic detergents, Jacobs 
and Cuatrecasas were able to isolate receptor-rich fractions that were 
analyzed by gel electrophoresis (31). They identified a component of 
135,000 daltons, but the affinity of the fractions isolated had a much 
lower affinity for insulin than the crude receptor preparation making 
interpretation of the data difficult. A major step in elucidating the 
structure of the insulin receptor was the development of ways to label 
the insulin receptor with [12 5 I]insulin either by the use of photo-
activable insulin analogues (32) or by cross-linkage with chemical 
reagents such as disuccinimidyl suberate as used by Pilch and Czech 
(33). Combining these techniques with affinity chromatography allowed 
the identification of the molecular weight and subunit composition of 
the insulin receptor (33,34,35). As shown in Figure 1 the insulin 
receptor is considered to be a heterotetramer composed of 2 a and 2 ~ 
subunits of molecular weight of - 125,000 daltons and ~ 95,000 daltons 
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respectively. The subunits are held together by disulfide bonds. Using 
various concentration of reducing agents Massague and Czech (36) have 
shown that the disulfide bonds that link the ~-subunits to the a-sub-
units are much stronger than thea-S-S-a bond. This proposed structure 
of the insulin receptor was confirmed in a report by Fujita-Yamaguchi 
(37) who used affinity chromatography to obtain an apparently homogene-
ously pure preparation of the insulin receptor. She identified subunits 
of 135,000 and 95,000 daltons and determined by peptide mapping that an 
often identified subunit of approximately 50,000 daltons was a proteo-
lytic degradation product of the ~-subunit. 
On the basis of their relative labeling after cross-linkage of 
insulin, it has been suggested that the a-subunit of the insulin recep-
tor is the primary binding subunit with perhaps only a small domain of 
the ~-subunit involved in insulin binding (38). This is consistent with 
the orientation of the subunits in the membrane of intact cells. The 
a-subunit is sensitive to digestion when cells are treated with trypsin 
added to the media while the ~-subunit remains intact (38). Likewise, 
the a-subunit is preferentially labeled when membrane proteins are 
surface iodinated with much weaker labeling of the ~-subunit (39,40), 
indicating that the ~-subunit has less of its protein sequence on the 
outer face of the cell. It has been shown that the ~-subunit of the 
insulin receptor is very susceptible to proteolytic cleavage by elastase 
type enzymes (41). Using this property, Roth et al. (42) demonstrated 
that the ~-subunit could be preferentially degraded while leaving the 
a-subunit intact. The a-subunit in these preparations could bind 
insulin nearly as w~ll as the insulin receptor before degradation. 
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Since most, if not all surface proteins and receptors are glyco-
proteins (43) , it is not surprising that the insulin receptor too is a 
glycoprotein. This was first assumed based on studies that showed that 
insulin binding to isolated adipocytes was severely impaired after 
treatment with neuraminidase and other glycosidases (44). Subsequently 
it was shown that concanavalin A and wheat germ agglutinin could modu-
late insulin binding (45) as well as specifically adsorb insulin binding 
activity when the lectins were immobilized on an insoluble matrix (46). 
Direct demonstration of the glycoprotein nature of the insulin receptor 
was carried out by Hedo et ala (39) by metabolically labeling IM9-
lymphocytes with [3H]monosaccharides and specifically immunoprecipi-
tating the insulin receptor with anti-insulin receptor antibodies. The 
results presented suggest that both the Q- and ~-subunits contain com-
plex carbohydrate side chains since all the major [3H]monosaccharides 
known in complex carbohydrate sugar side chains were incorporated into 
both subunits. It appears that the a-subunit has a relatively greater 
abundance of galactose and N-acetylglucosamine residues whereas the 
f3-subunit has a higher sialic acid content. 
Tunicamycin, a potent inhibitor of core oligosaccharide addition to 
asparagyl residues (n-linked core glycosylation) effectively reduces 
cell surface insulin binding capacity (47) but has no effect on recy-
cling of previously synthesized receptors (48). Furthermore, tunica-
mycin causes the accumulation of intracellular aglycoreceptor precursors 
which will appear on the cell surface after removal of tunicamycin from 
the media (49). Using pulse chase labeling techniques in 3T3-LI adipo-
cytes Ronnett et a1. (50) have proposed a model for the synthesis and 
~~~t-t~anslational processing of the insulin receptor. They proposed 
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that in these cells both the a- and ~-subunits are synthesized as a 
180-190kDa pro-receptor peptide that is rapidly converted to a 210kDa 
core glycosylated peptide. Specific proteolytic cleavage forms an 
immature a(12SkDa) and ~(83kDa) subunit which through further side chain 
modifications (conversion from a 'high mannose' to a 'low mannose' state 
and subsequent addition of monosaccharides) are converted to the mature 
135kDa a and 9SkDa ~ subunits. This latter glycosylation event appears 
to occur immediately prior to the mature receptors' appearance on the 
cell surface. Some refinements of the results presented in this paper 
were provided in a report by Salzman et al. (51). Using different 
concentrations of the ionophore monensin, the investigators were able to 
block processing of the core glycosylated pro-receptor (210 kDa above) 
or with a lower concentration block the maturation of the immature forms 
of the insulin receptor subunits. They were able to show that the 
uncleaved, pro-receptor and the immature subunits could accumulate on 
the cell surface, suggesting that the signal for transit to the cell 
surface resides in the core peptide or the core glycosylated peptide. 
The 210 kDa peptide and the immature a-subunit were able to bind insulin 
and the former peptide and the immature ~-subunit were able to autophos-
phorylate. The invesgigators in this report were also able to show that 
the mature a- and P-subunits were sensitive to the enzyme endoglycosi-
dase H, suggesting that not all the carbohydrate side chains on the 
receptor subunits are processed to a 'low mannose t state. 
Indirect evidence for the existence of possible O-link carbohydrate 
side chains on the insulin receptor ~-subunit was provided by Herzberg 
et al. (52). Using both enzymatic and chemical deglycosylation methods, 
they were able to show that both the a- and f3-subunits of the insulin 
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receptor were sensitive to digestion with endoglycosidase Hand endogly-
cosidase F. The former endoglycosidase removes 'high mannose' carbohy-
dr.ate side chains at the chitobiose core (the cleavage takes place 
between the two N-acetylglucosamine residues that are attached to the 
asparigyl group in N-linked glycoproteins) while endoglycosidase F 
removes both high and low mannose sugar side chains of most N-link~d 
glycoproteins, also at the chitobiose core. The a-subunit was appar-
ently completely deglycosylated by treatment with endoglycosidase F as 
judged by its mobility shift when compared to insulin receptors deglyco-
sylated by chemical means (treatment in this case was performed with 
trifluoromethanesulfonic acid, TFMS) and resolved at a molecular weight 
of - 98 kDa. The ~-subunit on the other hand did not achieve the same 
decrease in molecular weight after digestion with Endoglycosidase F as 
was observed after treatment with TFMS. This suggested to the authors 
that there may be Q-linked oligosaccharide side chains on the ~-subunit 
of the insulin receptor. Data relevant to this point are presented in 
Chapter 5 of this dissertation. 
The role of the carbohydrate moiety of the insulin receptor in 
insulin binding and signal transmission has been studied by several 
groups (53,54,55). In general it was shown that removal of sialic acid 
residues with neuraminidase did not affect insulin binding. Cuatrecasas 
and Illiano (56) showed however that the treatment affected the ability 
of insulin to promote glucose transport and inhibit lypolysis. A recent 
report by Fujita-Yamaguchi (57) using highly purified insulin receptor 
preparations showed that the removal of the sialic acids from the recep-
tor resulted in an increase in the binding activity and the tyrosine 
kinase activity of the insulin receptor (the tyrosine kinase activity of 
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the insulin receptor will be discussed in detail below). 
Two groups have recently produced a cDNA clone of the insulin 
receptor which allowed the peptide sequence of the receptor to be de-
duced (58,59). The data suggest that the insulin receptor is synthe-
sized as a single polypeptide and is post-translationally cleaved to 
form the a and ~-subunits. This is exactly the results that are ob-
tained in the pulse-chase studies of Ronnett et ale (50) and Salzman et 
al. (51). The predicted molecular weight of the unglycosylated a-and 
~-subunits are -84,000 and -70,000 kDa respectively. The a-subunit 
occupies the N-terminus of the precursor and is rich in cysteine resi-
dues that may compose a cross-linking domain on the external face of the 
membrane. This region is probably distinct from the insulin binding 
domain that also is predicted to lie in the C-terminus region of the 
a-subunit. At the end of the a-subunit coding sequences a run of basic 
amino acids are predicted which may code for the cleavage site of the 
polypeptide precursor which would then form a- and ~-subunits. The 
~-subunit coding region predicts a transmembrane region and a concenSllS 
sequence for an ATP binding site and an area that may code for phospho-
tyrosyl transferase activity. It is of considerable interest that even 
though the two reported cloned insulin receptor cDNAs came from pla-
cental mRNA, the sequence that were obtained were different in 22 nucleo-
tide residues and a block of additional nucleotides that were found in 
the Ebina paper that was not found in the Ulrich paper. The basis for 
these differences are not apparent. It is also of interest to note that 
while the Ulrich et al. found 15 possible glycosylation sites on the a-
subunit, Ebina et al. found only 13, while on the ~subunit 7 or 4 poten-
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tial glycosylation sites were quoted by the groups respectively. Part 
of these differences are due to differences in the predicted amino acid 
sequence and to the assessment of the groups of asparagine residues that 
are potentially glycosylated. Because of the absence of a hydrophobic 
domain in the a-subunit that is long enough to span the membrane, Ulrich 
et al. (58) have suggested that the a-subunit is entirely extracellular 
and anchored to the cell via disulfide linkages with the f3-subunit. The 
schematic representations of the insulin receptor as derived from se-
quence data is presented in Figure 2. 
By comparing predicted sequences, it was noted that there is a 
great deal of homology between the insulin receptor and the EGF receptor 
and, in the region that codes for the phosphotransferase activity, there 
is a great deal of homology with the src family of oncogene products. 
The consequences of these homologies will be discussed below. Jacobs et 
al. have recently published data on the structure and synthesis of the 
IGF I receptor (60). It shows that there is remarkable structural 
similarities between the receptors for IGF I and insulin. The hormones 
themselves are also homologous (61) and they can cross react, with lower 
affinity, with each others' receptors. These observations have lead to 
the suggestion that the growth promoting effects of insulin may be 
mediated through the IGF I receptor. 
INSULIN RECEPTOR KINASE ACTIVITY: Perhaps the most important 
recent discovery in the field of insulin research is the identification 
of the insulin stimulated protein kinase activity that appears to be an 
intrinsic part of the insulin receptor. The distinguishing feature of 
the insulin receptor associated protein kinase is that the phosphoryl-
transferase reaction uses tyrosine as the acceptor amino acid (62,63). 
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This tyrosine kinase activity was first recognized as a unique feature 
of the transforming gene product of the Rous sarcoma virus (64,65) and 
has been identified as a feature of many of the transforming peptides 
associated with retroviruses (64). In most cases the protein carrying 
out the phosphotransferase activity are themselves substrates for their 
own kinase activity (i.e. undergo autophosphorylation). Evidence sug-
gest$ that this tyrosine kinase activity is related to the transforma-
tion of cells infected with these viruses. The tyrosine content of 
cells that are transformed with the retroviruses increases substantially 
(65). Rous sarcoma virus that is temperature sensitive for the induc-
tion of the transformed phenotype also show a temperature lability of 
the tyrosine kinase activity associated with the transformation asso-
ciated peptide, pp60src (66). Mutation of the gene that codes for the 
tyrosine kinase containing peptide such that the tyrosine kinase acti-
vity is abolished (as assessed by in vivo tyrosine content of the cells 
thus infected and by in vitro assays) show a marked decrease or an 
elimination of the transforming activities of the alt.ered viruses 
(65,66,61). A recent report (68) demonstrated that the addition of 
vanadate ion, a potent inhibitor of phosphotyrosyl phosphatases, to the 
culture medium of several different cell types resulted in the morpho-
logical transformation of these cells. The transformation was dose-
dependent and correlated with an increase in the phosphotyrosine content 
of the cells. Thus, it seems that there ia evidence that the phosphory-
lation of tyrosine is correlated with cell multiplication and gr9wth. 
The fact that the transforming proteins of the retroviruses origi-
nated in the genome of eukaryotic cells strongly suggests that the 
tyrosine kinase activity is important for normal cellular growth and 
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differentiation. It is then perhaps not surprising in retrospect that 
many of the surface receptors for polypeptide hormones contain tyrosine 
kinase activity. Tyrosine kinase activity as an integral aspect of a 
normal cellular component was first identified in the epidermal growth 
factor (EGF) receptor (69) and has since been identified in the recep-
tors for the platelet derived growth factor receptor (70), the insulin 
like growth factor I receptor (71) and as mentioned above, the insulin 
receptor. 
The tyrosine kinase activity of the insulin receptor has been 
well-characterized and has been identified in numerous tissues (Table 
3). The initial characterization of the skeletal muscle insulin re-
ceptor was carried out as part of this dissertation (Ref. 72) and the 
data is presented in Chapter 3. The autophosphorylation event is seen 
in both the intact tissues as well as in the detergent solubilized 
system (62,63) and occurs on the ~-subunit which also contains the ATP 
binding site of the receptor (80,81). Eviden·ce that the ~-subunit is 
the actual moiety that carries out the phosphotransferase reaction comes 
from the experiments of Roth et al. (42) who preferentially digested the 
~-subunit of the insulin receptor and showed while binding remained 
intact the ability of the solubilized receptor to act as a kinase was 
eliminated. In the solubilized receptor the autophosphorylation is 
stimulated by insulin binding, is ATP dependent, requires Mn++ of Co++ 
cations and occurs almost exclusively on tyrosine residues (76). Avruch 
et a1. (76) have shown that the autophosphorylation event parallels 
insulin receptor occupancy and is saturated when insulin binding is 
saturated. In an elegant series of experiments White et al. (82) showed 
that insulin's effect on the reaction is to increase the Vmax while the 
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required cation reduces the Km. Using High Performance Liquid Chroma-
tography (HPLC) to separate peptides generated by trypsin digestion of 
the autophosphorylated receptor, this group showed that the solubilized 
receptor contained approximately 5 sites that were phosphorylated in 
response to insulin. Using a similar system Yu and Czech (78) identi-
fied 3 sites on the ~-subunit that was labeled by y[ 32p]ATP in response 
to insulin. 
In addition to its ability to autophosphorylate, the insulin re-
ceptor, in the solubilized system, has an insulin stimulatable exogenous 
substrate kinase activity. First identified by Rosen et ale (83) a wide 
variety of substrates have been identified for the tyrosine kinase of 
the solubilized insulin receptor system (Table 4). While many of these 
substrates are obviously not possible intracellular targets of the 
insulin receptor, they serve as useful tools in examining the exogenous 
substrate kinase activity of the insulin receptor. The identification 
of physiologically relevant intracellular targets for the insulin re-
ceptor has been elusive. The activation of the exogenous substrate 
kinase activity of the insulin receptor is dependent on the autophosphory-
lation of the insulin receptor ~-subunit (78,84) and is thought to be 
due to the phosphorylation of a specific tyrosine residue on the insulin 
receptor ~-subunit (78). The cation requirement of the exogenous sub-
strate kinase activity is complex and seemingly depends upon the sub-
strate, thephosphoacceptor, as well as on the concentration of ATP used 
in the kinase reactions (90,91). As expected from their similarity in 
structure and function, the properties of the EGF receptor and the IGF I 
receptor associated kinases are very similar to those of the insulin 
receptor (Table 5). 
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In the intact cell, the observed insulin stimulated autophosphory-
lation of the insulin receptor p-subunit is different than that seen in 
the solubilized system. The formation of phospho-tyrosine, serine and 
threonine is observ.ed in the immunoprecipitated insulin receptor p-sub-
unit after insulin stimulation. Recently it has been shown that the 
labeling of the serine and threonine residues are likely due to other 
kinases, distinct from the insulin receptor, and the initial autophos-
phorylation events occur almost exclusively on tyrosine residues (92). 
In this same report it was demonstrated that insulin receptors that were 
phosphorylated on serine residues prior to insulin binding were poorly 
labeled on tyrosine subsequent to insulin binding. This was done by 
first preCipitating the solubilized proteins from the labeled cells with 
anti-phosphotyrosine antibodies and then preCipitating with anti-insulin 
receptor antibodies. Within seconds after tbe exposure of the cells to 
insulin, the proteins that were precipitated with the anti-phospho-
tyrosine sera were almost exclusively labeled on tyrosine with the 
content of phospho serine and phoshhothreonine increasing with longer 
incubations. On the other hand the receptors precipitated with anti-
insulin receptor serum after the first immunoprecipitation were labeled 
almost exclusively on serine residues. 
The modulation of insulin receptors by serine phosphorylation was 
directly demonstrated by White et a1. (93) wherein treatment of hepatoma 
cells with the phorbolester 12-0-tetradeconoyl phorbol acetate (TPA) 
resulted in decreased phosphorylation of the insulin receptor on tyro'" 
sine residues upon exposure to insulin. It had previously been shown 
(94) that the treatment of lymphocytes with TPA resulted in a decrease 
in insulin receptor affinity. It is interesting to note that Pessin and 
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Czech (95) have recently reported that the treatment of fat cells with 
isoproterenol (a ~-adrenergic agonist) greatly reduces the affinity of 
insulin receptors for insulin and in a preliminary report Czech has 
stated that this treatment decreases the ability of the insulin receptor 
to autophosphorylate (62) possibly due to the cAMP mediated phosphory-
lation of the insulin receptor. It has been previously demonstrated 
that cAMP mediated hormones have the ability to phosphorylate the EGF 
receptor (96). 
White et a1. (97) compared the sites of autophosphorylation on the 
insulin receptor ~-subunit in the intact cell as compared to the solu-
bilized receptor. In the hepatoma cell line employed insulin was able 
to induce the autophosphorylation 3-4 fold. The increase in labeling 
occurred on all the phospho-accepting amino acids. Time course analysis 
showed that the stimulation of tyrosine phosphorylation was at steady 
state after 20 sec and that no change in the amount of phosphoserine or 
phosphothreonine occurred during this initial stage of autophosphory-
lation. The phosphotyrosine content of the receptor remained constant 
for one hour. Two in vivo sites of tyrosine phosphorylation on the 
~-subunit were autophosphorylated, one minor site corresponded to the 
major site seen in vivo, while a major site seen in the in vitro system 
was a minor site observed in vivo. One of the sites autophosphorylated 
in the solubilized system did not occur in the whole cell labeling 
experiments. This report points out that while there are similarities 
in the tyrosine autophosphorylation event in the intact cell and in the 
solubilized system, there are also differences that could make interpre-
tation of experiments performed in vitro difficult. 
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INSULIN RESISTANCE: This dissertation is concerned with the role 
of the insulin receptor in insulin resistance. As seen in the above 
discussion, the insulin receptor is a complex molecule that has two 
domains, a binding domain which presumably lies in the a-subunit, and a 
kinase domain which lies in the ~-subunit. It is not then surprising 
that pathologies exist that show alterations in one or another of these 
functional domains of the insulin receptor. 
Flier (98) has defined insulin resistance as "a state in which a 
given concentration of insulin produces less than the expected 
response". Two experimentally defineable endpoints of insulin action 
can be used to quantitate insulin resistance, (a) the dose of insulin 
that produces half-maximal response and (b) the maximal effect 
achievable with the hormone. Kahn (99) has proposed that an alteration 
in the dose to give half maximal effect is defined as a change in 
sensitivity whereas a change in maximal achievable effect is a change in 
responsiveness. 
A wide variety of physiological and pathological states exist which 
manifest themselves, at least in part, with alterations in the insulin 
receptor (Table 6). The most common alteration of the insulin receptor 
is down-regulation that occurs in the hyperinsulinemic state. With 
chronic exposure to insulin in the plasma, the number of insulin re-
ceptors decreases on the cell surface without an apparent change in the 
affinity of the insulin receptors which remain. Using lymphocytes this 
decrease in insulin receptor number was shown to be due to an increase 
in the rate of degradation with no alteration in the rate of synthesis 
(100). This is a common occurence and is a major part of the insulin 
resistance which is seen in obesity. 
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Experimental studies with obese animals have shown that all tissues 
respond to hyperinsulinemia with a decrease in receptor numbers and that 
the decrease is proportional to the degree of hyperinsulinemia (101). 
This decrease in insulin receptors, by mass action should only result in 
a shift in the dose response curve i.e. a decrease in sensitivity. 
However, in adipocytes there also develops a decrease in responsiveness. 
The nature of this defect is unclear but experiments directed towards 
understanding this phenomenon have recently been carried out by Garvey 
et al. (102). They showed that concommittant with a decrease in surface 
insulin receptors in adipocytes chronically exposed to insulin there 
occurred a decrease in the number of surface glucose transporters. 
These "co-down-regulated" transporters could not be recruited to the 
cell surface upon further stimulation of the adipocytes with insulin. 
This suggests that in the case of glucose transport the mechanism of 
down-regulation of the receptors is related to the insulin resistance 
seen in these cells. The relationship of down-regulation and defects in 
intracellular glucose metabolism is still to be determined. 
In many patients obesity is associated with the development of 
non-insulin dependent (type II) diabetes. These patients have fasting 
hyperglycemia and normal or high fasting insulin levels that are sub-
normal after the administration of an oral glucose load (103). These 
subjects have approximately the same degree of impairment of insulin 
binding as compared to obese individuals but a greater defect in insulin 
action thus the appearance of overt diabetes (104). That fibroblasts 
from obese type II diabetics bind and respond to insulin normally after 
culturing (105) suggests that the defect is due to an alteration in the 
metabolic milieu of the subject rather than a genetically defined defect 
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expressed constitutively in all cells. 
A rare subset of patients with severe insulin resistance have a 
defect in the action of insulin at the cellular level. Characterized as 
a syndrome with virilization, polycystic ovaries and acanthosis nigri-
cans, most of these patients have a genetic defect in the structure of 
the insulin receptor which results in defective insulin binding (106) or 
decreased or eliminated insulin receptor kinase activity (73,107). This 
has been deSignated the Type A syndrome of insulin resistance. Patients 
with Type B syndrome exhibit the acanthosis nigricans and rheumatic type 
symptoms but not the virilization of the Type A patients and are charac-
terized by a high titer of anti-insulin receptor antibodies (106). 
There has also been described a defect in the action of insulin in 
insulinopenic diabetes mellitus (Type I diabetes). A discussion of this 
problem and our experiments in trying to understand this is contained in 
Chapter 5 of this dissertation. 
DENERVATION INDUCED INSULIN RESISTANCE: Patients with peripheral 
neuropathies or paralysis often have glucose intolerance (108,109). In 
early work from this laboratory, it was shown that the glucose intoler-
ance could come from an alteration in the ability of skeletal muscle to 
respond to insulin. Buse and Buse (110) showed that in the absence of 
insulin there was no change in xylose uptake of denervated diaphragms 
but the response of the denervated diaphragms to insulin was signifi-
cantly less than controls. This effect was seen within twelve hours 
after denervation. Using relatively unrefined techniques there was no 
demonstrable change in insulin binding to the denervated muscle. In a 
later report it was shown that in addition to decreased hexose trans-
port, the denervated diaphragm was also resistant to insulin stimulated 
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accumulation of glycogen (111). Recently, numerous reports have ap-
peared in the literature investigating the effects of denervation on 
glucose and protein metabolism in the denervated skeletal muscle (112-
118). Our own efforts in this regard have been published (118) and are 
contained in Chapter 2 of this dissertation. 
Our observations and those of others on ,the insulin resistance of 
skeletal muscle following denervation can be summarized as follows: 1) 
The ability of skeletal muscle to transport glucose, both basal and 
insulin stimulated, is decreased and a change in both sensitivity and 
responsiveness is observed. 2) There is a decrease in basal and insulin 
stimulated glycogen synthesis. 3) As expected, due to decreased glucose 
transport, there is a decrease in glucose-6-phosphate levels. 4) There 
is a decrease in the active form of glycogen synthase and a decrease in 
the activation by insulin which is independent of the decrease in glucose-
6-phosphate concentration. 5) There is an impairment of pyruvate dehydro-
genase activity. 7) Both fast twitch, white and slow twitch, red skele-
tal muscle are affected. The effect of denervation has been seen in the 
soleus, diaphragm, extensor digitorum longus, the levator ani, and the 
epitrochlearis muscles. 8) Even with the severe insulin resistance 
there is no apparent effect of denervation on the muscles' ability to 
respond to epinephrine as assessed by a decrease in glycogen synthesis 
and increase in glycogenolysis in response to epinephrine. 
Identical results have been observed in the immobilized muscle 
(119,120). In this latter case it should be noted that the electromyo-
genic activity of immobilized muscles drops to 15-20% of control levels 
and thus, is v.ery similar to the denervated state. Using the immo-
bilized muscle system, Butler and Booth (121) saw a decrease in the 
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basal rate of protein synthesis in the extensor digitorum longus and the 
soleus muscle after 24 hrs but did not observe any impairment of insulin 
stimulated increase in the rate of synthesis, although in absolute terms 
the immobilized leg still synthesized significantly less protein than 
the contralateral control muscle. This raises the interesting possi-
bility that the pathway leading to an alteration in glucose transport 
and intracellular metabolism, thus the differences in the two system's 
respon.se to denervation. 
In contradistinction to the decrease in action of insulin on dener-
vated skeletal muscle the exact opposite is true of exercised muscle. 
There is an apparent insulin-like effect of exercise on glucose trans-
port (122). In addition to increasing the basal state of these activi-
ties (which apparently can occur in the absence of insulin (125), exer-
cise also increases the sensitivity of muscle to insulin (122-124). 
Changes which occur in the membrane of denervated skeletal muscles 
may have some bearing on the insulin resistance. There is a rapid 
appearance of extra-junctional acetylcholine receptors (126,127) which 
is due to an increase in the transcription of a subclass of these re-
ceptors (128). There is an increase in phospholipid turnover but no 
change in the total content of phospholipids (129). The membrane 
content of glycoproteins are increased as assessed by concanavalin A, 
ricin, and wheat germ agglutinin binding (130). The activities of 
sialyl-galactosyl- and N-acetylglucosaminyltransferases in the sarco-
lemmal fraction was increased while there was a decrease in fucosyl-
glucoprotein transferase. The changes wer~ observed to be due to an 
increase in the Vmax of the enzyme with no change in affinities. There 
is no change in the membrane associated Na/K ATP ase activity seen after 
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denervation (130), however, a decrease in the resting membrane potential 
of denervated muscles has been described (131). 
Even with these alterations in the membrane of skeletal muscle 
after denervation, there has been no observable change in insulin bind-
ing to its receptor after denervation that could account for the severe 
insulin resistance (114,118,132). Thus, two groups have suggested that 
the insulin resistance be classified as a 'post receptor' defect 
(114,132). This may have been premature considering the above mentioned 
cases of normal insulin binding associated with severe insulin resis-
tance and defects in the insulin receptor kinase activity. Studies 
investigating the possible alteration in activation of the insulin 
receptor kinase in denervated skeletal muscle are contained in Chapter 4 
of this dissertation. 
In summary, the mode of insulin action is unknown but the effects 
of insulin on many systems affected by insulin treatment are beginning 
to be well characterized. These include the glucose transport system, 
the various phosphorylation-dephosphorylation cascades and the insulin 
receptor associated tyrosine kinase activity. Inroads are also being 
made in elucidating the mechanism of various insulin resistant states 
(i.e. obesity, Type A and Type B syndromes of insulin resistance) and 
into the structural characteristics of the glycoprotein insulin re-
ceptor. In this dissertation I present data on the role of the insulin 
receptor and associated kinase activity in two models of insulin resis-
tance. In Chapter 2 I present the characterization of the insulin 
resistance seen shortly after denervation. In Chapter 3 I present a 
method that was developed for the purification of functionally active 
insulin receptors from skeletal muscle. In Chapters 4 and 5 this method 
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was used to investigate what, if any, role the insulin receptor plays in 
the insulin resistance seen in denervated skeletal muscle and in 
diabetic skeletal muscle from rats with insulinopenic diabetes. 
TABLE 1. Taken from Reference 63.' 
froposed second messengers for insulin 
action 
Cyclic nucleotides (cA~'lP. cGMP) 




Dt!gradation fra~menls of insulin 
Peplidcs of membrane or,~in that modify protein 
kinases and alter phosphorylatIon 
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TABLE 3 
Tissues and Cells where Insulin Receptor and 
Associated Kinase Have Been Identified 
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---------~-------~-~-----------~-~-~~-~--~-~-----~---~-------~-----~----
Tissue or Cell Species Reference 
Fibroblasts Human 73 
Erythrocytes Human 73 
Lymphocytes Human 74 
Monocytes Human 75 
Placenta Human 76 
Skeletal Muscle Rat 73 
Liver Rat 77 
Adipocyte Rat 78 
Brain Rat 79 
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TABLE 4 























TABLE 6. Taken from Reference 63.l 
Alterations in insulin receptors in disease states 
Receptor number 
Type II diabetes mellitus 
Obesity 
Uremia 




Lipoatrophic diabetes (some) 
Lcprechaunism (some) 
Growth hormone excess 
Insulinoma 
Obese-72 he fast 
Lipoatrophic diabetes (some) 
Leprechaunism (some) 


















FIGURE 1. Taken from ~ference 621 
Proposed structural features of the heterotetrameric insulin receptor complex. 










FIGURE 2. TAKEN from Reference 58.1 
Schematic comparison of insulin and EGF receptor~. 
Regions of high Cys-residue concentration are shown as hatch~d 
boxes, transmembrane domains as black boxes and ~ingle cysteine 
residues, possibly involved in formation of the Q2-i32 insulin recep-
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CHAPTER II: INSULIN RESISTANCE OF DENERVATED. RAT MUSCLE: 
A MODEL FOR IMPAIRED RECEPTOR-FUNCTION COUPLING 
Glucose metabolism and insulin response of skeletal muscle is 
profoundly affected by antecedent activity. In animals and hwnans, 
depleted glycogen stores are rapidly replenished after exercise to 
levels that exceed resting values. This phenomenon, termed supercompen-
sation, involves activation of glycogen synthase (1). Richter et ale 
(2) observed that prior exercise lowered the insulin-dose required for 
half-maximal stimulation of glucose transport and glutose utilization by 
skeletal muscle, suggesting that at least one of the mechanisms is 
enhanced insulin sensitivity. On the other hand, when muscles were 
denervated (3,48) or immobilized (5) for 24 hrs before experiments, 
their subsequent response to insulin was markedly impaired. Others 
reported that the impaired insulin response required 3 days of denerva-
tion (6). Early studies from this laboratory (3,4) using hemidiaphragms 
1-7 days after cutting the phrenic nerve suggested that denervation 
impaired the response to insulin without affecting insulin binding. 
However, at that time methods for assessing insulin-receptor interac-
tions were relatively unsophisticated. Since short-term denervation and 
immobilization affected the insulin responsiveness of muscles similarly 
(3-5), we felt that muscles studied early after denervation may serve as 
useful models to elucidate how work and/or nervous stimuli modify the 
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insulin receptor or its coupling to the glucose transport and glycogen 
synthase system. We addressed the following questions: a) Does short-
term denervation affect primarily insulin binding or coupling of the 
receptor to intracellular events; b) is there decreased insulin sensi-
tivity and/or impaired maximal response, c) are glucose transport and 
glycogen synthesis affected in parallel, d) are red and white muscles 
similarly affected by denervation? Our results indicate that 24 hours 
after denervation, specific insulin binding to muscles is minimally 
decreased, while insulin sensitivity and response of glucose transport 
and glycogen synthesis are markedly impaired, suggesting that in red and 
white muscles, contractile activity and/or nervous stimuli are needed 
for efficient coupling of the insulin receptor to intracellular re-
sponses. 
MATERIALS AND METHODS 
Denervation and muscle preparation. Male Wistar rats (50-100 g) 
were purchased from Charles River Breeding Laboratories (Wilmington, 
Mass.). One hind limb was denervated under methoxyflurane (Metofane, 
Pitman-Moore, Inc., Washington Crossing, N.J.) anesthesia via a small 
incision in the posterior aspect of the upper thigh 6 or 24 hrs before 
experiments. A small section (approx. 3mm) of the sciatic nerve was 
removed and the incision closed with a stainless steel clip. Rats were 
either allowed food and water ad libitum or food was withheld for 24 hrs 
before experiments. 
Rats were killed by decapitation and the soleus and/or extensor 
1 digitorum longus (EDL) were dissected free, split in half longitu-
dinally, rapidly weighed and placed either directly into 30% KOH for 
measurement of tissue glycogen or attached to stainless steel clips, 
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care being taken to attach muscles at in vivo resting length. Muscles 
were removed within 2 min. after decapitation and the time required 
between killing the animal and start of incubation was 4-5 min. 
Following decapitation, spontaneous muscle contractions were observed in 
non-denervated legs; the rapid removal of the muscles was aimed at 
minimizing their metabolic effects. 
Muscle incubation. Gey and Gey's balanced salt solution (7) 
(bicarbonate buffer), pH 7.4 containing 5 roM glucose or 2 ruM pyruvate as 
indicated, gas phase 95% 02 + 5% CO2 was used in all experiments. 
Bovine serum albumin, 1mg/ml, was included in all media except where 
indicated in Methods. In insulin binding studies higher concentrations 
of albumin (10 mglml) were used. Muscles were incubated with shaking 
(80 cycles/min.) at 37°C, except for insulin binding studies which were 
carried out at 25°C to minimize insulin degradation (8). 
Glycogen synthesis. Muscles were pre-incubated for 30 min. in 2 rol 
medium containing 5 roM glucose, with or without insulin at the doses 
indicated, then transferred to identical media supplemented with 
[UI4C]glucose (SmM, 0.2J,JCi/ml) and incubated for 1 hr. In experiments 
testing epinephrine responsiveness all media contained 5 roM glucose and 
1 mg/ml ascorbic acid; after 30 min. preincubation in this medium the 
muscles were transferred to media supplemented with [U14C]glucose with 
or without epinephrine (10-9 - lO-6M) and incubated for 60 min. 
[14C]glucose incorporation into glycogen was assessed by two 
methods which yielded identical results. The first method was used in 
initial experiments, the second was adopted to allow the simultaneous 
measurement of tissue glycogen. In the first method (2) muscles were 
digested in O.Sml 1 N NaOH containing 20 mg/ml oyster glycogen to which 
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1 ml absolute ethanol was added and glycogen was allowed to precipitate 
at -80°C overnight. The precipitate was centrifuged and washed twice 
with 1 ml 66% ethanol, dissolved in 0.5 ml H20 and an aliquot counted in 
Scintiverse scintillation cocktail (Fisher Scientific) in a Beckman 
LS-7000 J3-scintillation counter. In the second method (10), muscles 
were digested in 0.5 mI 30% KOH and glycogen preCipitated by the 
sequential addition of SO ~l 10% Na2S04 and 1 ml absolute ethanol and 
cooled at -20°C for 1 hr. The precipitate was washed twice by 
sequential addition of O.Sml 30% KOH and 1 mi absolute ethanol, 
dissolved in 0.75 ml 4 N H2S04 and an aliquot counted in Scintiverse. 
Dpm in muscle glycogen was related to the specific activity of the 
medium, and expressed as nmol of glucose incorporated/mg tissue. No 
change in muscle weight was observed within 24 hrs after denervation, in 
either fed or fasted animals. 
Glycogen content. Glycogen extracted by the second method (37) was 
hydrolysed in 4 N H2S04 at lOQoC for 2 hrs. The solution was neutral-
ized with 4N NaOH and glucose assayed by the glucose oxidase method. 
Glycogen recovery was greater than 95%. Values were expressed as 
glucose equivalents, nmol/mg wet weight. 
2-deo?cyglucose uptake. Muscles were preincubated for 30 min. in 
buffer containing 2 roM pyruvate with or without insulin at varying 
concentrations, then transferred to identical media supplemented with 
3 14 0.1 or 5 roM [ H]2-deoxyglucose (0.5 ~Ci/ml) and 0.1 mM [ C]sucrose 
(0.2 ~Ci/ml). After 15 or 30 min. incubations (with 5 and 0.1 mM 
2-deoxyglucose respectively) the muscles were extracted for 10 min. in 1 
ml of boiling water (11). Aliquots of the incubation media and of the 
tissue extracts were courited as described above. In preliminary 
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Glycogen synthase assay. Half-solei or EDL were preincubated for 
15 min. in buffer containing 2 ruM pyruvate without albumin then 
transferred to identical media, except for the presence of 10 mU/ml 
insulin in alternate vials. After 30 min. incubation the individual 
muscles were frozen in liquid nitrogen, placed in a precooled Potter-
Elvejhem homogenizer and crushed in 1.2 ml of Tricene buffer (25 roM) 
containing 50 roM KF; 20 roM EDTA; 1 mg/ml glycogen and 10% w/v glycerol 
pH 7.1 at 4°C. The frozen slurry waS homogenized as it thawed and the 
mixture placed in 1.5 ml microfuge vials and centrifuged at 15,OOOXg for 
5 minutes in a Fisher Model 235 microcentrifuge at 4°C. The supernate 
(30 ~l) was assayed for glycogen synthase activity by the method of 
Thomas et ale (13) as modified by Kochan et ale (14) using 0.075 roM 
[3H]UDP-glucose (6.75 Ci/mole) as the final substrate concentration. 
The reaction was run for 10 min at 30°C in 90 ~l final volume in the 
absence or presence of 100 or 1000 ~M G-6-P; the latter concentration of 
G-6-P resulted in complete activation of the enzyme. Results are ex-
pressed as activity ratio (-G-6-P/+I000 ~M G-6-P) and as fractional 
velocity (+100 ~M G-6-P/IOOO ~M G-6-P) (14). In some experiments the 
assay was also performed using 4.4 rnM UDP-glucose at pH 7.8, without or 
with increasing concentrations of G-6-P up to 10 mM (13). 
The low (0.075 roM) 3[H]UDP-glucose concentration in the assay was 
selected based on considerations discussed (1,15), indicating that the 
assay becomes more sensitive to changes in the phosphorylation state of 
the enzyme when subsaturating concentrations of UDP-glucose are used. 
With respect to muscle pretreatments (e.g. denervation and insulin) we 
obtained qualitatively identical results in solei with low or high 
substrate assays although baseline activity ratios were higher in the 
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latter system. Studies in EDL were done only with the low UDP-glucose 
concentration. The data presented are those obtained with 0.075 IBM 
UDP-glucose, except for assays of total enzyme activity, where both 
measurements are shown; the total activity measured with 4.4 mM UDP-
glucose represents Vmax (IS). 
Total enzyme activity was measured as UDP-glucose incorporation 
into glycogen during incubation with 1 or 10 mM G-6-P and related to the 
protein concentration.. Maximal enzymatic activity was observed with 
1 mM G-6-Pin the low s.ubstrate assay and with 10 mM in the high 
substrate assay. The assay was linear with time for 15 min, UDP-glucose 
was depleted less than 10% during either assay.. Protein was measured by 
the method of Lowry et ale (16) against bovine serum albumin standards. 
Insulin Binding. Monocomponent porcine insulin was labeled with 
1251 by the lactoperoxidase method to a specific activity of 100-
200mCi/mg and was purified before each experiment as previously 
described (17) by adsorption to and elution from a Whatman CF11 
cellulose column. Before use 1251-insulin was 99% precipitable with 
t . hI t- "d (TCA) 1251 , 1" b" d" d b th rlC oroace 1C aC1 . . -lDSU 1D In lng was measure y e 
method of LeMarchand-Brustel et al .. (23). Briefly,muscles were 
preincubated for 30 min. at 25°C in 3 ml buffer containing 2 roM pyruvate 
and 10 mg/ml bovine serum albumin; the muscles were then transferred to 
vials containing the same buffer supplemented with 0.135 ~Ci/ml 1251_ 
insulin and increasing concentrations of non-labeled insulin and incu-
bated for an additional 2 brs. The muscles were then washed with 5 ml 
0.9% NaCl containing 5 mg/ml albumin at 4°C for 15 min three times, 
digested in 1 N KOHand counted in a Beckman Gamma 4000 SCintillation 
counter. Non-specific binding was estimated in the presence of 50 IJg/ml 
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unlabelled insulin and was subtracted from all measurements to calculate 
specific binding. Non-specific binding was typically 30-40% of total 
b · d" . h f 1 Th d d" f 125 I" 1 . 1n 1ng 1n t e presence 0 tracer on y.e egra atlon 0 -1nsu 1n 
in the medium during 2 hrs. incubation was 5-7% as assessed by TCA 
precipitation. 
Although this insulin binding assay was originally developed for 
mouse soleus muscles (8) it has been adapted with various modifications 
(6,18) to rat solei. We found the hemisected soleus of young rats 
(muscle weight 17.2 ± 0.5 mg, n = 128) to be suitable for the assay. 
Experiments varying the time of incubation with 125I-insulin between 1 
and 3 hrs at 25°C indicated that most of the specific insulin binding 
occurred during the first hour of incubation; with gradual smaller 
increases thereafter. After 2 hrs incubation, specific binding was 80% 
of that observed at 3 hrs .. , although the difference between binding at 2 
and 3 hrs was not statistically significant. Concommitantly the % of 
degraded insulin in the medium increased significantly (p < 0.001), 
reaching 15% of total in some experiments. The 2 hrs. incubation time 
was selected as a compromise between the achievement of binding equili-
brium and minimizing insulin degradation. When muscles were homogenized 
. 6°1 TCA f . b· .. h 125 1 . 1 . ( 1 50 / 1) f 1 2 1D * a ter 1ncu at10n w1t -1nsu In ng or ~g m or, 
or 3 hrs~ followed by 45 min. washing at 4°C as described above, it was 
found that 85 ± 1% (n = 12) of the muscle associated radioactivity was 
TCA precipitable at 2 hrs. The respective values after 1 and 3 hrs. 
incubation were 86 ± 1 and 83 ± 1.5. Because the fraction of TCA solu-
ble radioactivity associated with the muscles appeared constant and 
relatively small and the additional manipulations involved in homogeniz-
ing, precipitating and washing with TeA may introduce errors of similar 
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magnitude in the measurements the TCA prec~pitation step was not 
routinely applied. 
Time course experiments as described above were run in parallel 
using control and denervated solei of rats 24 hrs. after unilateral 
denervation. There was no significant difference in the time course of 
specific or non-specific insulin binding or in the rate of insulin 
degradation (assessed by muscle associated TCA precipitable 
radioactivity) between control and denervated solei. 
Materials. Monocomponent porcine insulin was a gift from Dr. 
Ronald Chance, Eli Lilly Co. (Indianapolis, Ind.) Na I2S ! (carrier 
free), [1_3H]UDP-glucose, D-[U_14C]glucose, [1,2-3H]2-deoxy-D-glucose, 
and [U_1 4C]sucrose were purchased from New England Nuclear (Boston, MA). 
Oyster glycogen, bovine serum albumin (Fraction V), and 1(-) 
epinephrine(+)bitartrate were from Sigma (St. Louis, MO). 
Lactoperoxidase beads were from Bio-Rad Laboratories (Richmond, CAl and 
glucose-6-phosphate dehydrogenase (Type XII) from Boehringer-Mannheim 
(Indianapolis, IN). Stainless steel clips (Autoclips) and Scintiverse 
were purchased from Fisher Scientific Co. (Pittsburgh, PA). 
Statistical Analysis. Data are presented as Mean ± SE. Statis-
tical analysis was performed by paired or unpaired Student's t test 
where appropriate. 
RESULTS 
Glycogen Synthesis. Fig. lA illustrates the insulin dose response 
curves of intact and denervated solei, isolated following a 24 hr fast 
and 24 hrs after cutting one sciatic nerve. Control muscles showed a 
three-fold stimulation of [14C]glucose incorporation into glycogen in 
response to physiological concentrations of insulin (50 J-JU/ml) .. 
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Denervated solei synthesized less glycogen than controls in the absence 
of insulin (p < 0.01). While insulin at concentrations of 250 IJU/ml or 
greater caused a significant stimulation of glycogen synthesis in 
denervated solei, both the relative stimulation C% of baseline) and the 
absolute increment over baseline (~ insulin) were significantly smaller 
in denervated than control solei, e.g. maximal rates of glycogen 
synthesis in the presence of 500 IJU/ml insulin were five-fold greater in 
control than denervated muscles. The insulin dose required for ~ 
maximal stimulation was - 30 IJU/ml in control muscles and - 100 IJU/ml in 
their denervated pairs. Increasing the insulin concentration to 2.5 and 
5 mU/ml failed to cause further stimulation in intact or denervated 
muscles (data not shown). 
Similar results were obtained in rats fed ad libitum (Fig. 1B). 
Although basal rates of glycogen synthesis were lower in 24 hr 
denervated solei, they were not significantly different from controls. 
Insulin (500 ~U/ml) increased glycogen synthesis four-fold in control 
solei, while no significant stimulation was observed in their denervated 
pairs up to 1 mU/ml, the highest dose tested. 
The impaired insulin response was already detectable 6 hrs after 
denervation using rats fed ad lib (Fig. Ie). Stimulation of glycogen 
synthesis by insulin in control solei was less than that observed in the 
preceding studies (Fig. 1A and IB), which may be attributed to the 
relatively recent stress of anesthesia and surgery_ Basal rates of 
glycogen synthesis were identical in denervated and control solei, while 
stimulation by insulin was greater (p < 0.05-0.01) in controls than in 
denervated muscles at all insulin concentrations tested. The lowest 
dose of insulin tested (100 ~U/ml) was ineffective in denervated 
muscles, while it caused 70% of apparent maximal stimulation in 
controls. 
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We used the non-denervated contralateral leg as control, to 
minimize rat to rat variation, and expose the denervated and control 
limbs to the same nutritional and hormonal milieu. In preliminary 
experiments we compared glucose incorporation into glycogen by non-
denervated solei of unilaterally denervated rats 24 hrs. after operation 
to those of sham operated controls and found no difference in either 
basal or insulin stimulated glycogen synthesis (data not shown). 
Soleus muscle contains predominantly slow-twitch red fibers (19). 
To determine whether or not insulin resistance after denervation 
occurred in a muscle with predominantly fast-twitch white fibers (19), 
EDL muscles were studied 24 hrs after unilateral denervation (Fig. 2). 
Control EDL appeared to be less responsive to insulin than solei; and 
this was particularly apparent in muscles obtained from fed rats. Such 
differences in insulin responsiveness between red and white muscles have 
been reported (20). Basal rates of glycogen synthesis were lower in 
denervated EDL than in their control pairs (p < 0.01) in fed and in 
fasted rats. The most significant finding was that while insulin 
stimulated glucose incorporation into glycogen ~2 fold in control EDL, 
insulin was completely ineffective in their denervated pairs, in both 
fed and fasted rats. 
Effect of denervation on the uptake of 2-deoxyglucose. Resistance 
of glycogen synthesis to stimulation by insulin could represent the 
inability of insulin to stimulate the transport of glucose and/or a 
block in a subsequent reaction e.g. phosphorylation of glucose or 
activation of glycogen synthase. 2-deoxyglucose uptake was measured to 
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assess the response to insulin of the glucose transport system, since 
this analogue enters muscle on the same transporter as d-glucose, and 
upon entry is phosphorylated to 2-deoxyglucose-6-P04 but not further 
metabolized. The analogue was tested at 0.1 and at 5 roM concentrations 
in the medium. Pyruvate was substituted for glucose ,as an energy 
source, to avoid competition of glucose with the labelled analogue for 
the transport system. 
The highest dose of insulin tested (1 mU/ml) increased 
2-deoxyglucose uptake 2-fold in control solei of fasted rats during 
incubations with 0.1 roM or with 5 mM 2-deoxyglucose (Fig .. 3A and 3B). 
Their denervated pairs showed decreased uptake in the absence of 
insulin, as well as decreased insulin sensitivity (p < 0.01) when 
incubated in the presence of either 0.1 mM or 5 mM 2-deoxyglucose. 
While a complete dose-response curve was not obtained decreased insulin 
sensitivity in denervated solei is suggested by the fact that - 40 IJU/ml 
insulin was required for ~ maximal stimulation of 2-deoxyglucose uptake 
in control muscles, while only the highest dose tested (1000 IJU/ml) 
caused a significant stimulation in denervated solei. With 0.1 roM 
2-deoxyglucose the maximal insulin response over baseline (~ insulin) 
was not significantly different between control (83 ± 15nmol/g/30 min) 
and denervated muscles, (60 ± 16nmol/g/30 min). After 15 min. 
incubation in 5 roM 2-deoxyglucose the increment in 2-deoxyglucose uptake 
induced by 1 mU/ml insulin was significantly greater in controls than in 
denervated solei, (1150 ±224 vs. 310 ±186nmol/g/15 min., p < 0.01). 
Hexokinase activity did not appear to be limiting 2-deoxyglucose 
uptake by denervated solei,since the ratio of2 .... deoxyglucose-6-P04/ 
[free + phosphorylated 2-deoxyglucose] in the intracellular compartment 
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was essentially identical in intact and denervated muscles. In all 
experiments more than 80% of the intracellular analogue was in the 
phosphorylated form (Fig. 3C and 3D). 
Denervation for 24 hrs affected 2-deoxyglucose uptake in EDL 
muscles similarly to solei (Table 1). Using 5 roM 2-deoxyglucose insulin 
sensitivity and insulin response were significantly decreased. In 
control muscles 50 JJU of insulin caused near maximal stimulation, while 
this dose was ineffective in their denervated pairs. 1000 ~U stimulated 
2-deoxyglucose uptake by denervated and control EDL but the response of 
denervated muscles was smaller than that of the controls (p < 0.01). 
Basal uptake was lower than that of controls, although the difference 
was not significant. 
Glucose-6-phosphate content was measured in control and 24 hr 
denervated solei of fasted rats following incubations in 5 mM glucose 
identical to those used in studies of glycogen synthesis. Since 
phosphorylation at C-6 is the first and obligatory reaction for glucose 
metabolism after entry into the cell, impaired glucose transport may 
result in decreased intracellular G-6-P. Following incubation without 
insulin, G-6-P in denervated muscles was 45% lower than in controls 
(p < 0.05). Following incubation with 1 mD/ml insulin, G-6-P increased 
in control muscles more than two-fold (p < 0.01) while there was no 
significant change in their 24 hr. denervated pairs (Table 2). 
Activation of glycogen synthase by insulin. (Table 3) While 
impaired stimulation of glucose transport by insulin could account for 
the observed insulin resistance of glycogen synthesis in denervated 
muscles, the magnitude of the defect suggested that a second step may 
also be involved such as the activation of glycogen synthase by insulin. 
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Total glycogen synthase activity was greater in soleus than in EDL and 
was not affected by 24 hrs denervation in either muscle. The fractional 
velocity of the enzyme was lower in denervated than in control solei 
after incubation without insulin (p < 0.05); while the trend was similar 
in EDL muscles, it was not significant. When solei and EDL were 
incubated with 10 mU/ml insulin both the activity ratio and the 
fractional velocity of glycogen synthase increased slightly (20-30%) but 
significantly (p < 0.05) in control muscles whereas changes were not 
significant in their denervated pairs. 
Glycogen content. The glycogen content of muscles may control the 
rate of glucose transport and glycogen synthesis, possibly through a 
feedback mechanism (2,21). Since work induced glycogenolysis is 
abolished in denervated muscles, they may contain more glycogen than 
controls before incubation. Table 4 shows that this was the case in 
denervated solei, obtained from fed or 24 hr fasted rats. However, in 
EDL the glycogen content of control and 24 hr denervated muscles was not 
significantly different either in the fed state or after a 24 hr fast. 
Since glycogen synthesis and glucose transport in denervated EDL and 
solei was equally resistant to insulin, increased initial glycogen 
content does not appear to be the cause of the insulin resistance. 
Effect of denervation on the binding of insulin (Fig. 4). Specific 
insulin binding by intact and 24 hrs denervated solei of rats fasted 
overnight was studied. In initial experiments half-solei of the intact 
and the denervated leg of 6-9 rats per experiment were randomly 
distributed between media containing increasing concentrations of 
insulin, 3 control and 3 denervated muscles were used in each experiment 
for determination of non-specific binding. Each dose was tested in at 
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least 6 separate muscles. While denervated muscles tended to bind 
slightly less insulin than controls at all concentrations up to 50 ng/ml 
(1.3 mD/ml) using this experimental design differences between control 
and denervated muscles were not significant. In one series of experi-
ments (Insert, Fig. 4) a paired experimental design was used; only one 
dose of insulin was tested (1 ng/ml) and one hemisoleus of each control 
and each denervated leg was used for measurement of non-specific 
binding. The means of 13 paired measurements yielded a significant 
difference (p < 0.05), demonstrating that in the presence of a 
physiological insulin concentration (26 ~U/ml), denervated muscles bound 
30% less insulin than the controls. Scatchard analysis of the data (not 
shown) yielded the classical curvilinear plot reported for insulin 
binding in a number of tissues. The differences in binding between 
control and denervated muscles are not large enough to allow meaningful 
kinetic analyses; the data would be compatible with a small decrease in 
binding affinity or decreased number of high affinity binding sites in 
denervated muscles. 
Effect of epinephrine in denervated muscles. To assess whether or 
not the insulin resistance of denervated muscles extends to other 
hormones we examined the response of control and denervated solei to 
epinephrine in vitro. Two well-characterized effects of the hormone 
served as end points: the ability to accelerate glycogen degradation in 
vitro and to inhibit the incorporation of [
14
C]glucose into muscle 
glycogen (22). 
Intact and 24 hrs denervated solei were removed from ad lib fed 
rats and half-solei incubated with or without increasing concentrations 
of epinephrine (10-9 - 10-6M) in 5 roM [U_
14C]glucose (Fig. 5). The 
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glycogen content of intact and denervated solei was similar following 
incubation without epinephrine. Increasing concentrations of epine-
phrine resulted in progressive depletion of tissue glycogen. The sensi-
tivity and the response of glycogenolysis to epinephrine appeared iden-
tical in control and denervated muscles (Fig. SA). 
As shown previously (Fig. 1), denervated solei incorporated less 
glucose into glycogen during incubation than controls. However, signi-
ficant inhibition by epinephrine was observed with identical doses 
(IO-7M). The highest dose of epinephrine used (IO-6M) decreased glucose 
incorporation into glycogen to approximately 50% of that observed in the 
absence of epinephrine in both intact and in denervated muscles respec-
tively (Fig. SB). 
DISCUSSION 
Short-term denervation affects multiple parameters of glucose 
metabolism in skeletal muscle. We observed diminished incorporation of 
glucose into glycogen, decreased transport of 2-deoxyglucose reduced 
glucose-6-P0
4 
content and decreased activation of glycogen synthase. 
While in many instances these effects were demonstrable without insulin, 
insulin resistance was the most salient characteristic of denervated 
muscles. 
Isolated solei and EDL seemed to be appropriate models for studies 
of insulin responsiveness, since control muscles responded to physio-
logical doses of insulin, and the sensitivity and magnitude of the 
responses were similar to those reported for perfused hindlimbs (2). 
Yet, after 24 hr. denervation, when assessed by glucose incorporation 
into glycogen, solei of fed rats, and EDL of fed and fasted rats showed 
no response to even pharmacological doses of insulin and the response of 
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solei from fasted rats was greatly diminished. Thus, insulin resistance 
after denervation is a feature of both red and white muscles. Whether 
or not the decreased baseline observed in a number of experiments in 
denervated muscles represented an impaired response to endogenous 
insulin which persisted during incubation or an insulin-independent 
deceleration of glucose transport following denervation) needs further 
investigation. Vigorous exercise has been reported to stimulate glucose 
transport in skeletal muscle by an insulin-independent mechanism and the 
effect persists for many hours after the cessation of work (21). 
However, insulin may playa permissive role, since no stimulation of 
glucose uptake is observed when hindlimbs of diabetic rats are exercised 
without insulin in the perfusion medium (23). 
The insulin resistance of denervated muscles seemed to entail both 
decreased sensitivity and impaired maximal response to the hormone. 
This seemed evident in those studies of glucose incorporation into 
glycogen, where a significant response to supraphysiological doses of 
insulin was obtainable in denervated mus·cles (Fig. lA and Ie). In 
studies of glucose transport, the decreased sensitivity to insulin of 
denervated solei was evident using 0.1 or 5 roM 2-deoxyglucose. (Figs. 
3A, 3B, and Table 1). Using 5 mM 2-deoxyglucose a significant 
diminution of the maximal insulin response was also demonstrated in 
denervated muscles incubated with 1 mU/ml insulin (Fig. 3B and Table 1). 
Since this dose exceeds the in vivo physiological range -S-fold, and 
since further increments in insulin concentration were ineffective in 
our in vitro studies of glycogen synthesis, higher doses were not 
tested .. 
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In contrast to the markedly impaired insulin response, we observed a 
small decrease in insulin binding which was demonstrable only in paired 
experiments. Since denervated muscles were resistant to 20-50 fold higher 
doses of insulin than those which elicited maximal response in control muscle, 
it seems likely that the major defect caused by denervation is not decreased 
insulin binding, but a defect in Signal transmittal from the receptor to 
intracellular events. Note however that because of technical considerations, 
insulin bi~ding was measured after longer incubations ata lower temperature 
(25°C vs 37°C) than was used to test metabolic responses; therefore the above 
conclusions need further validation_ Forsayeth and Gould (6) obsetved no 
significant change in insulin binding by solei after 7 days denervation, 
although binding by denervated muscles was slightly lower. The values of 
fmoles insulin bound per mgmuscle in their study and ours are in remarkable 
agreement. 
The results presented here are in essential agreement with our earlier 
studies in denervated diaphragms (3,4) and with a recent study of Forsayeth 
and Gould (19) who reported that in solei, 3-7 days after denervation 
insulin-stimulated sugar transport was inhibited at some early post-receptor 
step. In contrast to the latter study (6), we found that insulin resistance 
develops very early after denervation in muscles, is detectable after 6 hrs., 
and profound at 24 hrs. 
Our results also indicate that 24 hrs after denervation total glycogen 
synthase activity in red and white muscles is unchanged, but there is a 
significant decrease in the enzyme's basal activation state in the soleus as 
well as impaired activation in response to insulin in soleus and EDL. These 
observations differ from those in Ref. 19 but are congruent with a preliminary 
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report of Smith and Lawrence who studied glycogen synthase activity of 
rat diaphragms 24 hrs after denervation (24), and with the reported 
increase in glycogen synthase kinase activity in denervated muscles 
(25). The total glycogen synthase activity of incubated solei measured 
here at saturating substrate concentrations is similar to that reported 
for red vastus lateralis muscles of rats in vivo (14). 
The measured changes in the activity ratio of glycogen synthase 
following incubation of control muscles with insulin were relatively 
small, in view of the marked stimulation of [
14
C]glucose incorporation 
into glycogen by insulin. Similar discrepancies have been noted using 
the perfused rat hindlimb (26) as well as a number of isolated tissues 
(for additional references and theoretical considerations see 14, 15, 
26). Relatively small changes in the activity ratio reflect larger 
changes in the phosphorylation state of the enzyme, the effects of which 
may be magnified under the conditions prevailing in the intact tissue. 
Further optimization of incubation or assay conditions may have yielded 
larger responses. However, since all measurements in denervated and 
control muscles were carried out in parallel, we believe the data 
demonstrate the denervation induced relative insensitivity of glycogen 
synthase to activation by insulin. 
Seider et ale (5) reported severely impaired sensitivity and 
response to insulin in disused mouse solei as assessed by 2-deoxyglucose 
uptake and glucose incorporation into glycogen 24 hrs. after hindlimbs 
were immobilized in a plaster cast. The striking similarity between our 
results indicate that the insulin resistance which develops rapidly 
after denervation is not due to the lack of a "neurotrophic factor" but 
to decreased electromyogenic and/or contractile activity. Note that 
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when solei are immobilized at resting or shorter than resting length, 
their electromyogenic activity decreases to 10·15% of normal resting 
activi ty (27). 
Other changes that occur rapidly in immobilized or denervated 
muscles include an increase in the number of cytosolic cortisol 
receptors (28,29) as well as an increase in the number of extrajunc-
tional acetylcholine receptors (30). We postulated that a denervation 
induced change in membrane fluidity and/or permeability may cause gen-
eralized non-responsiveness of membrane associated hormone receptors. 
This appears not to be the case since epinephrine mediated glycogeno-
lysis in isolated solei was not affected by 24 hours denervation. 
Impaired glucose tolerance with peripheral insulin resistance has 
been demonstrated in healthy humans after one week bed rest (reviewed in 
31) as well as in patients with spinal cord injuries (32) and with a 
number of musculoskeletal disorders. (33). It is tempting to speculate 
that the early morning insulin resistance observed in insulin dependent 
diabetic patients (34) may be related in part to decreased muscular tone 
and activity during sleep. On the other hand, physical activity de-
creases the insulin requirements of diabetic patients (for review see 
35). Antecedent work enhances glucose transport in muscles (21) in-
creases muscle sensitivity to insulin (21,26,35) without affecting 
insulin binding to muscle (36,37) and induces activation of glycogen 
synthase (1). All of these findings taken together suggest that nervous 
stimuli and/or contractile activity regulate the insulin response of 
skeletal muscle, resulting in a continuum of graded responses, which 
include at the two extremes the insulin resistance observed shortly 
after denervation or immob.ilization, and enhanced sensitivity after 
72 
work. Such a mechanism would assure the rapid replenishment of glycogen 
stores after exhaustive work, and spare glucose, by limiting its supply 
to non-working muscles; it appears to operate primarily at the level of 
receptor-function coupling (36,37). The observed inverse relationship 
between insulin response and glycogen levels in control and denervated 
solei would support the proposed negative feedback of muscle glycogen 
content on the insulin response (2,21); however, since severe insulin 
resistance was observed in EDL muscles 24 hrs after denervation without 
a detectable change in glycogen content, it appears that, at least in 
the EDL, glycogen content is not the major regulator of the insulin 
response .. 
The mechanism by which nervou.s stimuli and/or contractile activity 
modulate the response to insulin in muscle is conjectural. Denervation 
may inhibit the generation or the propagation of a signal(s) from the 
occupied receptor or, alternatively, changes in the intracellular milieu 
may impair the response.. Since at least three separate insulin regu-
lated systems appear affected (glucose transport, glycogen synthase 
activation and in Ref.19 amino acid transport), impaired signal-
transmission seems to be the more attractive hypothesis. 
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TABLE 1 
3 Uptake of [ H]-2-deoxyglucose CSmM) by control and denervated EDL. 
2-deoxyglucose uptake Cnmoles/mg wet weight/IS min) 
Insulin CfJU/ml) Control Denervated 
0 1.42 ± 0.12 1.22 ± 0.08 
50 2.37 ± + 0.22+ 1.36 ± 0.13* 
1000 2.56 ± + 0.21+ 1.81 ± 0.09*+ 
Half EDL from fasted rats, unilaterally denervated for 24 hrs, were 
preincubated, incubated and processed as described in Fig. 4 for solei. 




Effect of insulin on glucose-6-phosphate content of control and denervated 
solei. 
Insulin Glucose-6-phosphate 
uD/ml nmol/g tissue 
Denervated Control 
.. ~ 
0 87 ± 19 (9) 159 ± 25 (9) 
1\ 
L~ 
50 94 ± 40 (4) 
1\ 
207 ± 24 (5) 
1000 98 ± 33 (4) 351 ± 52 (5) 'i"t 
Control and 24 hr denervated solei from 24 hr fasted rats were 
preincubated for 30 min in 5 mM glucose with or without insulin and for an 
additional 60 min in identical medium. Means ± SE are shown. The number of 
observations is in parentheses. 
* p < 0.05 vs. non-denervated pairs 
t p < 0.01 vs. control without insulin 
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TABLE 3 
Effect of denervation and insulin on glycogen synthase activity. 
Solei 
Muscle Total Activity Activity Ratio Fractional Velocity 
(pkat/mg protein) 
Control, -I 297 ± 18 (656 ± 71) 
Control, +1 297 ± 25 (668 ± 110) 
Denervated, -I 285 ± 18 (733 ± 93) 
Denervated +1, 290 ± 25 (688 ± 87) 
EDL 
Control, - I 155 ± 25 
Control, +1 121 ± 18 
Denervated, -I 129 ± 15 
Denervated, +1 144 ± 22 
0.14 ± 0.02 
0.18 ± 
+ 0.02+ 
0.11 ± 0.01 
0.12 ± 0.02* 
0.16 ± 0.01 
+ 0.19 ± 0.01+ 
0.12 ± 0.02 
0.14 ± 0.02* 
0.50 ± 0.03 
0.61 ± 
+ 0.04+ 
0.43 ± 0.03·" 
0.48 ± 0.04* 
0.57 ± 0.03 
+ 0.66 ± 0.03+ 
0.52 ± 0.03 
0.58 ± 0.04 
Muscles were obtained from fasted rats 24 hrs after unilateral denervation. 
They were preincubated for 15 min in buffer containing pyruvate without insulin or 
albumin and incubated for 30 min ± 10 mU/ml insulin. Glycogen synthase activity of 
the 15,OOOxg supernate of muscle homogenates was measured, and activity ratios 
(-G-6-P/1mM G-6-P) and fractional velocities (0.1 roM G-6-P/1mM G-6-P) calculated as 
described in Methods. pkat = pkatals, amount of enzyme activity converting 1 pmol 
of glucose from UDP glucose into glycogen per second under standard assay condi-
tions. All data shown are measurements made using subsaturating concentrations of 
UDP glucose (0.075 mM) except for data in parentheses where UDP-glucose was 4.4 mM. 
Total activity was measured as described in Methods. Results are expressed as mean 
± S.E. of 6-7 observations. *p < 0.05 vs. non-denervated pairs. + + p < 0.05 vs. 
incubation without insulin. I = insulin, 10 mD/ml. 
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TABLE 4 
Initial glycogen content of muscles 
Glycogen (glucose equivalents) 
nmol/mg wet weight 
Soleus 
24 hr. Fasted Rats 
Control 17.5 ± 1.38 
Denervated 34.8 ± 1.38* 
Ad Lib. Fed Rats 
Control 22.3 ± 1.42 
Denervated 27.5 ± 1.60-;'\" 
EDL 
24 hr. Fasted Rats 
Control 19.1 ± 1.46 
Denervated 17.7 ± 1.21 
Ad Lib. Fed Rats 
• Control 24.0 ± 2.00 
Denervated 23.3 ± 1.82 
Control or 24 hr. denervated soleus and extensor digitorurn longus 
muscles from fasted or fed rats were dissected and glycogen extracted 
immediately as described in Methods. Values are Means ± SE of 8-24 
observations. 
* p < 0.05 vs. paired control. Fed and fasted animals were studied 
in separate experiments. 
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FIGURE LEGENDS 
Fig. 1. Glucose incorporation into glycogen by solei. Half solei were 
preincubated for 30 min in 5 roM glucose with or without increasing 
concentrations of insulin and incubated for 1 hr in identical media 
supplemented with [U_ 14C]glucose (0.2 ~Ci/ml). Each point represents 
the mean ± SE of 6-8 observations. Controls , Denervated Panel 
A: Rats fasted and one sciatic nerve severed 24 hrs before experiments. 
B: Rats fed ad lib.; one sciatic nerve severed for 24 hrs. C: Fed rats, 
unilateral denervation 6 hrs .. before experiment. 
* control >denervated, p < 0.01. Insulin effects were significant 
at all doses tested in control muscles in each panel (p < 0.01); in the 
denervated, insulin effects were not significant in panel B, but were 
significant at 250 ~U/ml or higher doses in panels A and C (p < 0.01). 
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Fig. 2. Glucose incorporation into glycogen by extensor digitorum 
longus (EDL)muscle. Half EDL were incubated as described in Fig. 1. 
Bars are Means ± SE of 6 observations. Panel A: Rats fasted and one 
sciatic nerve severed 24 hrs. before experiment. B: Fed rats, unilateral 
denervation 24 hrs. Black bars indicate denervation, clear bars controls. 
* Control> denervated, p < 0.01. Insulin effects were significant at both 
doses in control muscles in A (p < 0.01) and at 500 ~U/ml in B (p < 0.05); no 
insulin effect in denervated muscles. 
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Fig. 3. Uptake and phosphorylation of 2-deoxyglucose. Half solei from 
rats, fasted and unilaterally denervated for 24 hrs, were preincubated 
14 and incubated as described in Fig. 3 but [ C]sucrose served as an 
extracellular marker and r3H]2-deoxyglucose as the transported sugar. 
Panel A: intracellular 2-deoxyglucose after 30 min. incubation in 0.1 mM 
2-deoxyglucose; B: 15 min incubation in 5 mM 2-deoxyglucose. 
Control ; denervated The % of intracellular 2-deoxyglucose 
as 2-deoxyglucose-6-phosphate after incubation is shown in Panel C and D 
for experiments A and B respectively. Black bars represent denervated, 
clear bars control muscles. Means ± SE of 6-8 observations are shown in 
A and B, 8-10 observations in C and D. 
* Control> denervated, p < 0.05. In A and B insulin effects in 
control muscles were significant at each dose (p < 0.05 - p < 0.001); in 
denervated muscles the only significant insulin effect is in Panel A at 
1000 ~U/ml, p < 0.05. 
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Fig. 4. Insulin binding by solei. Rats were fasted and one sciatic 
nerve severed 24 hrs before experiment. Half solei were preincubated 
for 30 min in 2 roM pyruvate, then incubated for 2 hrs in identical media 
supplemented with 100,000 dpm 125I-insulin and increasing concentrations 
of unlabeled insulin. Specific insulin binding was measured as 
described in Methods, each point is the Mean± SE of 6-14 observations 
in control and in denervated muscles. 
Inset: One half-soleus of each side was incubated with 1 ng/ml 
insulin, the other with 50 ~g/ml for non-specific binding. Each bar 
represents the mean specific binding ± SE of 13 control (clear bars) and 
13 denervated solei (black 
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Fig. s. Effect of epinephrine on glycogen content and glucose incorporation 
into glycogen. Solei were obtained from ad lib. fed rats 24 hrs. after 
unilateral denervation. Half-solei were preincubated for 30 min in 5 mM 
glucose, then incubated for 60 min in identical media supplemented with 
[U_1 4C]glucose (0.2 ~Ci/ml), with and without increasing concentrations of 
epinephrine. At the end of incubation muscles were processed for measurement of 
glycogen content (Panel A) and [14C]glucose incorporation into glycogen (Panel 
B). Means ± SE of 6-10 observations are shown. * p < 0.05 vs. muscles 






- 16 .,..,,-.... , 1.6 QJ --'" '\ -:J '\ ~ 
'" '\ "".c '" 
, --. - V\ ... ~ 14 w.c 1.4 
C'l l:.2l 1/ zE t-CIJ 
W""'-: 12 2 ~ 1.2 
CJC'" > ... O~ ""CIJ 
l) !( , 2 ~ 1.0 
> 0 , LUg, '\ _, v 1-,- ""E lJ.2 -~. ~ 8&;; 0.8 
'" >~ ~ ...10 
0 "" E 0.6 E c: Q ........ 








1. Kochan, R.G., D.R. Lamb, S.A. Lutz, C.V. Perrill, G.M. Reimann and 
K.K. Schlender. "Glycogen Synthase Activation in Human Skeletal 
Muscle: Effects of Diet and Exercise. Am. J. Physiol. 236;E660-
E666, 1979. 
2. Richter, E.A., L.P. Garretto, M.N. Goodman, and N.B. Ruderman. 
"Muscle Glucose Metabolism following Exercise in the Rat: Increased 
Sensitivity to Insulin. J. Cline Invest. 69;785-793, 1982. 
3. Buse, M.G. and J. Buse. :Glucose Uptake and Response to Insulin of 
the Isolated Rat Diaphragm. The Effect of Denervation. Diabetes 
8;218-225, 1959. 
4. Buse, M.G. and J. Buse. "Effect of Denervation and Insulin on the 
Penetration of D-xylose into Rat Hemidiaphragms. Diabetes 10;134-
141, 1961. 
5. Seider, M.J., W.F. Nicholson and F.W. Booth. "Insulin Resistance 
for Glucose Metabolism in Disused Soleus Muscle of Mice." Am. J. 
Physiol. 242;E12-E18, 1982. 
6. Forsayeth, J.R. and M.K. Gould. tflnhibition of Insulin-stimulated 
Zylose Uptake in Denervated Rat Soleus Muscle: A Post-receptor 
Effect. tI Diabetologia 23; 511-516, 1982. 
7. Gey, G.O. and M.K. Gey. The Maintenance of Human Normal and Tumor 
Cells in Continuous Culture. Am. J. Cancer 27;45-76, 1936. 
8. LeMarchand-Brustel, Y., B. Jeanrenaud, P. Freychet. "Insulin 
Binding and Effects in Isolated Soleus Muscles of Lean and Obese 
Mice." Am. J. Physiol. 234;E348-E358, 1978. 
9. Cuendet, G.S., E.G. Loten, B. Jeanrenaud, and A.E. Renold. rtDe-
creased Basal, Non-insulin Stimulated Glucose Uptake and 
88 
Metabolism by Skeletal Soleus Muscle Isolated from Obese-
Hyperglycemic (ob/ob) Mice. J. Clin. Invest. 58;1078-1088, 1976. 
10. Van Handel, E. 1965. "Estimation of Glycogen in Small Amounts of 
Tissue. Anal. Biochem. 11;256-265, 1965. 
11. Olefsky, J.M. "Mechanisms of the Ability of Insulin to Activate 
the Glucose-transport System in Rat Adipocytes. Biochem. J. 172; 
137-145, 1978. 
12. Lowry, D.H., and J.V. Passoneau. HATP, Phosphocreatine and Glucose-
6-phosphate Assay, Method B." In: A Flexible System of 
Enzymatic Analysis. New York: Academic, 1972,p. 151-153. 
13. Thomas, J.A., K.K. Schlender, and J. Larner. "A Rapid Filter Paper 
Assay for UDP-glucose-glycogen Glucosyltransferase, Including an 
Improved Synthesis of UDP_ 14C Glucose. Anal. Biochem. 25;486-499, 
1968. 
14. Kochan, R.G., D.R. Lamb, E.M. Reimann, and K.K. Schlendler. 
"Modified Assays to Detect Activation of Glycogen Synthase 
following Exercise." Am. J. Physiol. 240 (Endocrinol. Metab. 
3);EI97-E202, 1981. 
15. Guinovart, J.J., A. Salavert, J. Massague, C.J. Cuidad, E. Salsas, 
and E. Itarte. "Glycogen Synthase: A New Activity Ratio Assay 
Expressing a High Sensitivity to the Phosphorylation State." FEBS 
Lett. 106;284-288, 1979. 
16. Lowry, O.H., N.Y. Rosebrough, A.L. Farr, and R.J. Randall. 
"Protein Measurement with the Folin Phenol Reagent. tI J. BioI. Chern. 
193;265-275~ 1951. 
89 
17. Galbraith, R.A .. , C. Wise, and M.G. Buse. "Insulin Binding and 
Response in Erythroblastic Leukemic Cells." Diabetes 29;571-578, 
1980. 
18. Crettaz, M., M. Prentki, D. Zaninetti, and B. Jeanrenaud. "Insulin 
Resistance of Soleus Muscle from Obese Zucker Rats." Biochem. J. 
186;525-534, 1980. 
19. Ariano, M.A., R.B. Armstrong, and V.R. Edgerton. "Hindlimb Muscle 
Fiber Population in Five Mammals. J. Histochem. Cytochem. 21;51-
55, 1973. 
20. Bonen, A., M.H. Jan, W.M. Watson-Wright. "Insulin Binding and 
Glucose Uptake Differences in Rodent Skeletal Muscles." Diabetes 
30;702-704, 1981. 
21. Ivy, J.L. and J.O. Holloszy. "Persistent Increase in Glucose 
Uptake by Rat Skeletal Muscle following Exercise. Am. J. Physiol. 
241;C200-C203, 1981. 
22. Davidheiser, S., E.F. Haugaard and N. Haugaard. "Effects of Epine-
phrineand the Cyclic AMP Phosphodiesterase Inhibitor SQ 2009 on 
Glucose and Glycogen Metabolism in kSeletal Muscle." Biochem. 
Pharmacol. 28;807-813, 1979. 
23. Berger, M., S.A. Hagg and N.B. Ruderman. "Glucose Metabolism in 
Perfused Skeletal Muscle. Interaction of Insulin and Exercise on 
Glucose Uptake." Biochem. J. 146;231-238, 1975. 
24. Smith, R.L. and J.C. Lawrence. I1Mechanism of Denervation-induced 
Insulin Resistance in Skeletal Muscle. Diabetes 32 (Suppl. 1), 
128A (Abstract), 1983. 
25. DePaoli Roach, A.A., C .. Villar-Palasi and E. Bergamini. "Effect of 
Denervation on Glycogen Synthase Kinase Activity." Exp. Neurol. 
62;494-496, 1978. 
90 
26. Chiasson, J.-L., M.R. Dietz, H. Shikama, M. Wooten and J.R. Exton. 
"Insulin Regulation of Skeletal Muscle Glycogen Metabolism." 
Am. J. Physiol. 239; E69-E74, 1980. 
27. Fischbach, G.D. and N. Robbins. "Effect of Chronic Disuse of Rat 
Soleus Neuromuscular Junctions on Post-synaptic Membrane." 
J. Neurophysiol. 34;562-569, 1971. 
28. DuBois, D.C. and R.R. Almon. "Disuse Atrophy of Skeletal Muscle is 
Associated with an Increase in Number of Glucocorticoid Receptors." 
Endocrinology 107;1649-1651, 1980. 
29. DuBois, D.C. and R.R. Almon. "A Possible Role for Glucocorticoids 
in Denervation Atrophy." Muscle and Nerve 4;370-373, 1981. 
30. Booth, F.W. ttEffect of Limb Immobilization on Skeletal Muscle." 
J. Appl. Physiol: Respirat. Environ. Exercise Physiol. 52;1113-
1118, 1982. 
31. Dolkas, C.B. and J.E. Greenleaf. "Insulin and Glucose Responses 
during Bed Rest with Isotonic and Isometric Exercise." J. Appl. 
Physiol.: Respirat. Environ. Exercise Physiol. 43;1033-1038, 1977. 
32. Duckworth, W.C., S.S. Solomon, P. Jallepalli, C. Heckemeyer, J. 
Finnern and A. Powers. "Glucose Intolerance Due to Insulin Resis-
tance in Patients with Spinal Cord Injuries." Diabetes 29;906-910, 
1980. 
33. National Diabetes Data Group. "Classification and Diagnosis of 
Diabetes Mellitus and Other Categories of Glucose Intolerance." 
Diabetes 28;1039-1057, 1979. 
34. Bright, J.M., T.W. Melton, A.D. Rogol and W.t. Clarke. "Failure of 
Cortisol Blockade to Inhibit Early Morning Increases in Basal 
Insulin Requirements in Fasting, Insulin-dependent Diabetics." 
Diabetes 29;662-664, 1980. 
91 
35. Berger, M., P. Berchtold and F.W. Kemmer. "Metabolic and Hormonal 
Effects of Exercise in Diabetic Patients." In: Diabetes Mellitus, 
Vol. III, Intermediary Metabolism and Its Regulation, edited by M. 
Brownlee. New York: Garland STPM Press, 1981, pp 273-305. 
36. Garetto, L.P., E.A. Richter, M.N. Goodman, and N.B. Ruderman. 
"Enhanced Insulin Sensitivity of Skeletal Muscle following 
Exercise." In: Biochemistry of Exercise, edited by J. Poortmans. 
Champaign, Ill.: Human Kinetics Publishers, 1983, 681-687. 
37. Horton, E.S., E.D. Horton, M. Hirshman, E. Ravussin. "Increased 
Insulin Sensitivity without Altered Insulin Binding in Rat Soleus 
Muscle following Exercise." Abstract, Program of Xlth 
International Diabetes Federation Congress, 1982. 
CHAPTER 3: PHOSPHORYLATION OF INSULIN RECEPTORS 
SOLUBILIZED FROM RAT SKELETAL MUSCLE 
Introduction: Elucidation of the mechanism of insulin action has 
advanced significantly with the recent characterization of the structure 
of the insulin receptor, and the discovery of its autophosphorylation 
and associated protein kinase activity upon binding of insulin. These 
studies have been performed in adipocytes (1), hepatocytes (2), erythro-
cytes (3), monocytes (4), brain (5), placenta (6), and various cells in 
culture (7); however, direct study of the insulin receptor in skeletal 
muscle has been hampered by technical difficulties. 
In view of its mass, skeletal muscle is the most important target 
tissue of insulin action. Regulation of the insulin receptor in muscle 
is of particular interest, since contractile activity modulates its 
sensitivity and response to insulin, apparently at an early step after 
insulin binding (8). Furthermore, insulin resistance of skeletal 
muscle, a salient feature of several pathological conditions e.g. type 
II diabetes, obesity and uremia, appears to involve primarily defective 
coupling between insulin binding and response (for review see 9). The 
methods reported nere should provide a system for probing the actions of 
insulin and the effect of modulators of insulin action in skeletal 
muscle. 
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Materials and Methods 
Receptor Purification. Male Wistar rats (Charles Rivers Breeding 
Laboratories, Wilmington, Mass.), weighing 60-100g, were decapitated 
after an overnight fast. Hind limb muscles were trimmed of fat and 
quickly frozen in liquid nitrogen. The frozen muscle was finely ground 
in a mortar precooled to -SOoC and to it was added ice-cold 3.5 v/w of a 
* buffer consisting of 25 roM Hepes , 1% Triton-X 100, 4 mM EDTA, 1 TID/ml 
aprotinin and 2 roM PHSF, pH 7.4. The frozen slurry was homogenized as 
it thawed in a Potter-Elvejhem homogenizer then centrifuged at 
10,000 x g for 10 min at 4°C. The resulting supernate was slowly 
stirred at 21°C for 60 min. then centrifuged at 4°C (150,OOOxg for 90 
min.) and the supernate (ISOK supernatant) applied to an agarose-bound 
wheat germ agglutinin column (WGA, approx. 3 g original muscle weight/ml 
resin). The column was washed with 25 mM Hepes, 0.1% Triton X-IOO pH 
7.4 (Buffer A, 75 ml/ml settled gel) and receptors eluted with this 
buffer supplemented with 0.3 M N-acetylglucosamine (WGA eluate). 
Typically 1 ml of WGA eluate/g original muscle weight was collected. 
Insulin binding to solubilized receptors was carried out according 
to Taylor et a1. (10). 150 K supernatant (20 1J1) or WGA eluate (100 lJ1) 
were incubated with either 10,000 or 100,000 cpm of 125I-insulin (11) 
(spec. act. 125 IJCi/lJg) in SOmM Hepes (pH 7.8), 0.1% Triton X-100, 150 
mM NaCl, 0.1% bovine serum albumin (fatty acid free, Sigma), 100 U/ml 
bacitracin and varying concentrations of unlabeled insulin (3xl0-11 -
8X10-6M) for 16 hrs at 4°C in a final volume of 0.2 mI. The receptor 
was precipitated by sequential additions of 0.1 ml bovine y-globulin (3 
mg/ml) anq 0.3 ml polyethylene glycol (25% wt/vol.). Each point was 
assayed i~ triplicate, non-specific binding. 
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In vitro phosphorylation of purified insulin receptors. WGA eluate 
(50 pI, approx. 0.03 mg protein) was preincubated in 25mM Hepes (pH 
7.4), 0.1% Triton X-IOO, 5 roM MnC12 and 0.1% bovine serum albumin 
(buffer B) with or without varying concentrations of insulin for 40 min. 




(leN) and Gammaprep vials, (Promegabiotec, Madison, WI.). [y_32p ]ATP 
(S f,Jl, final conc. Sf.JM, 5-15 mCi/Jjmole) was added to each sample and 
incubation continued for 20 min. The reaction was stopped with 20 J.ll 
25 roM Hepes buffer pH 7.4 containing 0.1% Triton X-100, 10 roM Na pyro-
phosphate, 20 mM ATP and 2 mM PMSF at 4°C. Polyclonal anti-rat insulin 
receptor antibody diluted 1:500 (kindly provided by Dr. Steve Jacobs, 
Burroughs-Wellcorne) or control rabbit serum was added and the mixture 
incubated overnight at 4°C. The immune complex was precipitated with 
Protein A (Pansorbin, Calbiochem) (6),washed 3 times in buffer A and 
boiled for 5 min. in Laemmli's sample buffer (13) with or without 5 roM 
2-mercaptoethanol. In studies of the time-course of autophosphorylation 
and of histone phosphorylation, this protocol was modified, as described 
in the Legends of Fig. 3 and Fig. 4, respectively. 
In situ phosphorylation of insulin receptors from solei. Solei 
from 18 hr fasted (50-70 g) rats were removed, divided longitudinally 
and mounted on stainless steel frames at resting length. Individual 
half-solei were incubated for 1 hr at 25°C in 3 ml Earle's Minimal 
Essential Medium (MEM) modified to contain 0.1 roM Na2HP04 . Groups of 6 
muscles were then transferred to flasks containing 9 ml of phosphate 
32 
free MEM supplemented with 0.25-0.4 mei/rul of 0.1 roM Na2 [ P]P04 and 
incubated for 3 hrsat 37°C. After labelling endogenous ATP pools the 
muscle groups were incubated for 30 min at 37°C in 9 rol G~y and Gey's 
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balanced salt solution (bicarbonate buffer,15) containing 0.1 mM 
32 Na2H[ P]P04 of identical spec. act., with or without 10 mU/ml insulin. 
All incubations were under 95% 02 + 5% CO2 atmosphere. The muscles were 
quickly removed from the supporting frames, immediately frozen in liquid 
nitrogen, and each group of 6 muscles crushed in a glass Potter-Eljevhem 
homogenizer precooled in liquid nitrogen. Buffer (2 ml) containing 50 
roM Hepes, 1.5% Triton X-IOO, 10 mM NaF, 0.2 roM Na3V04 , 10 roM sodium 
pyrophosphate, 40 mM ATP, 1 TIU/ml aprotinin, 100 mU/ml Bacitracin and 2 
roM PMSF, pH 7.5 at 4°C was added and the frozen slurry homogenized as it 
thawed. The homogenate was centrifuged at 200,000 x g for 60 min at 4°C 
and the supernate applied to 0.75 ml WGA. The column was washed with 75 
ml Buffer A containing 5 roM EDTA, 10 roM sodium pyrophosphate, I TIU/ml 
Aprotinin and 2 mM PMSF and eluted with 1.8 ml of this buffer supple-
mented with 0.3 M N-acetylglucosamine. The insulin receptor was then 
immunoprecipitated and washed as described above. 
Electrophoresis and Autoradiography. Reaction samples or immuno-
precipitates were applied to either a 5% (for non-reduced receptors), or 
7.5% (for reduced receptor samples) or a 5-25% gradient polyacrylamide 
gel (for histone samples) with molecular weight standards (Sigma) ac-
cording to Laemmli (12). Following electrophoresis gels were fixed, 
stained with Coumassie blue, destained and dried under vacuum. Auto-
radiography was performed with Kodak AR Film with or without a DuPont 
Lightening Plus intensifying screen. For quantitation of radioactivity 
gel slices were digested overnight at 55°C in 1 ml 30% H202 and then 
counted in Scintiverse (Fisher). 
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RESULTS AND DISCUSSION. 
Insulin binding by receptors solubilized from hind limb skeletal 
muscle display classic curvilinear Scatchard plots (Fig. 1a). The 
150,000 x g supernate reproducibly yielded approximately 0.4 pmoles of 
insulin binding activity/mg protein; assuming that each insulin receptor 
bound two insulin molecules (17), the calculated yield was approximately 
0.5 pmol solubilized receptor/g wet weight of original muscle mass. 
Subsequent WGA chromatography resulted in approximately 8-10 fold 
purification (per mg protein) and 75-80% recovery of binding activity 
(Fig. Ib). 
Incubation of WGA purified receptors with increasing concentrations 
of insulin and [y_32p]ATP followed by immunoprecipitation with poly-
clonal anti-insulin receptor serum revealed that insulin stimulates the 
incorporation of 32p into a 95KD protein when the immunoprecipitate is 
electrophoresed under reducing conditions (Fig. 2). As reported, for 
other tissues, this corresponds to the (l-subunit of the insulin receptor 
(16). Autophosphorylation of the 95KD subunit was stimulated 
half-maximally at approximately Sx10-9M insulin with a four-fold 
". 10-7M· I" 1ncrease at 1nsu 1n. Insulin stimulated phosphorylation of the 
++ 95KD subunit showed an absolute requirement for Mn (data not shown). 
A labelled protein with apparent MW of 130KD (a-subunit) was also 
observed in the immunoprecipitate but its phorphorylation was not 
stimulated by insulin. Under nonreducing conditions, receptors 
incubated with lO-6M insulin showed 32p incorporation into bands with 
apparent MW of 360, 290, 9sKD;probably corresponding to tl2~2' tl2~f!1 and 
~ ~ubunit stoichometries (17) (Fig. 2, Lan~s I and J). 
Determination of the time required for autophorphorylation of the 
97 
insulin receptor ~-subunit (Figure 3) necessitated rapid quenching of 
the reaction, the concommitant denaturation of the receptor precluded 
immunoprecipitation. Since on autoradiograms of reduced gels only the 
9SKD protein showed increased labelling after addition of insulin, we 
were confident that this was the f3-subunit of the insulin receptor (Fig. 
2, lanes G and H). The t~ for autophorphorylation in the presence of 5 
mM MnC12 and 5 ~M ATP was approximately 100 sec; maximal phosphorylation 
remained relatively constant between 4 and 10 min. and gradually de-
creased thereafter. 
Insulin induced autophosphorylationof the receptor, probably 
through an intramolecular event (18), stimulates its activity as a 
kinase towards exogenous substrates (14,19). This property was also 
observed with insulin receptors purified from skeletal muscle, using 
histone H2B as the exogenous substrate, (Fig. 4). The incorporation was 
linear for 5 min but decreased by 15 min suggesting the presence of 
phosphoprotein phosphatase activity. The phosphorylation events 
probably occurred on tyrosine residues since incubation of gels in 0.5 N 
NaOH did not diminish the 32p content of the 95KD protein nor that of 
histones (data not shown). Mild base treatment has been reported to 
selectively hydrolyse phosphoserine and phosphothreonine residues 
leaving most phosphotyrosine residues intact (20). 
Long term incubation of soleus muscle in phosphate poor minimal 
essential medium supplemented with [32P1P04 was required to equilibrate 
endogenous ATP pools with 32p. Preliminary experiments showed that even 
after 4 hrs in low phosphate medium,' solei were still responsive to 10 
14 mU/ml insulin as shown by a 4-fold increase in [ C]glucose 
incorporation into glycogen (data not shown). By quick~y £ree~ing, 
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grinding and homogenizing muscles which were incubated for 3.5 hours 
with [32P1P04' the last half hour with or without insulin, we were able 
to observe an approximately 2-fold increase in 32p labelling of the 
insulin receptor fl-subunit of muscles stimulated with insulin (Fig. 5). 
As alluded to above, the most common conditions associated with 
insulin resistance of skeletal muscle, have been classified as "post-
receptor" events, since decreased insulin binding could not account for 
the observed decrease in insulin sensitivity and/or response. However, 
intact insulin binding (primarily a function of the a-subunit) does not 
preclude the possibility of receptor abnormalities (0£ structure or 
function due to an altered microenvirorunent) which may result in im-
paired propagation of signals. Indeed, in a subgroup o~ patients with 
type A insulin resistance, insulin binding to monocytes was normal, but 
insulin mediated receptor autophosphorylation was impaired (21). The 
demonstration of insulin stimulated in situ phosphorylation of the 
fl-subunit of the insulin receptor in intact muscles and the easy avail-
ability of solubilized receptors from this tissue should further the 
investigation of factors which modulate receptor-functipn coupling in 
muscle, such as disuse and exercise. 
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Fig. 1. Scatchard plot of insulin binding by solubilized receptors. 
Receptors were solubilized as described in Methods; 20 ~l of lS0,OOOxg 
supernatant (A) or 100 J.Jl of WGA eluate (B) were incubated with O.4-4ng 
125I-insulin and increasing concentrations of non-labelled insulin. 
Non-specific binding (20-25%) was subtracted from each point. Data 
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Fig. 2. Identification of muscle insulin receptor. Wheat germ eluate 
(SOIJ1) was incubated with or without insulin for 40 min at 21°C after 
which [y32p ]ATP was added for an additional 20 min. Proteins were 
separated by SDS-PAGE (7.5%). Autoradiographs of 32P-labeled proteins 
are shown. Lanes A-E:SDS-PAGE under reducing conditions of insulin 
receptors immunoprecipitated by polyclonal anti-insulin receptor 
antibody or non-immune rabbit serum (Lane F) after incubation with O(A), 
lO-9(B), 10-B CC ), lO-7(D), lO-6(E&F) M insulin. Lanes G and H:SDS-PAGE 
under reducing conditions of the complete reaction mixture (without 
immunoprecipitation) after incubation without (G) or with (H) lO-6M 
insulin. Lane I: SDS-PAGE under non-reducing conditions of WGA after 
incubation with 10-6 M insulin followed by immunoprecipitation. Lane J: 
Same as I but using non-immune rabbit serum. Graph represents relative 
32p incorporation into the ~-subunit of the insulin receptor incubated 
as described for Lanes A-E and immunoprecipitated by anti-receptor 
antibody. Points are means ± SE of 3 observations. Arrow indicates the 
~-subunit of the insulin receptor. 
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F . 3 T . f 32p . .. h ~ b . f h ~g . 1me course 0 1ncorporat1on 1nto t e p-su un1t 0 t e 
insulin receptor. Wheat germ eluate (300 ~l) was preincubated with 
2xlO-7 M insulin for 40 min at 21°C in a final volume of 360 ~l followed 
by the addition of 10 ~l [y_32p ]ATP (final conc. 5 ~M, 5-15 mCi/~mole). 
At the times indicated 35 ~l aliquots were transferred into 3S ~l twice 
concentrated Laemmli's sample buffer and boiled for 5 min. After 
SDS-PAGE under reducing conditions the 95 KD bands were identified by 
autoradiography, excised and counted for radioactivity. Bars represent 
means ± SE for 3 experiments. Inset: Representative autoradiogram of 
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Fig. 4. Insulin stimulated phosphorylation of Histone H2B. WGA eluate 
(150 ~l) was preincubated in Buffer B (final volume 700 ~l) with or 
without 2xlO- 7 M insulin for 46 min ~t 21°C; y[32plATP (5~M, 
5-15mCi/~mole) was included for the last 6 min. Aliquots (35 ~l) were 
then added to 5~1 histone H2B (Worthington Biochemical,final concen-
tration 0.4 mg/ml) and further incubated for the times indicated. The 
samples were then either boiled in Laemmli's solution (for subsequent 
gel electrophoresis) or precipitated with 40 ~l of 25% trichloroacetic 
acid. The precipitates were hydrolysed at 55°C in 0.5 M NaOH for 1 hr 
(14), reprecipitated, collected on gl~ss filter papers and counted for 
radioactivity. Points are means of 2 experiments. Inset: Autoradiogram 
of SDS-PAGE (reducing conditions) of incubation mixture after 15 min in 
the absence (Lane A) or the presence of insulin (Lane B). Arrow indi-
cates ~-subunit of the insulin receptor. Histones are between MW 
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Fig. 5. Autoradiogram of insulin receptors phosphorylated in situ. 




an additional \ hour in bicarbonate medium supplemented with NaZH[3Z
p) 
without (Lane A) or with (Lane B) 10 mU/ml insulin. Receptors were then 
solubilized, parti~lly purified by WGA chromatography qnd immunoprecipi-
tated as described. Arrow indicates p-subunit of insulin receptor. 
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CHAPTER 4: IN VITRO AND IN VIVO ACTIVATION OF THE INSULIN 
RECEPTOR KINASE IN CONTROL AND DENERVATED SKELETAL MUSCLE 
Introduction: 
Antecedent activity modulates the insulin response of skeletal 
muscle. Following exercise the muscle's sensitivity to insulin is 
increased as assessed by insulin-stimulated glucose transport (1) 
glycogen synthase activation (2) and amino acid transport (3). Basal 
glucose transport into muscle cells is also stimulated following 
vigorous exercise (4). The converse is also true) e.g. muscles which 
have been denervated (5-9) or immobilized (10) develop within 6-24 hrs 
decreased sensitivity and response to insulin. The insulin resistance 
encompasses mUltiple parameters of insulin action e.g. glucose transport 
(5-9)) glycogen synthesis (7-9)) glycogen synthase activation (7-9) and 
amino acid transport (7). Baseline glucose transport and glucose 
incorporation into glycogen are also decreased in denervated muscles. 
Several changes occur in the membrane of skeletal muscle after 
denervation. Extra junctional acetylcholine receptors appear (11) as 
well as sodium channels that are insensitive to tetrodotoxin (12). The 
resting membrane potential is decreased (13) and phospholipid turnover 
accelerates (14). However, no significant change in the binding of 
insulin to its receptor has been observed shortly after denervation, to 
account for the severe insulin resistance (7)9,15) and thus the defect 
in denervated skeletal muscle may be classified as a post-binding 
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defect. It has recently become evident that in some insulin resistant 
states there is little or no change in insulin binding yet there is 
impaired insulin-stimulated autophosphorylation of the insulin receptor 
f3-subunit (16-18). In the intact cell and in the solubilized insulin 
receptor system the initial, insulin stimulated autophosphorylation 
occurs on tyrosine residues of the f3-subunit and this intramolecular 
event activates an intrinsic, tyrosyl phospho-transferase to exogenous 
substrates. The latter may initiate the cascade of phosphorylation-
dephosphorylation which ensues upon insulin binding to the cell surface 
(for review see 19, 20). 
Since the insulin resistance in denervated muscles encompasses 
multiple parameters, we postulated that the defect involves an early 
step in insulints action (9). The autophosphorylation of the ~-subunit 
is the earliest recognized event after insulin binds to its receptor. 
We therefore addressed the following questions: a) Is the insulin 
stimulated receptor autophosphorylation and/or insulin-activation of the 
receptor tyrosyl kinase (using exogenous substrate) impaired after 
denervation in receptors solubilized from skeletal muscle? b) Is the 
insulin-stimulated receptor autophosphorylation affected in situ, in 
incubated muscles, after denervation? c) In the intact animal, is the 
activation of muscle insulin receptor exogenous substrate tyrosyl kinase 
impaired after denervation? The latter question led to the development 
of methods to assess the in vivo activation of the skeletal muscle 
insulin receptor kinase activity by the hormone. Our data indicate that 
insulin-mediated receptor-kinase activation is unimpaired in muscle 24 
hrs after denervation, suggesting that in this model impaired receptor-
function coupling is a true post-receptor defect. 
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MATERIALS 
Monoiodinated A[14I ]insulin was kindly provided by Dr. B.H. Frank 
(Lilly Research Laboratories, Indianapolis, IN). Monocomponent, crys-
talline pork insulin was a gift of Dr. Ronald Chance (Lilly Research 
Laboratories). Polyclonal anti-insulin receptor antibody was a gift of 
Dr. Steve Jacobs (Wellcome Research Laboratories). Wheat germ agglu-
tinin was from Vector, Aprotinin was from FBA Pharmaceuticals, Baci 
tracin from Pfizer. Electrophoresis reagents were from Serva and appar_ 
atus from LKB. Protein A bearing S. au reus was from Calbiochem. CnBr-
activated Sepharose 4B was from Pharmacia. Precoated cellulose TLC 
plates were from Brinkmann Instruments. Autoradiography Film, X-omat 
AR, was from Kodak and Lightening + intensifying screens from duPont. 
y[32PJATP was prepared from 32P-orthophosphate (ICN) in Gamroaprep vials 
(Promegabiotec) as described by the manufacturer. [l4C]glucose was from 
New England Nuclear. All other reagents and chemicals were from Sigma 
unless otherwise specified. 
METHODSl 
Animals. Male rats, of the Wistar strain, weighing 60-110g were 
used in all experiments. They were allowed access to food and water ad 
libitum until 24 hr before experimentation when .food was removed. In 
all experiments rats were unilaterally denervated 22-26 hr before experi 
ments, by cutting the sciatic nerve through a small incision in the 
posterior aspect of the thigh as previously described (9). 
Insulin receptor solubilization. Insulin receptors were solu-
bilized from the muscle groups innervated by the sciatic nerve (lower 
leg muscles). The muscles were rapidly removed and quickly frozen in 
liquid nitrogen, powdered and the insulin receptors solubilized by 
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homogenization in 25 roM Hepes, pH 7.4, 1% Triton X-IOO, 1 TIU/ml 
aprotinin, 5 mM EDTA, and 2 roM Phenyl methyl sulfonyl fluoride (PMSF) .. 
After 10 min. centrifugation at 10,000 x & the supernatant was stirred 
for 30 min at 22°C to complete solubilization and then centrifuged at 
150,000 x 8. for 90 min. (Method 1). The supernatant was passed three 
times over an agarose bound wheat germ agglutinin (WGA) column and the 
resin washed with 25 bed volumes of 25 mM Hepes, pH 7.4, 0.1% Triton 
X-lOa (buffer A) and the partially purified glycoproteins eluted with 
buffer A supplemented with O.3MN-acetylglucosamine. The WGA eluate was 
aliquoted and stored at -80°C without loss of binding or kinase 
activity. In some experiments the insulin receptors were isolated in 
the phosphorylated state by homogenization in at least 10 volumes of a 
buffer containing 50 roM Hepes, pH 7 .. 4, 1.5% Triton X-100, 1 TIU/ml 
aprotinin, 5 mM EDTA, 10 roM NaF, 10 roM Na pyrophosphate, 1.5 mg/ml 
bacitracin, 100 ~M Na3V04, and 2 roM PMSF. After centrifugation at 
10,000 x & for 10 min the supernatant was immediately centrifuged at 
150,000 x ~ for 1 hr (Method 2). The resulting supernatant was applied 
to a WGA column pre-equilibrated with buffer A supplemented with 10 roM 
Na pyrophosphate, 5 roM EDTA, 1 TIU/ml aprotinin and 2 roM PMSF (buffer B) 
and recycled three times. The column was then washed with 25 bed 
volumes of Buffer B and the insulin receptors eluted with buffer B 
supplemented with 0.3 M N-acetylglucosamine .. 
Insulin binding to the solubilized insulin receptors was according 
to Taylor et al. (21) using A14[125I]insulin. The binding data were 
normalized to the protein content of the wheat germ eluate as determined 
by the Bradford reaction using bovine y-globulin standards (22). All 
studies of receptor-kinase activities were carried out using equal 
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insulin binding activities from WGA eluates prepared from control and 
denervated muscles. The latter were always prepared and assayed in 
parallel with the contralateral control muscle insulin receptors. 
Insulin induced autophosphorylation of the solubilized insulin 
receptor was performed as previously described (23). Briefly, WGA 
eluate from control and denervated skeletal muscles were incubated 
without or with 10- 9 or 10- 7 insulin in 65 ~l Buffer A supplemented with 
5 mM MnC1 2 and 0.05% BSA (phosphorylation buffer), for 1 hr at 25°C. 
The autophosphorylation was initiated by the addition of 10 ~l y[32p]ATP 
(50 ~M final concentration, 7.5 ~Ci/vial) and the reaction continued for 
4 min. when 4X concentrated Laemmli's sample buffer (24) (supplemented 
in all experiments with 5 roM 2-mercaptoethanol) was added and the 
samples placed in boiling water for 3 min. The proteins were separated 
by NaDodS0 4 polyacrylamide gel electrophoresis (SDS-PAGE), the p-subunit 
was localized by autoradiography, excised and digested, and the 
radioactivity determined, as described in "Electrophoresis". 
Estimation of exogenous substrate kinase activity of the insulin 
receptors purified by Method 1 above was performed with histone H2 b as 
the phosphoacceptor after the receptors were bound to insulin-agarose 
using the protocol of Yu and Czech (25). Wheat germ eluates from 
control and denervated skeletal muscles were incubated first with 50 1J1 
dithiothreitol-heat inactivated insulin-agarose (150 1J1 wheat germ 
eluate in a final volume of 500 ~l) at 25°C for 1 hr and the supernatant 
then incubated with active insulin-agarose for an additional 1 hr. 
After washing twice with 1 ml Buffer A supplemented with 0.5 M NaCl and 
once with 1 ml Buffer A alone the exogenous substrate kinase activity of 
the insulin-agarose bound receptor was activated by incubating it in 
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buffer A supplemented with 5 roM MnC1 2 and 750 IJM unlabeled ATP at 25°C 
for 20 min. After washing twice in 1 ml Buffer A, the resin was 
resuspended in 65fJl Buffer A supplemented with 5 mM MnC12, 0.05% BSA 
and 1 mg/ml Histone H2b. The kinase reaction was initiated by adding 10 
JJl y[32p]ATP (5 IJM final concentration, 5 IJCi/vial) and continued for 4 
min, when 4X concentrated Laemmli's sample buffer was added and the 
solution placed in boiling water for 3 min. After separation of the 
proteins on SDS-PAGE the his tones were localized by autoradiography and 
the radioactivity incorporated d'etermined as described under "Electro-
phoresis". 
Autophosphorylation of the insulin receptor in the intact soleus 
was carried out as previously described (23). Briefly, hemisolei 
(groups of 5-6 muscles) were incubated in Dulbeccots Modified Eagles 
Medium (DMEM) containing 0.1 mM Na phosphate for 1 hr at 25°C to lower 
endogenous phosphate pools. The muscles were then transferred to DMEM 
with 0.2 mCi/ml (0.1 mM) Na [32p]phosphate and incubated at 37°C for an 
additional 3 hrs. (preliminary experiments showed this was sufficient 
time to reach steady state labeling of nucleotide pools, as determined 
below). The muscles were then transferred to Gey and Gey's balanced 
salt solution (26) which was modified to yield a concentration and 
specific activity of phosphate identical to that of the modified DMEM 
medium described above, with or without 10 mU/ml of insulin and the 
incubation continued for ~ hour. The individual herni-solei were then 
frozen with metal tongs precooled in liquid nitrogen and the insulin 
receptors solubilized and partially purified by Method 2 described above 
except that 40 roM unlabeled ATP was added to the homogenization buffer .. 
Immunoprecipitation of -the phosphorylated insulin receptor was achieved 
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by incubating the WGA eluate overnight at 4°C with polyclonal anti-
insulin receptor antibody (1:250 dilution), followed by protein A 
bearing, formalin fixed Staphylococcus for an additional 2 hrs. After 
centrifugation, the precipitated complex was washed 3X in Buffer A, and 
the pellet boiled in Laemmli's sample buffer. Electrophoresis and 
quantitation of 32p incorporated into the p-subunit was as described 
above. 
A parallel set of control and denervated herni-solei were incubated 
in an identical fashion in the modified Dulbecco's MEM with 1/100 the 
specific activity of 32p, to estimate the concentration and specific 
activities of the nucleotide pools prior to the transfer to the insulin 
containing medium. After freezing, the individual muscles were powdered 
with a glass rod in a microfuge vial and the nucleotides extracted by 
the addition of 60 JJl of 3M perchloric acid and incubated for 20-30 min 
at -IOoe (27). Cold distilled water (200 JJl) was added and incubation 
continued for an additional 10 m~n at 4°C. The protein precipitate was 
removed by centrifugation for 15 min in a microfuge at 4°C and the 
supernate neutralized with 65 JJl 2N RHe0 3 , and clarified by centrifu-
gation. The supernatant was filtered and 20 JJI injected onto a 5 cm CI8 
reverse phase column on a Perkin-Elmer Series 4 high pressure liquid 
chromatograph. The nucleotides (ATP, ADP, and GTP) were eluted iso-
cratically using a buffer composed of 350 roM phosphoric acid brought to 
pH 6.5 with triethylamine (98%) and methanol (2%) (28). The location of 
the eluted nucleotides was determined by the injection of appropriate 
standards monitored by absorbance at 259 nm. Each peak was collected in 
duplicate determinations and counted in a liquid scintillation counter. 
The concentration of nucleotides was estimated by the peak area as 
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determined by a Perkin-Elmer LCI-IOO integrator. The specific activity 
was calculated as cpm/nmole nucleotide, nucleotide content of the tissue 
was normalized to the protein content, mea·sured by the Lowry reaction 
using bovine serum albumin standards (29). 
In vivo activation of the exogenous kinase activity of the insulin 
receptor was studied as follows. Unilaterally denervated rats were 
anesthetized with metophane and divided into two groups. One group 
received an intravenous injection of SU regular insulin (Humulin, 
recombinant DNA origin, Eli Lilly Co.) via the femoral vein, the other 
received an equal volwne of saline. Five or 30 min later the hindleg 
muscles were exposed, the soleus muscles rapidly removed, mounted on 
wire frames and incubated for \ hour in [14C]glucose containing buffer 
to estimate glycogen synthesis. The remaining leg muscles (primarily 
gastrocnemius and anterior compartment muscles) were removed, frozen in 
liquid nitrogen, homogenized and the insulin receptors solubilized by 
Method 2 above. After elution from the WGA column, the exogenous kinase 
activity of the receptors was estimated by incubation in media 
containing SO mM MgS04 (which was added first to precipitate inorganic 
phosphate and EDTA) , 5 mM MnC1 2 , 0.05% BSA, Img/ml histone H2b, with or 
without 10- 7M insulin for 10 min at 25°C. y[32p]ATP was then added (5 
or SO ~M final concentration, 7.5-10 ~Ci/vial), in a final reaction 
volume of 75 ~1. After 4 min. the reaction was stopped by the addition 
of 4X concentrated Laemmli's sample buffer and the solution placed in 
• 
boiling water for 3 min. The proteins were separated by electropho-
resis, autoradiographed and 32p incorporated into histones determined as 
described under "Electrophoresis". 
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In a second assay WGA eluted receptors were incubated with insulin-
agarose (50 fJ1/150 1J1 WGA eluate, the latter diluted with 2 vol buffer 
A) for 15 min'at 22°C after which the resin was washed twice with 50 roM 
Hepes, pH 7.4, 0.1% Triton X-IOO, 0.5 M NaCl and once with the same 
buffer without NaCl, according to Yu and Czech (25). The insulin-
agarose bound receptors were then resuspended in 75 fJl Buffer A, supple-
mented with 5 mM MnC12, 0.05% BSA and 1 mg/ml histone H2b. The kinase 
reaction was initiated by adding 10 fJl y[ 32p]ATP (5JJM finalconcentra-
tion, 7.5 JjCijvial).. In a parallel reaction the receptor kinase was 
maximally activated by first incubating the washed insulin-agarose bound 
receptors in the above phosphorylation buffer (without histone) with 750 
IJM unlabeled ATP for 20 min at 25°C.. After washing twice in 1 ml Buffer 
A the kinase activity against histone H
2
b was measured as described 
above. 
Plasma glucose determination. Blood obtained via cardiac puncture 
was used for plasma glucose determinations with a Beckman Glucose 
Analyzer 2.. Only those animals whose plasma glucose fell below 65 mg% 
were considered "treated" in the in vivo activation experiments. The 
mean plasma glucose of insulin treated rats was 39 ± 4 mgldl at 5 min 
and 33 ± I1mg/dl at 30 min after insulin injection (n = 4 and 10 
respectively), while the mean plasma glucose of saline treated controls 
was 85 ± 6 mg/dl. 
Glycogen synthesis bI control and.denervated solei.. Solei were 
divided lengthWise and mounted on wire frames as described previously 
(9) and incubated in 2 ml Gey and Geyts balanced salt solution (26) 
supplemented with 0.1% BSA and 5 roM [14C]glucose (0.3 ~Ci/ml) under 95% 
O2 /5% CO2 atmosphere at 37°C for 30 min. The muscles were then digested 
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in 0.5 ml 30% KOH for 20 min at 10QGe and the glycogen precipitated by 
the sequential addition of 50 ~l 10% Na2S04 and 1 ml 100% ethanol. The 
precipitate was collected by centrifugation, washed twice with 66% 
ethanol, dissolved in 1 ml IN Hel and the radioactivity determined by 
scintillation counting. 
Phosphoaminoacid analysis. The position of the histone samples for 
phosphoamino acid analysis was determined by autoradiography of an 
unfixed, undried gel and aligned with fluorescent dye marks (Ultemit, 
New England Nuclear). The desired portion of the gel was excised and 
placed in a dialysis bag with 2 ml electrophoresis buffer. The bag was 
closed with dialysis clips and the gel slice trapped between the plates 
of the vertical electrophoresis unit, one end plugged with acrylamide. 
A voltage of 300 V was applied for 40 min and the eluted protein 
precipitated with 20% trichloroacetic acid using 100 ~g bovine gamma 
globulin as a carrier. The precipitate was hydrolysed in 6 N Hel, 
lyophilized, absorbed to 500 ~l Dowex 1-X8 and eluted with 0.25 M Hel 
(30). After lyophilization the samples were resuspended in a small 
volume of mixed phosphoamino acid standards (0.33 mg/rol each of 
phosphotyrosine, phosphoserine and phosphothreonine), spotted on 0.1 rom 
cellulose coated plates and electrophoresed at pH 3.5 (pyridine/acetic 
acid/water, 1:10:189) at 1000 V for 40 min (30). The positions of the 
phosphoaminoacids were located by ninhydrin staining and the 
radioactivity detected by autoradiography. 
Electrophoresis was performed using the discontinuous system of 
Laemmli (24) under reducing conditions. For samples identifying only 
the f3-subunit of the insulin receptor a 7.5% resolving gel was employed. 
For samples identifying both the ~-subunit of the insulin receptor and 
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histone H2 b a linear 6-20% polyacrylamide gel system was used. In all 
cases a 4.5% stacking gel was used. After electrophoresis, the gels 
were stained in 50% methanol, 10% acetic acid with 0.125% Coomassie 
brilliant blue R, destained in 30% methanol, 10% acetic acid, and dried 
in vacuo with heat. Phosphorylated peptides were localized by autoradio-
graphy using Kodak AR-S film, in some cases in the presence of a duPont 
lightening + intensifying screen. Phosphorylated bands of interest were 
excised and the radioactivity estimated by digestion of the gel slice 
for 10 hrs in 1 ml 30% H20 2 and subsequent counting in a Beckman LS 7000 
f3-counter after dissolving the sample in Scintiverse E (Fisher). 
RESULTS 
Eguilibrium binding of 125I-insulin to insulin receptors in the WGA 
eluate solubilized from control and denervated hind limb muscles yielded 
typical curvilinear binding kinetics (Fig. 1). When expressed per mg of 
protein in the WGA eluate, there was no significant difference in the 
number of insulin receptors isolated from control and denervated muscles 
(although the latter was slightly lower), nor was there a difference in 
the apparent insulin binding affinity or in the amount of glycoprotein 
eluted from the WGA column/tissue weight. 
Solubilized insulin receptor kinase activities. Upon binding 
insulin, the receptor, both in the intact cell and in the solubilized 
system, undergoes rapid autophosphorylation (for review see 19,20). 
This property of the solubilized receptor was tested, by incubating WGA 
eluates, prepared from control and denervated muscles, with increasing 
concentrations of insulin, using equal insulin binding activities from 
each preparation. Insulin induced a dose-dependent increase in 32p 
incorporation into thef3-subunit of the receptor (Fig. 2a). The latter 
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was identified as the fJ-subunit by its apparent molecular weight 
(-97,000), its insulin dependent labeling with 32p and its precipita-
bility with specific antibodies (23 and Figure 2c). There was no 
apparent difference in autophosphorylation between receptors derived 
from control and denervated muscles at all insulin doses tested (Fig. 
2a). The metal ion dependence of the autophosphorylation reaction 
(Mn++>Mg++»Ca++) was also identical in the two groups, as was the time 
course of the autophosphorylation (data not shown). Similarly, the 
exogenous substrate kinase activity of the fully activated insulin 
receptor was not altered by denervation using histone H2 b as the 
phosphoacceptor (Figure 2b). 
Phosphorylation in the intact soleus. When insulin receptors were 
isolated by Method 1, no attempt was made to prevent dephosphorylation 
of the receptor. In vivo, the basal state of phosphorylation of the 
insulin receptor ~-subunit, especially phosphorylation on serine 
residues, is thought to modulate the autophosphorylation on tyrosine 
residues upon binding of insulin (31,32). To investigate whether or not 
denervation affects the insulin stimulated autophosphorylation of the 
receptor in the intact cell, soleus muscles from control and denervated 
hind limbs were incubated in [32p]P04 containing media for 3 hrs to 
label intracellular nucleotide pools and then placed into media with or 
without insulin for \ hr to stimulate receptor autophosphorylation. The 
muscles were quickly frozen, and the insulin receptors solubilized and 
partially purified in a buffer which, as determined in preliminary 
experiments, minimized dephosphorylation. After immunoprecipitation and 
electrophoresis under reducing conditions the ~-sub.unit was localized by 
autoradiography, eXCised, and radioactivity determined. Table 1 
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summarizes the results of five such experiments. While in each case 
denervated and control muscles responded to insulin with increased 
labeling of the insulin receptor p-subunit, 32p incorporation in the 
presence of insulin was 19% less in the denervated group. Whenfl. 
insulin, e.g. 32P-incorporation above baseline was calculated, the 
magnitude of the insulin effect was decreased in denervated muscles, but 
the decrease was not significant by paired analysis.. The concentration 
and specific activities of ATP, ADP, and GTP were determined immediately 
before insulin stimulation. The concentrations of the three l1ucleotides 
were identical in denervated and control solei after three hours of 
incubation (Table 1) but in both muscle groups the ATP concentration 
decreased 20% from pre-incubation levels (data no"t shown).. The specific 
activity of the ATP pool on the other hand was 11% lower in the 
denervated muscle groups. Thus, the slight decrease in insulin 
stimulated labeling of the ~-subunit from denervated muscles may reflect 
the decrease in the specific activity of intracellular ATP; this would 
suggest, however, that there may be a slight increase in the basal 
phosphorylation of the ~-subunit from denervated muscles. Unfortu-
nately, the low receptor associated radioactivity precluded the analysis 
of the labelled phosphoaminoacids before and after in situ insulin 
stimulation. 
Kinase activity of in vivo activated receptors. A method was 
developed to solubilize muscle insulin receptors in the presence of 
phosphoprotein phosphatase and kinase inhibitors and determine their in 
vivo activation state by assessing their ability to phosphorylate exo-
genoussubstrates, in vitro. Since the exogenous substrate kinase 
activity of the receptor is" dependent on its phosphorylation state (25), 
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if the sites on the insulin receptor which were phosphorylated in 
response to in vivo insulin remained phosphorylated during receptor 
isolation, the exogenous kinase activity should reflect the degree of in 
vivo activation. Rats were anesthetized and one group was given an i.v. 
bolus of insulin via the femoral vein. After 5 or 30 min, the hind limb 
muscles innervated by the sciatic nerve were removed and quickly frozen 
in liquid nitrogen. The procedure used to solubilize and partially 
purify insulin receptors from hind limb muscles was similar to that used 
previously in isolating the autophosphorylated insulin receptors from 
incubated soleus muscle (Method 2). In an initial attempt to quantitate 
the exogenous substrate kinase activity MgS04 was added to the insulin 
receptor containing WGA eluate to precipitate inorganic phosphate and 
EDTA. The receptor kinase activity was then assessed with 5 ~M 
y[32P]ATPand 1 rug/ml histone H2b as the substrate. Using equal insulin 
binding activities the histone kinase activity of muscle insulin 
receptors from rats which had been treated in vivo with insulin was 
- 2-fold greater than that of untreated controls (Fig. 3) with no 
significant difference between receptors isolated 5 or 30 minutes after 
the administration of insulin (30 min point not shown). The insulin 
receptor kinase from denervated skeletal muscles activated to the same 
level as that derived from the innervated pairs after i.v. insulin (Fig. 
3). When insulin (2xlO-7 M) was added to the incubation mixture for 10 
min before initiating the kinase reaction, stimulation of histone kinase 
activity was not observed in any group of receptors. When the same 
series of experiments were performed with 50 ~M ATP, the receptor 
associated histone kinase activity prepared from rats which had received 
insulin was still greater than that of receptors prepared from saline 
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treated controls. However, when WGA eluates were preincubated with 
insulin before the addition of 50 ~M ATP, histone phosphorylation by 
receptors derived from saline treated controls increased two-fold and a 
smaller but significant increase was observed usin.g the WGA eluate 
derived from insulin treated animals. Again no difference was observed 
between receptors prepared from denervated and innervated muscles. 
These results demonstrate that 5 ~M ATP is too low to allow the in vitro 
activation of the exogenous substrate kinase by insulin, at least in the 
time frame investigated. Increasing the concentration of ATP ten-fold 
allowed the in vitro activation of histone kinase by insulin in both the 
control and denervated derived WGA eluates, but this increase in kinase 
activity was not as great as that seen in the in vivo activated re-
ceptors. Phosphoamino acid analysis of histones .showed that the 
increase in labeling after in vivo activation of the insulin receptor 
occurred exclusively on tyrosine residues (not shown). 
The differences in kinase activity between insulin receptors 
derived from insulin and saline treated rats may have been due to 
insulin carried through the receptor purification procedure or to a 
co-purified histone kinase activity that was independent of the insulin 
receptor. To test this, a second assay was performed. The WGA purified 
receptors were incubated with insulin-bound agarose beads and after 
centrifugation and washing the kinase activity towards histone H2b was 
assessed in a reaction using 5 )JM y[32p]ATP, a concentration which, as 
shown above, does not allow the further activation o£ the insulin 
receptor kinase. As in the previous assay, receptors isolated from 
insulin treated rats showed increased histone kinase activity, and in 
vivo activation by insulin was not affected by denervation (Fig. 4). 
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When these insulin-agarose bound receptors were first allowed to 
autophosphorylate with 750 JJM unlabeled ATP, the histone kinase activity 
increased to identical levels in all groups (Fig. 4). Histone 
phosphorylation after activation with 750 J..IM ATP was slightly lower than 
that observed after in vivo activation with insulin, this difference, 
although not significant, likely represents small losses of receptors 
during washing and/or slight dilution of the labeled ATP,resulting in 
decreased specific activity_ When WGA eluates were incubated with 
dithiothreitol-heat inactivated insulin-agarose beads the histone kinase 
activity observed was less than 10% of that seen in any of the 
experiments using fully activated beads suggesting that the bulk of the 
kinase activity pertained to insulin receptors bound to the insulin 
agarose. Phosphoamino acid analysis of the histones phosphorylated in 
the presence of insulin-agarose bound receptors revealed considerable 
32p incorporation into serine residues, which however was not affected 
by pretreating the rats with insulin in vivo, or by preincubating 
receptors from saline treated controls with 750 JJM ATP, while both 
maneuvers approximately doubled 32p incorporation into tyrosine residues 
(Fig. 5). Identical increments were observed us.ing receptors prepared 
from denervated muscles (not shown). 
The intravenous insulin bolus stimulated the metabolism of 
innervated muscles, as assessed by the in vitro incorporation of 
[14C]glucose into glycogen. Denervated muscles were resistant to 
intravenously administered insulin in the same way as they are resistant 
to insulin in vitro (7-9). Innervated solei from non-treated animals 
had a low basal rate of glycogen synthesis (Fig. 6) which was stimulated 
by adding insulin in vitro. The 24 hr denervated solei from saline 
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treated controls demonstrated a markedly reduced basal rate of glycogen 
synthesis and this did not increase significantly upon addition of 
insulin to the incubation medium. On the other hand, solei from the 
innervated legs of insulin treated animals synthesized twice as much 
glycogen than those from s~line treated controls when incubated without 
insulin and this rate was not increased further by adding insulin in 
vitro. Stimulation of glycogen synthesis in non-denervated solei was 
apparently complete within 5 min .. after the i.v. bolus of insulin (Fig. 
6) which correlates with the increase in the exogenous kinase activity 
of the receptors isolated from the ipsilateral muscle groups at this 
time. Attempts at investigating the activation after shorter time 
periods proved difficult in that at least 1 min. was required to remove 
both solei and excise and freeze the remaining muscles. We could 
demonstrate nearly complete activation of both glucose incorporation 
into glycogen and exogenous kinase activity within 30-45 sec after the 
i.v. injection of insulin, this result was variable, however (data not 
shown) . 
Discussion. Insulin resistance of peripheral tissues, including 
muscle, is associated with a number of physiological and pathological 
conditions which include hormonal imbalance (e.g. excess glucocorti-
coids, catecholamines or growth hormone), obesity, type II diabetes, 
uncontrolled insulinopenic (type I) diabetes, uremia, the catabolic 
state which accompanies severe trauma, burns and sepsis, some genetic 
abnormalities and in skeletal muscle, denervation and immobilization. 
Conditions of insulin resistance associated with increased circulating 
insulin levels are usually accompanied by a decrease in the number of 
insulin receptors on the cell-surface, a phenomenon termed ftdown-
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regulation". However, in most conditions, the ensuing decrease in 
insulin binding does not account for the magnitude of the insulin 
resistance, indicating that post-binding defects play an important role 
(for review, see 33). Recent findings suggest that in some conditions 
e.g. a genetic abnormality of the insulin receptor resulting in severe 
insulin resistance in man (16,17) as well as in uncontrolled insulin 
deficient diabetes in the streptozotocin treated rat (18) and in the 
goldthioglucose treated obese, diabetic rat (34) insulin binding (which 
involves primarily the a-subunit of the receptor) is unimpaired, but the 
insulin activated autophosphorylation and tyrosine kinase activity of 
the ~-subunit are diminished upon insulin binding in vitro. Thus, 
post-binding insulin resistance may include receptor abnormalities 
resulting in abnormal signalling by the occupied receptor, as well as 
true post-receptor defects. In the case of denervated muscles, we and 
others (7,9,15) found no defect in insulin binding; the current work 
demonstrates that in addition, the tyrosyl-kinase activity of the ~­
subunit is normally stimulated by insulin, thus the severe insulin 
resistance which develops in muscle shortly after denervation appears to 
be a post~receptor defect. It is possible, however, that other, undis-
covered properties of the receptor are impaired shortly after denerva-
tion. Whether the insulin unresponsiveness is due to alterations in 
membrane potential (13), defects in the generation of second messengers, 
development of a metabolic milieu which is unfavorable for the propaga-
tion of signals or alterations in the levels or properties of the pro-
posed substrates for the insulin receptor kinase is not known. Further 
studies of this model may provide clues concerning the mechanism of 
insulin action and its post-receptor modulation. 
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In the course of these studies we developed techniques to assess 
the in vivo activation state of the insulin receptor in skeletal muscle. 
Rapid freezing of the excised muscles in liquid nitrogen, . solubilizing 
and purifying the insulin receptors in the presence of phosphoprotein-
phosphatase and kinase inhibitors (NaF, Na4PZ07 Na2V04 and EDTA) al-
lowed the demonstration of increased histone H2b phosphorylation by WGA 
eluates from animals which had been treated in vivo with insulin. Two 
methods were used to clear the solution of EDTA and inorganic phosphate 
(which would chelate the Mn++ ions required for activ.ation). In the 
first assay, MgS04 was added in sufficient quantities to remove the 
chelators. Using 5 IJM ATP no stimulation of histone kinase activity was 
seen when insulin waS added to the incubation medium prior to the ini-
tiation of the kinase reaction. The inability to activate the exogenous 
substrate kinase of the receptor with insulin at this low ATP concentra-
tion has been previously reported (25,35) and is attributed to the 
decreased phosphorylation of a critical site on the insulin receptor 
~-subunit (25,35). By raising the ATP concentration to 50 IJM an in-
crease in the histone kinase activity could be demonstrated in the WGA 
eluates in response to maximally stimulating insulin concentrations in 
vitro; as expected the increment caused by insulin in vitro was much 
greater using receptors prepared from controls, than from insulin 
treated rats. It is noteworthy that while the baseline histone phos-
phorylation occurred predominantly on serine residues, the increment in 
histone phosphorylation elic~ted by insulin in vivo or in vitro occurred 
exclusively on tyrosine. 
In the second method the insulin receptors were further purified by 
binding them to insulin-agarose, thus removing them from the WGA eluate 
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containing Mn++ chelating anions as well as enzymes which may modify 
receptor-induced histone phosphorylation. Preliminary reports described 
a similar approach for assessing the activation state of the receptor in 
isolated cell systems (36,37). The results obtained with this method 
(Fig. 4) confirmed the preceding ones (Fig. 3). Insulin-agarose bound 
receptors prepared from insulin-treated rats demonstrated - 2-fold 
greater histone-H2 b phosphorylation, in the presence of 5 ~M [y_32p]ATP 
than identically prepared receptors from saline treated controls. When 
both sets of insulin-agarose bound receptors were preincubated with 
unlabelled, 750 ~M ATP, a concentration which fully activates the 
receptor tyrosyl-kinase (25 and our data, not presented), histone 
phosphorylation by receptors from saline treated controls was activated 
to the same level as that by receptors from rats treated in vivo with 
insulin. The insulin binding activity of the WGA eluates from insulin 
and saline treated rats was determined before incubation with insulin-
agarose, and the beads were incubated with equal binding activities. In 
preliminary experiments insulin binding curves prepared from WGA eluates 
derived from insulin treated and saline treated rats revealed no dif-
ference in binding kinetics between the groups. Furthermore, addition 
of Mn++ and ATP to binding assays did not alter the apparent affinity of 
the insulin receptor. This confirms previous observations that insulin-
induced receptor phosphorylation does not alter the affinity of insulin 
binding (38). 
It is unlikely that our data were compromised by insulin carried 
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over through the receptor purification procedure because a) when 1-
insulin was included in muscle homogenates, with or without unlabeled 
insulin (10 ~g/ml), less than 0.1% of the radioactivity was associated 
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with the WGA eluate and this was non-specifically bound, b) when 0 .. 5 
U/ml (20 ~g/ml) insulin was included in the buffer in which muscles from 
saline treated controls were homogenized, no activation of the receptor 
tyrosyl-kinase was detected in assays of the WGA eluate. Similarly, 
inclusion of 40 mM ATP in the homogenization buffer did not affect the 
subsequent measurements of histone kinase activity in any group. WGA 
eluates prepared from skeletal muscle were devoid of detectable phosphoprotein 
phosphatase activity (not shown). ATPase activity was assayed under a 
number of experimental conditions, by measuring the radioactivity associated 
with ),[32p]ATP and with inorganic phosphate, separated by HPLC (as 
described in Methods) after incubation of the receptor preparations with 
),[32p]ATP. Less than 10% of y[32p]ATP was degraded after 4 min. 
incubation in any histone kinase assay (or in assays of receptor 
autophosphorylation), and this measurement was not affected by previous 
treatments e.g. insulin or denervation. While significant serine-kinase 
activity was associated with the receptor preparations, even in the 
assay using insulin-agarose bound receptors, receptor-induced histone 
phosphorylation on serine residues was unchanged after treating rats 
with insulin in vivo or after activating the receptors in vitro. On the 
other hand, both maneuvers markedly stimulated the phosphorylation of 
histone H2b on tyrosine residues (Fig. 5). 
Since denervated muscles demonstrate decreased sensitivity as well 
as a decreased response to insulin (5-9) we injected high concentrations 
of the hormone to elicit maximal responses in both the denervated and 
innervated muscles. In innervated muscles both receptor activation and 
the biological response (assessed as glucose incorporation into 
glycogen) were essentially fully stimulated within 5 min of such 
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injections. In denervated muscles, identical activation of the receptor 
tyrosine kinase by insulin was not accompanied by the biological 
response. In experiments where receptor histone-kinase activity and 
stimulation of glycogen synthesis were measured in parallel 5 min. and 
30 min. after the i.v. injection of insulin, the responses were 
essentially identical at the two time points, suggesting that 
phosphorylation of the tyrosine, which is critical for activation of the 
receptor-tyrosyl-kinase, occurs rapidly and persists in vivo. Dose 
response curves injecting lower doses of insulin have not yet been 
tested; they may be required for the quantitative assessment of receptor 
activation in different physiological and pathological conditions~ 
While skeletal muscle is a major site of insulin action, similar 
measurements should be feasible in other tissues as well. The method 
for assessing the activation state of the insulin receptor in skeletal 
muscle in vivo is relatively rapid, easily applicable to various animal 
models of insulin resistance and in contrast to cell culture systems, 
the availability of tissue is not limiting- It should be useful in 
characterizing insulin resistant states, by identifying conditions which 
may be associated with defective activation of the fj-subunit 
tyrosyl-kinase upon insulin binding in vivo. 
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Table 1 
A. Autophosphorylation of the insulin receptor ~-subunit in incubated 
solei. Groups of 6 hemisolei (from control and denervated hindlimbs) 
were preincubated for 1 hr in low phosphate DMEM, then for 3 hrs in this medium 
supplemented with [32P]phosphate (0.15-0.25 mei/ml), followed by 30 min 
incubation with and without insulin as described in Methods. Solei were 
immediately frozen and insulin receptors solubilized and partially purified 
by Method 2, and immunoprecipitated and processed as described in Fig. 2C. 
Values represent the mean ± S.E. for 5 experiments. Cpm incorporated 
into the f3-subunit were normalized to the wet weight of the muscles 
prior to incubation. * p < 0.05 vs. no insulin, paired analysis. 
B. Nucleotide concentration and specific activity in incubated 
solei. Solei from control and denervated hind limbs were incubated 
exactly as described in A. except the specific activity of the 
[32p]phosphate was decreased to 1.5-2.5 IJCi/ml. The muscles were frozen 
immediately following the 3 hr. incubation in DMEM and nucleotides 
extracted and separated as described in "Methods". The concentration of 
the nucleotides was normalized to the protein content of individual 
muscles. Means ± S.E. of 5 different experiments are shown, 6 control 
and denervated hemi-solei were assayed individually in each experiment. 
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Table 1 
A. cpm incorporated into p subunit/IOO mg wet weight 




242 ± 32 
379 ± 45* 
Denervated 
252 ± 37 
320 ± 25* 




ATP 22 . 1 ±2. 8 
ADP 3.9 ± 0.6 
GTP 4.4 ± 0.8 
Denervated 
22.3 ± 1.9 
4.2 ± 0.6 




629 ± 116 
244 ± 69 
107 ± 22 
Denervated 
564 ± 106 
233 ± 69 
107 ± 25 
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Figure 1. Equilibrium Binding of A14[12 SI]insulin to solubi11zed, 
WGA-purified insulin receptors. Aliquots of WGA eluate (7.5 ~g of 
protein) from control and denervated skeletal muscle were incubated with 
tracer A14[1 25I]insulin (specific activity 100-140 ~Ci/~g) and 
increasing concentrations of unlabeled insulin in a total volume of 200 
1J1 buffer containing 50 mM Hepes, 100 mM NaCl, 0.05 mg/ml BSA, 0.1% 
Triton X100 and 0.075 M N-acetyl glucosamine, pH 7.8 for 16 hr. at 4°C. 
The receptor and bound insulin were precipitated by the sequential 
addition of 100 ~l 0.3% bovine ~-globulin and 300 ~l 25% polyethylene 
glycol. Non-specific binding was considered that which occurred in the 
presence of 10 JJg/ml unlabeled insulin and was subtracted from each 
point. The main figure shows a Scatchard plot of data from control 
(0---0) or denervated muscle (x---x) derived receptors. Each point is 
the mean ± S.E. of three receptor preparations, each point assayed in 
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Figure 2. A. Insulin induced autophosphorylation of the 
solubilized, WGA-purified insulin receptors. In the standard assay 
equal insulin binding activities of control and denervated derived WGA 
eluates were incubated in phosphorylation buffer without or with 10-9 or 
IO- 7M insulin for 1 hr. as described in "Methods u • y[32P] ATP (50 I-IM 
final concentration, 7.5 JJCi/vial) was added and the autophosphorylation 
allowed to continue for 4 min. at 25°C. After electrophoresis and 
autoradiography the excised fl-subunit was digested and the radioactivity 
quantitated by scintillation counting. [II], control derived receptors; 
[ ], denervated muscle derived receptors. Each value is the mean ± 
S.E. of 4 receptor preparations from control and denervated skeletal 
muscles respectively, each assayed in triplicate. 
B. Phosphorylation of histone H2b by the solubilized insulin 
receptor activated on insulin-agarose. Equal insulin binding activity 
of control and denervated derived wheat germ eluate (approx. 150 J.ll) 
were preincubated with 50 JJl dithiothreitol-heat inactivated insulin 
agarose at 25°C for 1 hr and subsequently with 50 1-11 active insulin-
agarose for 1 hr. at 25°C as described in BMethods ft • The suspension was 
washed and then incubated in the presence of 5 mMMnC1 2 and 750 pM 
unlabeled ATP for 20 min. at 25°C. After extensive washing the beads 
were resuspended in phosphorylation buffer with 1 mg/ml Histone H2b. 
The kinase reaction was initiated by the addition of y[32p]ATP (5 ~M 
final concentration) and incubated at 25°C for 4 min. The samples were 
electrophoresed and the histone bands localized by autoradiography, 
excised and the radioactivity determined by scintillation counting. 
[II], Histone phosphorylation by control or [ ], denervated derived 
receptors. 
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c. Immunoprecipitation of the autophosphorylated insulin receptor. 
WGA eluates were incubated without or with increasing concentrations of 
insulin as described in A. After autophosphorylation, anti-insulin 
receptor antibody (1:400 dilution) was ad.ded and incubated for 16 hr. at 
4°C then for an additional 2 hr. with protein A bearing, formalin fixed 
S. aureus (final 1% solution). After washing, the solution was 
electrophoresed under reducing conditions and autoradiographed. Lanes 
A and B, control; C and D, denervated derived receptors, without (A and C) 
or with 10-7 M (B and D) insulin. 
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Figure 3. In vivo activation of the insulin receptor tyrosyl-kinase. 
Unilaterally denervated rats were anesthetized and injected i.v. with 
regular insulin (5U) or with normal saline. After 5 min. the hindlimb 
muscles innervated by the sciatic nerve were removed and immediately 
frozen in liquid nitrogen. The insulin receptors were solubilized and 
partially purified on WGA by Method 2 described in tlMethods". The WGA 
eluate was incubated without or with 2XIO- 7 M insulin in phosphorylation 
buffer which was made 50 mM in MgS04 to precipitate the phosphatase 
inhibitors. The kinase reaction was initiated by adding either 5 or 50 
~M y[32p]ATP and terminated after 4 min. After electrophoresis and 
autoradiography, the histone bands were excised, digested and the radio-
activity determined. The values plotted are the mean ± S.E. of 
duplicate determinations from four different control and denervated 
muscle receptor preparations. The schema for the different treatments 
is indicated below the histogram and above the histone H2b containing 
area of a representative autoradiogram. 
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Figure 4. In vivo activated insulin receptor kinase assayed on 
insulin-agarose. Treatment of rats and insulin receptor solubilization 
is described in Figure 3.. WGA eluate from control and denervated 
skeletal muscle (approx. ISO 1-'1, with equal insulin binding activity) 
was incubated with 50 ).Jl insulin-agarose and the resin washed as 
described in "Methods".. Part of the samples were allowed to autophos-
phorylate in the presence of 750 IJM unlabeled ATPat 25°C for 20 min. 
The samples were resuspended in phosphorylation buffer with 1 mg/ml 
Histone H2b and the kinase reaction initiated by the addition of 10 1-11 
y[32p]ATP (5 IJM final concentration), stopped after 4 min. and the 
samples processed as described in Fig. 3. Panel A: Samples obtained 
after 5 min. in vivo treatment with either saline or insulin.. Panel B: 
30 min. after treatment. The values plotted are the mean ± S.E. of 
duplicate determinations from 4-6 different control and denervated 
muscle receptor preparations. The schema for the different treatments 
is indicated below the histograms and above the histone Hzb containing 
area of a representative autoradiogram (5 min treatment experiment). 
The slightly lower histone phosphorylation in panel A was due to a lower 
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CHAPTER 5: DIABETES INDUCED FUNCTIONAL AND STRUCTURAL CHANGES 
IN INSULIN RECEPTORS FROM RAT SKELETAL MUSCLE 
Insulinopenic diabetes in man is associated with peripheral insulin 
resistance (1-4), which appears to be related to prior glycemic control 
(5). Using a closed-loop subcutaneous insulin infusion system, Mayfield 
et al (5) reported a direct correlation between elevated HbA1c levels 
and increased insulin requirements in Type I diabetic patients. Strict 
control of blood glucose levels increased the subjects' sensitivity to 
insulin (5,6,7). Insulin resistance is also seen in animals with 
experimentally induced insulinopenia. Reaven et a1 (8) observed insulin 
resistance in alloxan diabetic dogs when fasting plasma glucose levels 
exceeded 150mg/dl while those with lower glycemia responded to insulin 
as the controls. In rodents, streptozotocin-induced diabetes results in 
a diminished response to insulin in isolated adipocytes (9,10,11), liver 
(12,13) as well as skeletal (14) and heart muscle (15), while insulin 
binding (e.g. the apparent number of insulinrecepto:rs) is increased 
(9,10,13). This has led to the suggestion that the insulin resistance 
associated with poorly-controlled Type I diabetes is primarily a 
post-receptor defect. Alternatively, it may represent a defect in 
signal transmission by the occupied -insulin receptor. 
The initial event in insulin action on target tissues is its bind-
ing to specific cell surface receptors. The insulin receptor is a 
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heterotetramer glycoprotein, consisting of two a and two ~ subunits. 
The a subunit with a MW - 135000 daltons appears to contain the app 
insulin binding domain, while the (3-subunit MW app 95000 daltons may be 
primarily involved in signal transmission. Insulin binding induces the 
autophosphorylation of the ~ subunit in both intact cells and in cell-
free systems (16-23). Subsequent to this autophosphorylation, the 
insulin receptor acquires the ability to act as a kinase towards exo-
genous substrates (18,21,23). These phosphorylation events occur on 
tyrosine residues and have been suggested to trigger the phosphorylation-
dephosphorylation cascade seen in cells upon exposure to insulin 
(16,20,22). 
Since skeletal muscle is an important site of insulin action, we 
investigated the effect of streptozotocin-induced diabetes on the 
functional and structural properties of the solubilized rat skeletal 
muscle insulin receptor. We found that the insulin-stimulated autophos-
phorylation and exogenous substrate kinase activity of diabetic derived 
receptors was impaired. This alteration was reversed by in vivo insulin 
treatment. The functional changes were paralleled by the appearance of 
a subpopulation of insulin receptor ~.-subunits in diabetic skeletal 
muscle with a slower electrophoretic migration; the latter may reflect 
altered glycosylation of the f3-subunit. 
Materials: Streptozotocin was a gift from Dr. William Dulin, 
Upjohn Research Laboratories, Kalamazoo, MI. Polyclonal anti-insulin 
receptor antibody (A410) was a gift from Dr. Steven Jacobs (Wellcome 
Research Laboratories, Research Triangle Park, NC) and from Dr. C. 
Ronald Kahn (B9) (Joslin Research Laboratories, Boston, MA). Mono-
component, crystalline pork insulin was a gift from Dr. Ronald Chance, 
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Lilly Research Laboratories, Indianapolis, IN. Monoiodinated 
A14[125 I ]insulin used in some studies was kindly provided by Dr. B. H. 
Frank, Lilly Research Laboratories. Wheat germ agglutinin was from 
Vector (Burlingame, CA); Aprotinin from FBA Pharmaceuticals (New York, 
NY); Bacitracin from Pfizer (New York ,NY). Electrophoresis reagents 
were from Serva (Heidelberg, Germany) and the apparatus from LKB 
(Houston, TX). Protein A-bearing S. Aureus (Pansorbin) and neuramini-
dase (Vibrio Cholera) were from Calbiochem (San Diego, CA). S. Aureus 
VB protease and endoglycosidase H were from Miles (Elkhart, IN). 1251_ 
iodine was from New England Nuclear (Boston, MA). ",[32p]ATP was pre-
pared from 32p orthophosphate (ICN, Cambridge, MA) in Gammaprep Vials 
(Promegabiotec, Madison, WI) as described by the manufacturer. CNBr-
Sepharose-4B beads were from Pharmacia (Piscataway, NJ). Thin layer TLC 
plates, Polygram CEL300, were from Brinkmann Instruments (Westbury, NY). 
Autoradiography film, X-Omat AR was from Kodak (Rochester, NY). 
Lightening + intenSifying screens were from Dupont (Wilmington, DE). 
All other reagents and chemicals were from Sigma (St. Louis, MO) unless 
otherwise specified. 
Animals: Male Wistar rats (Charles River Breeding Co., N.J.) 
100-140 g initial body weight were used in all experiments. They were 
allowed food and water ad libitum. Diabetes was induced by i.p. injec-
tion of streptozotocin in citrate buffer, pH 4.5, 130 mg/kg body weight, 
to overnight fasted animals. In insulin reversal experiments diabetic 
rats were initially treated with 2U regular and 2U protamine zinc 
insulin (PZI) s.c. at 1700 hr on the fifth day after streptozotocin and 
subsequently with 2U PZI at 0900 hr and 1700 hr. the next two days for a 
total of five treatmen.ts. Glycosuria was monitored by Tes-Tape (Lilly) 
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and was 4+ in untreated diabetic rats, and trace, or negative in insulin 
treated rats by the second day of treatment. Plasma glucose levels were 
determined with a Beckman Glucose Analyz.er 2 on blood samples obtained 
at sacrifice. Diabetic rats with or without insulin treatment were 
studied on the 7th day after streptozotocin, and compared to control 
animals. Rats were killed by decapitation, the hindlimb muscles were 
rapidly removed and frozen in liquid nitrogen. Insulin receptors from 
control and experimental animal groups were always processed on the same 
day and analyzed in the same experiments. 
Solubilization and partial insulin receptor purification were per-
formed as previously described (23). Briefly, the frozen muscles, 
approx. Sg, were powdered and membrane components solubilized by homo-
genization as a frozen slurry in 4 vol .. 25mM Hepes, pH 7.4, SmM EDT-A, 
1 TIU/rol aprotinin, 2mM phenylmethyl sulfonylfluoride (PMSF) and 1% 
Triton X-IOO. The homogenate was centrifuged at 10,000 x g for 10 min 
and the supernate stirred at room temperature for 1 hr. The mixture was 
then centrifuged at IS0,OOOxg for 90 min. The receptors were further 
purified by adsorption to a<nd elution from Agarose-bound wheat germ 
agglutinin (WGA). Receptors were eluted from the ·WGA column with 2SmM 
Hepes pH 7.4, 0.1% Triton X-IOO containing 0.3 M N-acetylglucosamine 
(approx 1 ml/gm original tissue weight) and used directly or further 
purified by precipitation with polyclonalanti-insulin receptor anti-
body. In some preparations 125I-insulin (-1.5 ~Ci) was added after 
homogenization of muscles with or without 50 f.Jg/ml unlabeled insulin. 
Aliquotswere taken at various times during the isolation procedure and 
125I-insulin specifically bound was determined by polyethylene glycol 
precipitation. Recovery and trichloroacetic acid (TCA) precipitability 
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of th 1251 . 1" d . d b ~ 1" . e -1DSU 1n were eterm1ne . y CQUnt1ng a 1quots 1n a y-counter 
as described below. 
Insulin Binding: WGA eluate (50 IJl) was incubated with 10,000 cpm 
125I-insulin (sp. act. 125-175 IJCi/lJg, prepared by the lactoperoxidase 
method as described in 24) and increasing concentrations of unlabelled 
insulin for 16 hrs at 4°C in a buffer containing 25 mM Hepes, 0.1% 
Triton X-100, 150 roM NaCl, 0.1% bovine serum albumin and 100 U/ml 
Bacitracin as described by Taylor et al (25). The receptor and bound 
insulin were precipitated by the addition of 100 IJl 0.3% bovine y-
globulin and 300 IJl 25% polyethylene glycol and collected by 
centrifugation. The resulting pellet was washed with 300 IJl 12.5% 
polyethylene glycol and counted in a Beckman Gamma 4000 y-counter. 
Non-specific binding (10-15%) waS estimated as that occurring in the 
presence of 10lJg/ml unlabelled insulin. Binding was related to the 
protein concentration in the WGA eluate estimated by the Bradford 
reaction (26). 
Equalization of receptor number: In all experiments assessing 
functional and structural properties of solubilized insulin receptors 
derived from experimental and control animals, approximately equal 
insulin binding activity was used in comparing groups. Since no change 
in insulin binding affinity was apparent in receptors from diabetic 
animals (see results) equal numbers of insulin receptors were estimated 
as follows: 125I-insulin binding per 50 1-11 WGA eluate was determined in 
the presence of 1, 5, 25, 100, 1000 and 10,000 ng/ml unlabelled insulin 
(the latter used as estimate of non-specific binding after overnight 
incubation at 4°C or 45 min at 25°C). Ratios of the specifically bound 
counts in the experimental group vs. the control were determined at each 
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insulin concentration, these ratios were averaged and the mean value 
used as an estimate of relative number of insulin receptors. Individual 
values were within 10-15% of this mean. Appropriate volumes of the WGA 
eluate were then used in subsequent experim.ents. Identical ratios were 
obtained after overnight or 45 min incubation with 125I-insulin; the 
latter resulted in approximately 60-70% of the equilibrium binding 
obtained in the former. All dilutions of WGAelute were made with 25 roM 
Hepes pH 7.4, 0.1% Triton X-IOO. The presence of 0.3 M N-acetylgluco-
samine had no effect on the functional properties of the insulin 
receptor (18, and our data). Experimental groups were always compared 
to control insulin receptors prepared the same day from untreated 
animals. 
Insulin specifically bound to receptors in the wheat germ eluate 
was linear between 12.5 and 7S fJl of the eluate assayed in a constant 
volume (r = 0.97 and 0.96 for control and diabetic receptor preparations 
respectively). The 32p incorporated into the f3-subunit of the insulin 
receptor, after exposure to maximally stimulating insulin concentrations 
_7 
(10 ), was also linear between 10 and 50 ... 1 of the wheat germ eluate, 
(r = 0.98 and 0.97 for control and d.iabeticreceptor preparations re-
spectively). These values were derived from three different pairs of 
receptor preparations (diabetic and control), each point assayed in 
duplicate or triplicate. 
Receptor autophosphorylation. Fifty ~l of WGA eluate from control 
animals and appropriately diluted receptors from diabetic or insulin-
treated diabetic animals were incubated in 25 roM Hepes pH 7.4, 0.1% 
Triton X-100, 5 roM MnC1
2
, 0.05% bovine serum albumin (Buffer A) with 
increasing insulin concentrations in 75 ~l final volume for 4S min at 
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25°C. The reaction mixtures were then cooled to 4°C and y[32p ]ATP 
(10 ~l - 15 ~Ci,100 ~M final concentration) was then added and after 30 
min at 4°C the phosphorylation reaction was terminated by the addition 
of 28 ~l 4X concentrated Laemmli's sample buffer, heated at lOQGe for 3 
min and the proteins separated by SDS-PAqE (see below) '. The f3-subuni t 
of the insulin receptor was localized by autoradiography, excized and 
digested in 1 ml 30% H202 at 60°C for 10 hrs and 32p content determined 
by counting in 10 mlScintiverse II (Fisher Scientific, Norcross, GA) in 
a Beckman LS7000 scintillation counter. Insulin degradation by the 
receptor preparation during incubation at 25°C in buffer A was estimated 
by TCA precipitability of added 125I-insulin tracer; less than 2% of 
added insulin became TGA soluble after 2 hours of incubation. 
Exogenous substrate kinase activity was determined using Angio-
tensin II as the phosphoacceptor, as described by Rosen et al. (18). 
Approximately 10-20 fmoles insulin binding activity was incubated with 
or without insulin at 25°C forI hr in 225 ~l buffer A. Autophosphory-
lation was initiated by the addition of y[32pIATP (50 tJCi, 100 tJM final 
concentration) and allowed to proceed for 30 min at 4°C. Aliquots (35 
~l) were then added to 5 J.Jl of buffer A or buffer A containing 2 roM 
angiotensin II and the phosphorylation carried out at 4°C for 5 min 
which was in the linear part of the velocity curve as determined in 
preliminary experiments. The reaction was stopped by the addition of 5 
~l 1.5% BSA and 50 J.Jl 5% TCA. After centrifugation, duplicate 40 IJl 
aliquots were spotted onto phosphocellulose paper, washed and counted as 
described (18). 
Kinase activity of insulin·receptors bound to. insulin-agarose. 
Control receptors (120 J.Jl) and equal binding activity of diabetic 
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derived receptors were diluted to a final volume of 320 ~i with buffer 
consisting of 50 roM Hepes, pH 7.4, 0.1% Triton X-100, 1 Jj&/ml leupeptin, 
and 2 mM PMSF (buffer B); 50 1J1 insulin-agarose beads or agarose-beads 
inactivated with hot dithiothreitol (27) were added and the mixture 
incubated for 1 hour at 25°C.. After centrifugation the pellet was 
washed twice with 1 ml buffer B supplemented with 0.5 M NaCl and then 
with buffer B alone. The pellet was then resuspended in 75 1J1 50 mM 
Hepes, pH 7.4, 0.1% Triton XI00, 0.025% BSA, 5 roM MnC12 (phosphorylation 
buffer) supplemented with 750 J..IM ATP and incubated for 15 min at 25°C to 
induce maximal receptor autophosphorylation (27) .. The mixture was then 
diluted with 1 ml of salt supplemented buffer B, centrifuged, the pellet 
washed with 1 ml buffer B, and then resuspended in 751J1 phosphorylation 
buffer, supplemented with 1 mg/ml histone H
2
b and 50 .... M ),[32p ]ATP (2.5 
~Ci/vial) and incubated for 4 min at 25°C. The reaction was stopped by 
the addition of hot 4X Laernmlits sample buffer and the sample separated 
on SDS-PAGE and autoradiographed as described below. 
The bands corresponding to Histone H
2
b were excized and the 32p quanti-
tated as described above for the insulin receptor fj-subunit. 
ATPase activity: Equal binding activities of control and diabetic 
derived wheat ge.rm eluates were incubated as described for the autophos-
phorylation assays except that the specific activity of the ATP was 
decreased (- 6 IJCi/ml, ATP final concentration 10-100 J.lM). At various 
time intervals (30 sec-120 min) the reaction was stopped by the addition 
of 65 pl of 3M perchloric acid and after 5 min equilibration at 4°C 200 
fJl of dH
2
0 were added and the protein removed by centrifugation. The 
supernatant (300 }Jl) was neutralized with 60 1J1 2 M KHC03 , clarified by 
centrifugation, supplemented with 2 1J1 of a 2 M solution of unlabeled 
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carrier ATP and 20 pI were analysed on a Perkin-Elmer High Performance 
Liquid Chromatograph using a 5 em CIS reverse phase column. ATP was 
eluted isocratically in a buffer composed of 20 roM phosphoric acid (pH 
to 6.5 with triethylamine, 98%) and methanol (2%) ata flow rate of 2 
ml/min (28). The first 1.5 min of the run (containing inorganic 
32 
phosphate) and the ATP peak were collected separately and P cpm 
quantitated by liquid scintillation counting. These assays were 
performed in parallel with assays of insulin-receptor kinase activities .. 
All kinase assays reported here were carried out under conditions where 
ATP degradation was less than 10%. 
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Cross-linkage of solubilized insulin receptors with [ I]insulin: 
Wheat germ eluates (1 ml) from control and diabetic derived muscle 
extracts were dialyzed against 25 mM Hepes pH 7.6 and concentrated 
approximately four-fold with Aquacide (Calbiochem). Equal binding 
activities were incubated for 15 hrs at 4°C with A14[125 I ]insulin (0.5 
J,lCi) with or without 10 JJg/ml unlabeled insulin in 250 tJ1 final volume, 
then disuccinimidyl suberate was added in DMSO to a final concentration 
of 2 mM at 4°C, for 15 min (29). After addition of 4X concentrated 
Laemmli's sample buffer the mixture was boiled for 3 min. Electro-
phoresis and autoradiography were performed as described below. 
Immunoprecipitation and partial proteolytic digestion of 
phosphorylated insulin receptors. WGA eluate was incubated in the 
presence of IO-7M insulin for 45 min at 25°C in Buffer A (lOOJJl final 
volume) and y [32P1ATP (10JJM, l0J..lCi) added for an additional 10 min. 
The reaction was stopped by addition of 20 )..11 40 mM ATP, 10 mM Na4POS ' 
2mM PMSF, in Buffer A. Anti-insulin receptor antibody (1:400 dilution) 
was added and incubated overnight at 4°C. Protein A bearing formalin-
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fixed S~ aureus was added and incubated for an additional 2 hrs and the 
precipitated complex washed three times with 25 roM Hepes, 0.1% Triton 
X-lOO. Partial proteolytic digestion of the immune complex was achieved 
by resuspending it in SO roM sodium acetate pH 5 buffer (10 ~l) contain-
ing 75 ~g/ml V8 protease and incubating for 5 min at 37°C. The reaction 
was stopped either by the addition of an equal volume twice concentrated 
Laemmli's sample buffer or by the addition of 10 ~l Protease Inhibitor 
Cocktail I (PIC I) and 5 ~l PIC II (PIC I = 1.5 mg/ml Benzimidine, 1.5 
mg/ml leupeptin, 1.5 mg/ml Benzoyl arginine ethyl ester in 10 TIU/ml 
aprotinin. PICII = 1 mg/ml PMSF and 1 mg/ml antipain in DMSO). The 
protease inhibited mixtures were then treated with glycosidases as 
described below. 
Phosphoamino acid analysis: The phosphorylated, immunoprecipitated 
~-subunit was identified by autoradiography of the wet, unfixed gel 
after SDS-PAGE and solubilized by electroelution as follows: A 2x2cm 
gel slice was placed in a dialysis bag containing electrophoresis buffer 
(1.5M Tris, 58mM glycine, pH 8.8) and immobilized between the glass 
plates of the vertical gel electrophoresis apparatus, immersed in this 
buffer. One end of the sandwich was plugged with 15% acrylamide and a 
potential of 500 V was applied for 1 hour. The contents of the bag were 
removed, 30 ~g bovine y-globulin added and the protein precipitated by 
making the solution 20% in TCA. The precipitate was dissolved in 250 ~l 
6N HCI and hydrolyzed at 110°C for 60 min under N2 atmosphere. The 
hydrolysate was adsorbed to 0.5 ml Dowex 1-X8, washed with 2 ml dH20 and 
eluted with 1 ml O.IN Hel (30). The lyophilized sample was redissolved 
in 5 ~l of a mixed phosphoamino acid standard containing 0.33 mg/mi each 
of phosphoserine, phosphothreonine and phosphotyrosine and spotted on 
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thin cellulose TLC plates (0.1mm thickness). The plates were electro-
phoresed at 1000 V for 40 min in pyridine:acetic acid:H
2
0 (5:15:945) 
towards the anode (30). Thephosphoamino acids were localized by ninhy-
drin staining and by autoradiography at -80° with intensifying screen. 
Tryptic phosphopeptidemapping: Electroeluted receptors were 
precipitated at 4°C in 10% TCA with 30 ~g carrier bovine y-globulin and 
the precipitate extracted 3 times with 750 ~l 1:1 ether: ethanol (31). 
The washed pellet was oxidized at 25°C for 2 hrs by the addition of 
200 JJl 9:1 formic aCid:H20 2 , diluted to 2 ml with water and lyophilized. 
The lyophilizate was resuspended in 0.3 ml 50 mM (NH4)2C03' pH 8.0, 
containing 75 f.Jg/ml TPCK treated trypsin and incubated at 25°C for 12 
hrs when an additional 40 tJg trypsin was added and incubation continued 
for another 12 hrs. The mixture was brought to 3 ml with water and 
lyophilized three times, resuspending in 3 ml water each time (31). 
Phosphopeptides were separated in 2 dimensions on 20cm X 20cm X O.lmm 
TLC plates by electrophoresis in 1% auunoniumbicarbonate, pH 8.9, for 40 
min towards the anode and then by ascending chromatography in pyridine: 
butanol:acetic acid:water (70:50:15:60) in the second dimension (32). 
Phosphopeptides were localized by autoradiography at -BOoC for 4 with 
intensifying screens. 
Treatment of immunoprecipitated receptors with Endoglycosidase H. 
Washed, immunoprecipitated receptors with or without prior partial 
protease digestion were made 0.1% in sodium dodecylsulfate and heated 
for 1 min in boiling water. After cooling, 10 ~l PIC I and 5 ~l PIC II 
were added, followed by 50 tJl 30 mU/ml endoglycosidase H in 50 roM sodium 
acetate, pH 5 .. 5, 10 mM Cae1
2
, 0.01% bovine serum albumin and incubated 
for 4 hours at 37°C. The samples were boiled in Laemmli's sample buffer 
(4X concentrated) and separated on SDS-PAGE. 
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Neuraminidase: Immunoprecipitated receptors with or without prior 
partial VB digestion were resuspended in 10 ~l PIC I and 5 ~l PIClI, 
followed by the addition of 40 mU/ml neuraminidase in 50 mM sodium 
acetate, pH 5.0, 10 mMCaC12 , 150 mM NaCl and incubated 4 hours at 37°C. 
As above the reaction was stopped by the addition of 4X Laemmlits sample 
buffer and proteins separated on SDS-PAGE. Methods for treatment of 
insulin receptors with glycosidases were modified from those described 
by Ronnett et ale (33). 
Electrophoresis: SDS-PAGE was performed under reducing condition 
using the discontinuous buffer system of Laemmli (34) with a 7.5% poly-
acrylamide resolving gel for non-protease digested samples, a 9% poly-
acrylamide resolving gel for samples previously treated with VB protease 
and a linear 6-18% polyacrylamide resolving gel for reactions containing 
Histone H
2
b. A 4.5% polyacrylamide stacking gel was used for all sam-
ples. Samples were electrophoresed at 150-170 volts, constant voltage. 
Gels were stained, unless indicated, in 50% methanol, 10% acetic acid 
and 0.125% Coomassie blue Rand destained in 30% methanol and 10% acetic 
acid. The gels were dried in vacuo and autoradiography performed with 
Kodak AR autoradiography film with or without Dupont Lightening + 
intensifying screens at -BOoC. 
Results 
Animal condition: Rats rendered diabetic by i.p. injection of 
streptozotocin gained little or no weight during the subsequent 7 days. 
Final weights of the diabetic rats were 111 ± 4 gm (N = 23) vs 164 ± 4 
gm (N = 15) for the controls. Insulin treatment (60 hrs) of diabetic 
rats resulted in rapid weight gain (final weight 145 ± 5 gms; N = 10). 
At the time of sacrifice the plasma glucose concentration of control 
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rats was 130 ± 4 mg/dl (N = 15), that of untreated diabetic rats was 510 
± 14 mg/dl eN = 17), and that of insulin treated diabetic rats was 
94 ± 6 mg/dl; (N = 12). 
I 1 " B" d" E "lOb" b" d" f 1251 " 1" b h nsu 10 1n lng. QU1 1 r1um 1n lng 0 -lnsu ln y t e par-
tially purified insulin receptors extracted from hind limb muscles of 
diabetic rats increased approximately two-fold per mg protein in the 
wheat germ eluate as compared to controls (Figure 1). When calculated 
per gm muscle the increase in receptor number was 60-70% (~ 100-125 
pmoles insulin bound/gm in control vs. 180-250 pmoles bound/gm in the 
diabetic). Administration of insulin for 60 hours caused a reduction in 
insulin receptor number per mg protein and per gm tissue weight to 
nearly that of controls. The yield of glycoprotein mg/gm muscle from 
diabetic rats was ~ 25% less than that obtained from controls, 0.55 ± 
0.06 VS. 0.72 ± 0.07 respectively, (N=10/group, p < 0.01, paired 
analysis). The increase in receptor number solubilized from muscles of 
diabetic rats occurred without an apparent change in the affinity of the 
insulin receptor. These values were obtained after incubation at 4°C 
f 16 h B" d" f 1251 " 1" ttl d d" b . d " d or rs. ln lng 0 -lnsu ln 0 con ro an 1a et1c er1ve 
insulin receptors for 45 minutes at 25°C showed that 65-75% of 
equilibrium binding occurred in this time frame in both groups and the 
ratio of insulin bound by diabetic vs. control preparations was 
identical to that obtained with incubations for 15 hrs at 4°C. Since 
the kinetics of insulin binding were identical in diabetic and control 
animals, the tyrosine kinase activity of the solubilized insulin recep-
tors was routinely studied after 45 min to 1 hr incubation with insulin 
at 25°C. Experiments performed following incubation with insulin for 16 
hrs at 4°C yielded identical results to those shown below. 
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Insulin stimulated autophosphorylation: Insulin stimulates the 
autophosphorylation of the insulin receptor through an intramolecular 
event (20,35). As previously reported (23) when the WGA purified 
insulin receptors from rat skeletal muscles were incubated with 
32 
y[ P]ATP, 5 mM MnC1 2 and increasing concentrations of insulin there was 
32 
an insulin dose-dependent increase in the amount of P incorporated 
into a -97,000 dalton peptide when the reaction mixture was analysed by 
SDS-PAGE and autoradiography. This peptide was identified as the 
~-subunit of the insulin receptor by its apparent molecular weight, its 
ability to increase labelling after incubation with insulin, and its 
specific immunoprecipitability with anti-insulin receptor antibodies 
(see ref. 23). 
When equal binding activities of control and diabetic derived 
receptors were allowed to autophosphorylate at 4°C for 30 min in the 
presence of 100 ~M ATP, there was a significant decrease (p < 0.05) in 
32 
the amount of P incorporated into the f3-subunit of the insulin re-
ceptor derived from diabetic animals incubated without insulin and at 
all insulin concentrations tested (Fig. 2). At maximally stimulating 
insulin concentrations, the mean autophosphorylation of control recep-
tors was 40% greater than that of the diabetics, however the insulin 
stimulated autophosphorylation over baseline (6 insulin) was only 20% 
greater in controls than in diabetics. Although the latter difference 
was not significant,as will be shown below, it resulted in marked 
impairment of insulin stimulated exogenous kinase activity. Half-
_9 
maximal activation of autophosphorylation occurred at - 2xl0 M insulin 
in controls and diabetics. When diabetic rats were treated with insulin 
to normalize their blood glucose levels, the insulin receptors derived 
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from these animals showed nearly identical autophosphorylation kinetics 
as controls (Fig. 2). 
Exogenous substrate kinase activity: The insulin receptor displays 
exogenous substrate tyrosyl kinase activity that is activated by the 
autophosphorylation event (18,21). To investigate this property insulin 
receptors from control, diabetic or diabetic-treated animals were incu-
bated for 1 hr at 25°C with the indicated concentrations of insulin and 
32 
then allowed to autophosphory1ate in the presence of 100 fJM Y[ P]ATP at 
4°C for 30 min; exogenous kinase activtiy was then assessed for 5 min at 
4°C using Angiotensin II as the phosphoacceptor. Little exogenous 
kinase activity was observed in any of the groups in the absence of 
_9 _7 
added insulin. At 10 and 10 M insulin, a significant decrease in the 
exogenous substrate kinase activity was seen in the diabetic derived 
receptors (p < 0.01, Fig. 3). The ability of insulin to stimulate the 
exogenous kinase activity over basal was significantly less in diabetic 
derived receptors than in controls (p < 0.01). Treatment of diabetic 
rats with insulin restored the exogenous substrate kinase activity of 
the receptors toward normal (Fig. 3). 
The decreased ability of diabetic derived receptors to phosphory-
late exogenous substrates was not temperature dependent nor substrate 
specific, since similar decreases in the diabetic derived receptor 
kinase activity were observed at 25°C using histone H
2
b as the phospho-
acceptor. In these experiments the wheat germ eluates were preincubated 
with insulin coupled to agarose, the agarose-bound receptors were exten-
sively washed and then allowed to fully autophosphorylate in the 
presence of 750 ~M ATP. The exogenous kinase activity was then assessed 
using 50 ~M y[32p ]ATP. While equal insulin binding activities derived 
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from control and diabetic muscles were incubated with the beads, there 
was again a significant decrease in the amount of label incorporated 
into the histone by the diabetic derived receptors as compared to the 
controls (Fig. 4). When receptors were bound to insulin-agarose beads 
which had been inactivated with hot dithiothreitol (27), histone-H
2
b 
phosphorylation was - 10% of that observed with fully activated agarose-
bound receptors (data not shown). 
A number of mechanisms may explain the decreased kinase activity of 
the diabetic derived receptor population, including errors in the 
estimation of insulin receptor number or contaminants in the wheat germ 
eluate altering insulin receptor phosphorylation. Insulin that was 
"carried over tt in the preparation of the insulin receptor could lead to 
an underestimate of the true insulin receptor number, especially in the 
control derived preparations. This possibility was examined.by the 
125 
addition of I-insulin to the muscle homogenate and following its 
recovery during different stages of purification. We found that ~ 0.1% 
of the added radioactivity was recovered in the final wheat germ eluate 
and this was entirely nonspecific binding since an identical homogenate 
which was supplemented with 50 J.Jgjml unlabeled insulin showed identical 
125 
recovery of I-insulin. A second approach was to exhaustively dialyse 
the insulin receptors in the wheat germ eluate to remove insulin. Upon 
rebinding, identical ratios of estimated insulin receptor numbers from 
control and diabetic animals were obtained as those before dialysis. 
Furthermore, no change in basal or insulin stimulated autophosphory-
lation was observed in the dialysed receptors. 
The alterations in insulin receptor kinase activities did not 
appear to be due to contaminating insulinases in the diabetic derived 
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receptors nor to contaminating phosphatases since less than 2% of added 
125 
I-insulin was degraded by the WGA eluates over a two hour period and 
32 
no change in the amount of P associated with the insulin receptor 
fJ-subunit or with Angiotensin II or histone H
2
b were. seen for 30 min 
after the addition of unlabeled ATP to previously phosphorylated insulin 
receptors and kinase substrates in either the control or diabetic 
derived preparations (data not shown). While significant ATPase 
activity was detected in the wheat germ eluates under some conditions, 
the results shown here were derived from assays, where less than 10% of 
32 y[ P]ATP was degraded. 
Figure 5 shows the phosphoamino acid analysis of control and 
diabetic derived insulin receptor f3-subunits which were maximally 
32 
stimulated by insulin and then exposed to 10 ~M y[ P]ATP for 10 min at 
25°C. As with other insulin receptors phosphorylated in vitro (18,19) 
labeling occurred predominantly on tyrosine residues in both groups. 
Although a small amount of serine phosphorylation was observed, it 
contributed little to the total amount of phosphoamino acid present in 
either group. 
Two dimensional phosphopeptide maps generated from trypsin 
digestion of the f3-subuni't of the insulin receptors derived from control 
and diabetic animals and autophosphorylated at 25°C are shown in Figure 
6. Although slight variations occur in the relative labeling of the 
various phosphopeptides generated by this procedure, no consistent 
changes occurred in a number of maps analysed, to suggest that a site or 
sites are eliminated from the diabetic derived population that would 
account for the decrease in overall labeling. 
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Structure of the Insulin Receptor subunits. Incubation of wheat 
germ eluates from control and diabetic animals with A14 [12S I ]insulin 
with subsequent addition of disuccinimidyl suberate specifically labeled 
a protein ofMWapp 131kD (Fig 7), which corresponds to the approximate 
molecular weight of the a-subunit of the insulin receptor. No dif-
ferences were observed in the electrophoretic migration of the insulin 
cross-linked (X-subunit between control and diabetic derived insulin 
receptor populations. Furthermore, the amount of label bound per 
receptor was identical when diabetic or control derived wheat germ 
125 
eluates were cross-linked with I-insulin. 
Exploiting the property of autophosphorylation to localize the 
~-subunit of the insulin receptor, we investigated the possibility that 
the functional alterations observed in the insulin receptor from 
diabetic animals could stem from an identifiable structural alteration 
in this subunit. Insulin receptors were phosphorylated, immunoprecipi-
tated and separated under reducing conditions by SDS-PAGE. Autoradio-
graphy revealed that the ~-subunit of the insulin receptor derived from 
diabetic animals included a component that showed a small but reprodu-
cible slowing in electrophoretic migration as compared to controls (Fig. 
8 lanes A and B). This change in electrophoretic migration became more 
prominent after short proteolytic digestion of the phosphorylated, 
immunoprecipitated receptor with V8 protease (Fig. 8 lanes C and D). VB 
protease treatment reproducibly generated 2-4 major phosphorylated 
species each of which showed this altered migration when derived from 
diabetic muscle. 
The major phosphorylated peptides seen after V-8 digestion were 
shown to be derived from the ~-subunit (as opposed to the variably 
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phosphorylated ex subunit) in the following manner. Phosphorylated, 
immunoprecipitated insulin receptors were electrophoresed under reducing 
conditions and the unstained, unfixed gel autoradiographed at 4°C. The 
f3-subunit was localized and excised, the gel slice placed in a dialysis 
bag and the phosphoprotein eluted as described in "Methods". The 
dialysed, lyophilized protein was then subjected to partial V8 
digestion, equal numbers of counts from each treatment group (-4000 cpm) 
were loaded in each lane and reelectrophoresed. The autoradiograph, 
(Fig. 8, lanes F and G) shows the same major phosphorylated species as 
were generated by partial digestion of the immunoprecipitated intact 
receptor (lanes C and D) - with the fragments generated from diabetic 
derived ~-subunits again showing a component with retarded mobility when 
compared to controls. 
As shown in Figure 8, Lanes E and H, the diabetes associated 
alteration in electrophoretic mobility was reversed by 60 hrs of in vivo 
insulin treatment that normalized blood sugar. Lanes I and J show 
autoradiograms of control and diabetic derived insulin receptors that 
were immunoprecipitated and partially digested with V-8 protease. Brief 
autoradiography revealed the diabetic derived f3-subunit (Lane J) to 
consist of two distinct populations, one that comigrates with the 
control receptor (Lane I) and one with retarded migration. 
We next investigated the possibility that sugar side chains asso-
ciated with this glycopeptide could be altered in the diabetic state. 
Considering the difficulty in metabolically labeling the sugar side 
chains and the minute amounts of insulin receptors available for chem-
ical modification, we used enzymatic digestion of the insulin receptor 
with glycosidases in an attempt to characterize the structure of the 
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glycosyl residues. Incubation of the immunoprecipitated insulin re-
ceptor with endoglycosidase H caused an ,..., SkD decrease in MW in 
app 
control and diabetic derived insulin receptors (Fig. 9a, Lanes A, Band 
E, F) but did not correct (and actually accentuated) the difference 
between the control and diabetic. Endoglycosidase H digestion of the 
immunoprecipitated receptor after partial VB proteolysis was 
accomplished by adding an excess of protease inhibitors before the 
addition of the endoglycosidase. Again a decrease in MW of ,..., 4-5 kD 
app 
occurred in the major phosphopeptides generated from control and 
diabetic derived ~-subunits and allowed the separation of the diabetic 
derived receptors into two distinct .populations (Figure 9b, Lanes E & 
F), one that comigrates with the control and one with retarded 
electrophoretic migration. The decrease in MW of the l3-subunit after app 
endoglycosidase H treatment suggested that this glycoprotein contains 
'high mannose' sugar side chains. 
Neuraminidase is an exoglycosidase that removes terminal sialic 
acid residues from the sugar side chains of glycoproteins. When the 
immunoprecipitated insulin receptor was digested with this enzyme a 
decrease in MW of approximately 2 kD occurred in control lanes (Fig. 
app 
9a, lanes A and C). A similar decrease occurred in the diabetic derived 
insulin receptor (Fig. 9a, lanes B and D) and in addition there was an 
apparent normalization in the electrophoretic migration o£ this 
population as compared to control (Figure 9a, Lanes C and D). 
Neuraminidase treatment caused a slight decrease in MW of the major app 
(- 54 kD) phosphorylated peptide in the diabetic derived population 
(Fig. 9b, lanes B and D), and nearly normalized the migration of the 
diabetic derived phosphopeptides as compared to control (Figure 9b, 
lanes C and D). 
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However, double glycosidase digestion i.e. neuraminidase followed 
by endoglycosidase H showed that the second, slower migrating band in 
the diabetic derived preparation increased its electrophoretic migration 
but was not completely eliminated after neuraminidase treatment (Fig 10, 
demonstrating the main 54 kD phosphopeptide generated by VB protease 
digestion). This result raises the possibility that an additional 
component, possibly 'core t sugars, may contribute to the heterogeneity 
in electrophoretic migration of the diabetic de-rived ~-subunit. 
DISCUSSION 
An increase in the number of insulin receptors associated with 
insulinopenia has been observed in adipocytes (9,10), and hepatocytes 
(13,36). In the present study the number of insulin receptors solu-
bilized per gram hindlimb muscle was increased 60-70% after 7 days of 
diabetes, without an apparent change in affinity. Insulinopenic 
diabetes in rats has been reported to cause no change (10,36) or to 
increase the affinity of insulin receptors (10,37) in adipocytes and 
liver.. Studies of insulin binding to intact, incubated soleus muscles 
from streptozotocin diabetic mice reported increased binding affinity 
without a change in receptor number (3.8). These discrepancies may 
reflect the difficulty in interpreting changes in insulin binding 
kinetics, especially when intact tissues are used, as well as possible 
differences between solubilized, total receptors assessed in the present 
study versus surface receptors on intact muscle cells studied in Ref.38. 
It should be noted that the increased receptor number observed in 
muscles after 7 days diabetes in this report reflects in part 
differences in growth rate and muscle weight between control and 
diabetic rats and the - 25% decrease in the amount of glycoprote~n 
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eluted from the wheat germ affinity column in the isolation of insulin 
receptors from diabetic rats as compared to controls. 
The decrease in the ability of the diabetic derived insulin re-
32 32 
ceptors to incorporate P from y[ P]ATP into its ~-subunit and into 
exogenous substrates (angiotensin II or histone H2b) was a consistent 
finding and does not appear to reflect biased estimates of insulin 
receptor number nor contaminating insulinase, phosphatase or ATPase 
activities. Note that cross-linking experiments revealed identical 
labelling of a-subunits in diabetic and control receptor preparations 
(see Fig. 7). The decrease in autophosphorylation was presumably not 
due to a decrease in the number of J3-subunits in the diabetic derived 
wheat germ eluate since similar binding kinetics were observed and 
removal of a significant proportion of the insulin receptor J3-subunits 
would likely result in a noticeable change in receptor affinity. The 
impairment of insulin stimulated exogenous kinase activity of diabetic 
derived receptors (F~g. 3) was more evident than that of the insulin 
activated autophosphorylation (Fig. 2). Preliminary data (41) suggest 
that phosphorylation of different tyrosyl-sites on the p-subunit may not 
be equally important for the activation of the exogenous kinase. 
Our results are in essential agreement with those reported by 
Kadowaki et a1. (36) who showed impaired autophosphorylation of the 
insulin receptors derived from livers of strepto2otocin-diabetic rats 
and by the recent report of decreased autophosphorylation in skeletal 
muscle from rats rendered diabetic by gold thioglucose treatment (39). 
The latter report suggests that the defect in the insulin receptor 
kinase activity is secondary to the diabetic state and not due to 
insulinopenia per se since the rats ioref. 39 were hyperinsulinemic. 
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However, Amatruda et al. isolated hepatic plasma membranes from diabetic 
rats and found no defect in insulin stimulated receptor autophosphory-
lation (40). Whether or not the insulin receptor population which 
manifests diabetes related structural and functional alterations is 
actually present on the plasmalemma or represents an intracellular 
species requires further investigation. 
The phosphopeptides generated by treating the isolated ~-subunit 
with TPCK treated trypsin appeared identical in the diabetic and control 
muscle derived receptors. We consistently generated 10 or more phospho-
peptides from immunoprecipitated, electroeluted f3-subunits even after 
digesting for 72 hours. Previous studies utilizing high performance 
liquid chromatography to separate the products of trypsin digestion 
reported the isolation of 3-5 phosphopeptides (27,35). Whether the 
larger number observed in our system is due to incomplete digestion or 
to receptor heterogeneity or to the higher sensitivity of autoradio-
graphy after 2-dimensional peptide separation is not clear. Visual 
analysis of these maps failed to reveal salient differences in the 
relative phosphorylation of these fragments between controls and 
diabetics. The receptors used in generating these maps were phosphory-
32 
lated for 10 min at 25°C in order to maximize P incorporation for 
visualization of phosphopeptides. However, a more detailed, 
quantitative examination of the phosphopeptides separated from receptors 
autophosphorylated at lower temperatures or for shorter time periods at 
25°C may reveal differences between the two populations. 
The presence of a subpopulation of insulin receptor f3-subunits in 
diabetic rat skeletal muscle with retarded migration on SDS-PAGE 
suggests that diabetes affects the processing of the insulin receptor in 
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muscle. We were able to detect this subpopulation of receptors in some 
rats 24 hrs. after streptozotocin injection and in most animals by 3 
days. In some animals this slower migrating species comprised up to 50% 
of the phosphorylated ~-subunit band detected by autoradiography. It 
was difficult to discern this altered population consistently on a 7.5% 
polyacrylamide gel; however it became distinct after limited proteolytic 
digestion of the insulin receptor with VB protease. This is likely due 
to the inverse logarithmic relationship between molecular weight and 
relative mobility on isocratic polyacrylamide gels resulting in improved 
resolution of smaller proteins, as well as the increased relative 
preponderance of the component with decreased mobility in the fragments. 
The changes in the insulin receptor ~-subunit structure appear to be in 
response to insulinopenia and/or resulting changes in the metabolic 
milieu rather than to toxic effects of streptozotocin since the slower 
migrating component was reduced or eliminated by 60 hrs of insulin 
treatment which normalized blood sugar. It is interesting to note that 
approximately 10% of control animals studied demonstrated a small amount 
(most less than 10%) of a higher molecular weight subpopulation. 
The glycoprotein nature of the insulin receptor has been demon-
strated by direct labeling of the sugar moiety (33~42) and indirectly by 
its ability to bind to lectins (43). Ronnett et ale (33) observed that 
the insulin receptor is synthesized as a single polypeptide chain, which 
is cleaved and subsequently glycosylated on both the a and J3 subunits. 
These intermediates are sensitive to endoglycosidase H and neuraminidase 
resistant. Salzman et al. (44) and Herzberg et a1. (45) reported that 
the mature a and ~ subunits from 3T3-Ll adipocytes and IM-9 lymphocytes 
contain both endoglycosidase H sensitive and insensitive sugar side 
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chains. The latter report also showed that endoglycosidase F could not 
remove all the sugar side chains from the f3-subunit but treatment with a 
chemical deglycosylating agent resulted in an additional decrease in 
molecular weight suggesting the presence of O-linked side chains. The 
insulin receptor j3-subunit isolated here from skeletal muscle of control 
or diabetic rats appeared to be sensitive to digestion by endoglycosi-
dase H; on autoradiography the 95 kD band migrated at - 89 kD after 
endoglycosidase H treatment, suggesting that the f3-subunit isolated from 
skeletal muscle also contains 'high mannose t oligosaccharide side 
chains. The peptides generated after VB digestion, especially the 
prominent 54kD band was also endoglycosidase H sensitive. The diabetic 
derived f3-subunit population separated into two distinct bands after V8 
protease and endoglycosidase H treatment, one that comigrated with the 
control and one with"'" 1 .. 5 kD higher MW (Fig. 8b). The further app 
improvement in the resolution of the diabetes induced f!-subunit 
populations after endoglycosidase H treatment likely reflects the 
elimination of oligosaccharides which are known to affect protein 
migration on SDS-PAGE (46). Treatment of the immunoprecipitated, 
insulin receptor populations with neuraminidase increased the migration 
of the diabetic derived fJ-subunit more than that of the control, 
especially that of the prominent 54 kD peptide fragment (Fig. 9). This 
suggested that the heterogeneity of the diabetic derived fJ-subunit was 
due in part to an increase in its sialic acid content. When V8 digested 
insulin receptors were treated with neuraminidase followed by 
endoglycosidase H, the slower migrating component of the - 54 kD frag-
ment (seen in diabetic derived ~-subunits) appeared to decrease in 
molecular weight while the 'control band· did not change its migratory 
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behavior (Fig. 10). This suggests that there may be an additional sugar 
side chain on some diabetic derived ~-subunits or an alteration in the 
structure of one or more normally occuring oligosaccharide side chains. 
We encountered similar difficulties as Herzberg et al. (45) in attempt-
ing to completely remove the oligosaccharide side chains from the 13-
subunit with Endoglycosidase F or glycanase (broad spectrum N-linked 
glycosidases) suggesting that the f3-subunit may have O-linkedsugar side 
chains. 
Streptozotocin diabetes results in decreased sialic acid and other 
carbohydrate content of major glycoproteins on hepatocyte membranes (47) 
as well as decreased activity of certain glycosyltransferase enzymes, 
without a detectable change in sialyltransferase activity (48). The 
insulin receptor however is spared from the diabetes associated decline 
in hepatic membrane glycoproteins, since hepatic insulin binding and 
receptor number appear to increase in insulinopenic diabetes (13,36). 
The mechanism for the selectivity in hepatic glycoprotein synthesis or 
degradation is not understood; to our knowledge there is no information 
concerning the effect of diabetes on glycoprotein turnover or sialyl-
transferase activity in muscle. We did however see in diabetic rats a 
decline in the amount of glycoprotein per gram muscle eluted from the 
wheat germ columns in the insulin receptor purification protocol. 
In our hands, there appeared to be a relationship between the 
appearance of the ~-subunit population with decreased electrophoretic 
mobility and changes in tyrosyl-kinaseactivity, whenever one phenomenon 
was detected, so was the other. It is tempting to speculate that the 
metabolic alterations associated with insulin deficiency result in 
conformational changes in the receptor that renders the coupling between 
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insulin binding and autophosphorylation less efficient. The precise 
relationship, if any, between the observed alteration in the kinase 
kinetics in the diabetic derived insulin receptor and the structural 
heterogeneity of the f3-subunit remains to be defined. Yamaguchi et a1. 
(49) recently reported that neuraminidase treatment of highly purified 
placental insulin receptors increased insulin binding and tyrosine 
kinase activity. This observation suggests that alterations in sugar 
side chains may indeed modulate insulin-receptor function. 
The insulin resistance which accompanies poorly controlled 
insulinopenic diabetes involves both the liver and peripheral tissues; 
skeletal muscle has been implicated as the primary site (4). The work 
of Kadowaki in liver (36) and the present work in skeletal muscle 
suggest that diabetes induced changes in the ~-~ubunit of the insulin 
receptor may playa role in this insulin resistance. In recent years 
there has been increasing awareness that insulin resistance associated 
with different pathological conditions is caused to variable degrees by 
a defect in the binding of insulin to its targets, or to defects which 
occur after insulin binding. The latter abnormalities are generally 
referred to as post-receptor defects, with the tacit implication that 
they are distal to the receptor, involve the intracellular metabolic 
milieu, second messengers or their intracellular targets. Our data as 
well as those of others (36,39), including a rare genetic defect of the 
insulin receptor (50,51) suggest that post-binding defects may include 
"intra-receptor" defects, resulting in defective signalling by the 
receptor in response to hormone binding. 
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Figure 1 Scatchard analysis of 1251-insulin binding to solubilized, 
wheat germ agglutinin purified insulin receptors. Wheat germ 
agglutinin eluate (50 ~l) was incubated for 16h at 4°C in a 
. solution containing 25 mm Hepes, 0.1% Triton X-100, 150 roM 
NaCl, 0.1 mg/ml bovine serum albumin and 100 U/ml bacitracin 
with 1251-insulin (10,000 cpm; 125-175 ~Ci/~g) and increasing 
concentrations of unlabeled insulin in a final volume of 200 
~l. The receptor and bound insulin were precipitated by se-
quential addition of 100 ~l 0.3% bovine y-globulin and 300 ~l 
25% polyethyleneglycol. Non-specific binding was estimated as 
the radioactivity precipitated in the presence of 10,000 ng/ml 
unlabeled insulin. Specific binding was normalized to protein 
concentration in the wheat germ eluat.e estimated by the 
Bradford reaction (26). Control (0-0), diabetic (0-0) and 
diabetic-treated (a-~) muscle derived receptor population. 
Points are means of 3-5 determinations from two separate 
experiments. SEM of pmole bound/mg protein ranged from 7-17% 
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Figure 2 Dose-response of insulin-stimulated autophosphorylation of the 
~-subunit of solubilized insulin receptors. Wheat germ eluate 
(50-70 ~l) from control derived receptors (0-0) and equal 
binding activities from diabetic (0-0) and insulin treated 
diabetic rats (fi-8) were incubated for 4S min in 25 mM Hepes, 
pH 7.4, 0.1% Triton X-100, 0.05% bovine serum albumin, 
O.15-0.3M N-actylglucosamine and 5 roM HoCl 2 at 25°C without or 
in the presence of 10- 10 to 10- 6 M insulin in a final volume 
of 75 1J1. After cooling the vials to 4°C, autophosphory-
lation was initiated by the addition of y[32Pl ATP (100 ~M, 15 
IJCi/vial) and the reaction continued for 30 min at 4°C and 
terminated by the addition of 4X concentrated Laemrnli's sample 
buffer containing 5 roM 2-mercaptoethanol and heated for 3 min 
at 100°C. The samples were analysed by 7.5% SDS-PAGE, the 
f3-subunit was localized by autoradiography, excised, digested 
in 1 ml 30% H202 and counted in a liquid scintillation 
counter. Values are means for 5 separate preparations from 
control and diabetic rats respectively and 3 insulin treated 
diabetics; preparations were assayed in triplicate in each 
group. All points in the diabetic derived preparation are 
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Figure 3 Angiotensin II phosphorylation by skeletal muscle derived 
insulin receptors. Wheat germ agglutinin eluates were 
_9 _7 
preincubated with 0, 10 or 10 M insulin for 45 min at 25°C 
and then allowed to autophosphorylate for 30 min at 4°C in the 
presence of 100 ~M y[32p]ATP. Aliquots (35 ~l) were added to 
5 pI of buffer or Angiotensin II (2 mM final cone.) and the 
reaction continued for an additional 5 min when 50 IJI 5% TCA 
were added. After cooling on ice for 30 min the protein 
precipitate was removed by centrifugation and duplicate 40 1J1 
aliquots were spotted onto phosphocellulose paper. After 
washing, the papers were counted in a liquid scintillation 
counter. Equal binding activities were assayed in each 
preparation. ( ), control; ( ), diabetic, ( ), 
diabetic-treated. Means ± S.E.M. for 3-5 different receptor 
preparations are shown, each assayed in triplicate. * , 
significantly different from control, p < 0.05. 
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Figure 4 Autoradiogram of Histone H2b phosphorylated by skeletal muscle 
derived insulin receptors. Wheat germ eluates ~',lC )J1. from 
controls and equal binding activity from diabetics were 
incubated with insulin-agarose conjugates for 60 min at 25°C 
as described in "Methods". After washing, the insulin-agarose 
bound receptors were allowed to autophosphorylate in the 
presence of 750 ~M ATP, 5 mM Mne1 2 and 0.025% BSA for 10 min 
at 25°C, then washed and incubated in phosphorylation buffer 
32 
with 1 mg/ml of histone H2b and 50 ~M y[ P]ATP (2.5 ~Ci/vial) 
at 25°C for 4 min. The reaction was stopped by the addition 
of 4 times concentrated Laemmlits sample buffer and the 
samples separated by SDS-PAGE and autoradiographed. Histone 
bands were excised, digested and counted as described for the 
f3-subunit in Figure 2. Two separate sets of control and 
diabetic derived receptors are shown. Lanes A and C: H2b 
phosphorylated by control receptors; lanes Band D: H2b 
phosphorylated by diabetic derived receptors. Arrow indicates 
32 
the position of H
2
b. Inset: Mean ± S.E.M. of P cpm 
incorporated into histone-H
2
b from 4 different control and 4 
diabetic derived insulin receptor preparations (all with equal 






cpm ~nt9 Histone H2b 
Control: 1498+ 28 (n=4) 
Diabetic: 878+ 37 (n=4) 
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Figure 5 Phosphoaminoacid analysis of the f3-subunit of skel.etal rnu ... -. '.e 
insulin receptors. Wheat germ purified insulin receptors from 
control and diabetic animals were incubated with IO-7M insulin 
as described in Figure 2. y[32p]ATP (25~M, 10 ~Ci/vial) was 
added for 10 min at 25°C and the reaction stopped with 20 fJl 
25 roM Hepes, 0.1% Triton, 40 mM ATP, 10 mM sodium pyrophos-
phate and 2 roM PMSF, then anti-insulin receptor antibodies 
(1:400 dilution) were added and samples incubated overnight at 
4°C. The immune complex was precipitated by the addition of 
Pansorbin, washed 3 times and boiled in Laemmli's sample 
buffer. The phosphorylated f3-subunit was eluted from the wet, 
unfixed gel as described in Methods, precipitated with 20% TCA 
and hydrolysed for Ih at 110°C in 6N HCl. The hydrolysate was 
adsorbed to Dowex l-X8, the phosphoaminoacids eluted with 
O.2SN Hel and lyophilized. After addition of mixed phospho-
aminoacid standards, the mixture was spotted on a TLC plate 
and electrophoresed for 45 min in pyridine: acetic acid: H20 
(5:15:950) pH 3.5. The phosphoaminoacid standards were 
localized by ninhydrin and 32p by autoradiography. The 
autoradiogram presented shows control derived receptors (C) 
and diabetic derived receptors (D). The interrupted lines 
indicate the location of phosphoserine (P-ser), phosphothreo-
nine (P-thr) and phosphotyrosine (P-tyr) standards. A small 
amount of phosphoserine was detected on the autoradiogram but 
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Figure 6 Two-dimensional phosphopeptide analysis and autoradiography 
of insulin receptor ~-subunit. Insulin receptors from control 
(A) and diabetic (B) animals were phosphorylated, immunopre-
cipitated, eluted and TCA precipitated as described in Figure 
5. The precipitated protein was washed with ether/ethanol 
(1:1), oxidized with formic acidjH2 0 2 (9:1) and digested with 
TPCK treated trypsin in 50 mM (NH4)2C03 pH 8 for 24 hrs. 
After removal of (NH4)2C03 by lyophilization the hydrolysate was 
spotted on 20 x 20 cm TLC plates, electrophoresed for 40 min. 
. th f' t d" . " 1~ (NH )2C03 pH 8.9, and ascended 1n . e 1rs lmenSl0n 1n ~ 4 
chromatographically in the second dimension with N-butanol: 
pyridine: acetic acid: H20 (30:15:7:37.5). The dried plate 














Figure 7 Structural analysis of the insulin receptor a-subunit. 
Control and diabetic derived insulin receptors were dialysed 
against SO mM Hepes, pH 7.8, concentrated with ttAquacide" and 
equal binding activities incubated for 16 hrs with 0.5 ~Ci 
125 
A14[ I]insulin with or without 10 IJg unlabeled insulin at 
4°C. Disuccinimidyl suberate was added in DMSO to a final 
concentration of 2 roM and incubated for an additional 15 min 
when 4X concentrated Laemmli's sample buffer with 5 roM 
2-mercaptoethanol were added. The samples were separated on 
6% SDS-PAGE and the dried gel autoradiographed. Lane A, 
control derived receptors; lane B, diabetic derived receptors, 
lane C and D control and diabetic derived receptors 










Figure 8 Structural analysis of insulin receptor (3-subunit " Hheat 
germ eluates with approximately equal insulin binding 
activities, prepared from muscles of control, diabetic and 
diabetic treated-rats were incubated with 10- 7M insulin for 45 
min and autophosphorylated for 10 ~in in the pr~sence of 10 ~M 
y(32p]ATP, (- 15 fJCi/100 IJl).Receptors were immunoprecipi-
tated with anti-insulin receptor antibody and Pansorbin. The 
precipitates were either boiled in Laemmli's sample buffer and 
analyzed by 7.5% SDS-PAGE under reducing conditions or first 
digested for 5 min at 37°C in SO roM sodium acetate buffer pH 5 
with 75 f.Jg/ml S. Aureus VB protease and then analyzed by 9% 
SDS-PAGEunder reducing conditions. Dried, fixed gels were 
autoradiographed with intensifyin;g screens at -80°C for 12-24 
hrs. Lane A represents control, B diabetic derived receptors 
without protease digestion.. Lanes C, D, and E, repres~nt 
receptors derived from control, diabetic and insulin-treated 
diabetic rats respectively, with prior VB protease digestion. 
Lanes F, G and H .represent ~-subunitsfrom control, diabetic 
and diabetic-treated respectiv~ly, that were isolated from a 
7.5% gel by electroelution and subsequ~ntly digested with VB 
as described in the text. Lane I represents control and J, 
diabetic derived receptors after VB protease digestion, and 
short autoradiographic exposure. 
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Figure 9 Glycosidase digestion of phosphorylated, immunoprecipitated 
insulin receptors. Autophosphorylated insulin receptors were 
immunoprecipitated and incubated f·r ,; .. ~ ,,' •.. without (9a) or 
with (9b) VB protease as described in Figure 8. After 
addition of protease inhibitors samples were incubated with 
buffer alone (Lanes A and B) or with neuraminidase (40 mU/ml, 
Lanes C and D) or with Endoglycosidase H (30 mU/ml, Lanes E 
and F) at 37°C for 4 hours as detailed in "Methods" after 
which 4X concentrated Laemmli's sample buffer was added, the 
samples analysed by SDS-PAGE and autoradiographed. Lanes A, 
C, E: Control derived receptors; Lanes B, D, F: Diabetic 
derived receptors. The numbers on the left indicate the 
• 
positions of molecular weight markers. 
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Figure 10 Sequential neuraminidase and endoglycosidase H treatment of 
VB digested insulin receptors. Insulin receptors were 
immunoprecipitated and digested with VB protease as described 
in Figure 8. After addition of protease inhibitors and 
incubation with 40 roD/ml neuraminidase for 2 hrs at 37°C 
samples were placed in boiling water for 2 min. After 
cooling, endoglycosidaseH (final concentration 30 mU/ml) was 
added in 4X concentrated endoglycosidase H buffer (1/3 vol.) 
and the sample incubated for an additional 2 hrs at 37°C, then 
processed as described in Figure 9. The major (MW S4 Kd) app 
phosphopeptide generated by VB protease digestion is shown. 
Lane A: Control, endoglycosidase H treated; Lane B: Diabetic, 
endoglycosidase H treated; Lane C: Control, treated sequentially 
with neuraminidase and endoglycosidase H; Lane D: Diabetic, 
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CHAPTER 6: SUMMARY 
In this dissertation I have attempted to define the role of the 
insulin receptor in muscle insulin resistance. As pointed out in the 
introductory chapter, the insulin receptor has two domains: an insulin 
binding domain and an insulin stimulatable kinase domain. It is the 
working hypothesis that these two domans work in concert to transduce 
insulin's signal from the outside of the cell to the interior. In 
Chapter II investigations were undertaken to define the insulin response 
in denervated skeletal muscle. It was found that after severing the 
sciatic nerve, the soleus showed a very rapid onset of decreased insulin 
responsiveness and sensitivity. In as little as 6 hours there was 
nearly a 50% decrease in the ability of the denervated soleus to incor-
porate glucose into glycogen. The insulin unresponsiveness was complete 
at 24 hours. This effect was not unique to the slow twitch, red muscle 
in that the predominantly white, fast twitch extensor digitorwn longus 
was also resistant to insulin stimulation of glycogen synthesis after 
denervation. Other parameters of glucose metabolism were also affected. 
By 24 hours after denervation there was a decrease in glucose transport 
activity in the absence of insulin, as assessed by studies on 2-deoxy· 
glucose uptake experiments, as well as unresponsiveness to insulin 
stimulation of glucose transport. As expected, concordant with the 
decrease in glucose transport, the levels of glucose-6-phosphate fell 
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after denervation and did not increase after insulin treatment as was 
seen in the contralateral control muscles. This did not appear to be 
related to a defect in hexose kinase activity since in the 2-deoxy-
glucose experiments the percent of transported glucose that was in the 
2-deoxyglucose state was not different between controls and denervated 
muscle. 
Activation of glycogen synthase was defective 24 hours after 
severing the sciatic in both the soleus and EDL. It has been suggested 
that the ability to activate glycogen synthase is dependent on the 
levels of glycogen in the muscle and this may be true in the case of the 
denervated soleus in that there was a significant increase in the con-
tent of glycogen in solei after 24 hours denervation. However, there 
was no significant difference in the glycogen content of the EDL after 
denervation which suggests that the insulin unresponsiveness of the 
glycogen synthase system is due to factors other than an increase in 
glycogen stores secondary to inactivity. 
Even with the severe insulin unresponsiveness of the denervated 
muscle, there was not a parallel change in the muscle's response to 
adrenergic agents. Add~tion of epinephrine to incubation media resulted 
in a decrease in glycogen synthesis as well as a decrease in the gly-
cogen content of both control and denervated solei. No detectable 
differences in the sensitivity to the adrenergic agent between the 
groups was observed. 
Despite the many reported changes in the membrane of muscles after 
denervation there was no alteration £n insulin binding that could 
account for the insulin resistance that was observed in the studies of 
Chapter II. I was only able to demonstrate a statistically significant 
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change in insulin binding at low insulin concentrations using repeated 
determinations. This is unlikely to account for the insulin resistance 
since there was no difference in binding at high insulin concentrations 
while the denervated soleus was still unresponsive at supra-physio-
logical concentrations of insulin. Since mUltiple metabolic pathways 
that are responsive to insulin are affected by denervation it appears 
that the defect of denervated skeletal muscle occurs at a proximal step 
in insulin action. This led us to speculate that the other functional 
end of the insulin receptor, that of the insulin-sensitive kinase 
activity, may be affected by denervation. Investigation of this 
possibility required the development of a technique for the isolation of 
functional insulin receptors from skeletal muscle. 
The objective of Chapter III was to isolate and purify insulin 
receptors in sufficient quantities to allow the assessment of binding 
and enzymatic properties. The main difficulty to overcome was the 
resistance of muscle to homogenization which makes cellular fractiona-
tion difficult. Initial attempts at isolation of membrane fractions 
with subsequent solubilization of insulin receptors with non-ionic 
detergents proved unsuccessful. It was discovered that by freezing the 
tissue in liquid nitrogen, finaly powdering with a mortar and pestle and 
homogenizing in a buffer containing protease inhibitors and Triton XIOO, 
it was possible to obtain a solution that contained insulin receptors 
which gave typical curvilinear Scatchard binding curves. Further 
purification on agarose-bound wheat germ agglutinin purified the binding 
activity lO-fold and resulted in a solution that again showed specific 
insulin binding as well as an intact kinase activity. 
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The properties of the insulin receptor kinase were similar to those 
reported for other tissues. Incubation of the solubilized, wheat germ 
agglutinin purified fraction with [32p]ATP resulted in the labeling of a 
- 95,000 dalton protein which was immunoprecipitable with anti-insulin 
receptor antibodies. Addition of insulin increased phosphorylation of 
this protein which identified it as the ~-subunit of the insulin 
receptor. Addition of insulin to the wheat germ agglutinin eluate also 
increased the rate of phosphorylation of added exogenous substrates. 
In Chapter III the feasibility of assessing the in situ 
phosphorylation of the insulin recepto.r in incubated solei was demon-
strated. Incubation of the solei in inorganic [32p]phosphate containing 
medium resulted in the equilibration of the ATP pools with labeled 
phosphate. After stimulation of the intubated muscles with insulin and 
subsequent homogenization in buffer containing phosphatase inhibitors, 
we could demonstrate the increase in labeling of the J3-subunit of the 
insulin receptor. The methods developed in Chapter III were then used 
in studying the insulin receptor in denervated versus control muscles. 
Equilibrium binding studies of the insulin receptor solubilized 
from 24 hour denervated skeletal muscle showed a slight but not 
significant decrease in the number of insulin receptors when normalized 
to the protein content of the final wheat germ eluate. This is 
consistent with the finding presented in Chapter II where binding of 
insulin to whole muscles showed only a small decrease after denervation. 
Likewise, the purified insulin receptors from denervated skeletal muscle 
showed no change in the ability to autophosphorylate in response to 
insulin nor was there a change in the exogenous substrate kinase 
activity of the fully activated insulin receptor. The activation of the 
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insulin receptor was accomplished by binding the receptors to an 
insoluble matrix of insulin agarose. The receptors were fully activated 
by an initial autophosphorylation in the presence of 750 ~M ATP and, 
after washing, the exogenous kinase activity was assessed. 
The assessment of in situ autophosphorylation of denervated 
skeletal muscle insulin receptors gave inconclusive results. The amount 
of autophosphorylation of the insulin receptor f3-subunit that occurred 
in the presence of insulin was lower than that observed in controls. 
However, the decrease in autophosphorylation was paralleled by a 
decrease in the specific activity of the ATP pools attained just prior 
to insulin addition. It was of interest that there was no difference in 
the amount of radioactivity associated with the ~-subunit in the absence 
of insulin despite the consistent finding of a decrease in ATP specific 
activity. This result suggests there may be an increase in the basal 
autophosphorylation of the receptor. 
With the in situ phosphorylation results somewhat murky in their 
interpretation, we developed an alternate method for assessing the 
activation of the insulin receptor in the denervated versus the control 
muscle. An intravenous injection of saline or insulin and subsequent 
homogenization of the hind limb muscles in buffer containing phosphatase 
inhibitors allowed the demonstration of an increase in the kinase 
activity of the insulin receptors isolated from insulin treated rats. 
Two different methods were used to clear the solutions of phosphatase 
and kinase inhibitors with identical results obtained in each. 
Furthermore, the increase in the exogenous substrate kinase activity 
witnessed after insulin treatment was due to an increase in tyrosine 
phosphorylation, most likely due to insulin receptor associated tyrosine 
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kinase activity.. In these experiments no difference was seen in the 
ability of the kinase activity from denervated skeletal muscle to be 
activated even though the ipsilateral soleus muScles from the same legs 
demonstrated resistance to both in vivo and in vitro insulin stimulation 
of glycogen synthesis .. 
The finding that the insulin receptors in denervated skeletal 
muscle can bind insulin and the intrinsic tyrosine kinase activity of 
the insulin receptors can be activated as well as controls demonstrates 
that the insulin resistance of denervated skeletal muscle is a true 
'post receptor' defect. As such, the denervated skeletal muscle can 
serve as a model for insulin resistance. The exact cause of the insulin 
resistance of denervated skeletal muscle remains unsolved. It may be 
due to a change in the activity of the tsecond messenger' of insulin or 
perhaps to a decrease in the sought substrate for the insulin receptor 
kinase, or may be related to the change in the membrane potential seen 
after denervation. Whatever the reason, finding the cau.se will likely 
give insight into the mechanism of insulin action. 
In contrast to denervated skeletal muscle, there was a pronounced 
change in the insulin receptor derived from diabetic skeletal muscle. 
The binding domain of the insulin receptor did not appear to be altered 
after 7 days of insulinopenic diabetes induced in the rat by treatment 
with streptozotocin except that the nwnber of insulin receptors in-
creased nearly two fold when normalized to the protein in the wheat 
germ agglutinin eluate without a change in binding affinity. Cross-
linking of the a-subunit showed no changes in the migration in the 
diabetic derived muscle receptor as compared to the control. When the 
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kinase activity of the diabetic derived insulin receptor was investi-
gated a significant decrease in the ability to autophosphorylate was 
observed as well as a concommitant decrease in the exogenous substrate 
kinase activity when assessed by two different methods with two dif-
ferent phosphoacceptors. The kinetic changes that occurred could be 
reversed by treatment of the animals with insulin to normalize blood 
glucose levels. 
In addition to the change in kinase'activity of the f)-subunit of 
the insulin receptor, we also discovered that 7 days insulinopenic 
diabetes also resulted in the appearance of a subpopulation of ~-sub­
units that had a retarded migratory behavior on electrophoresis gels. 
This subpopulation could be eliminated by insulin treatment of the 
diabetic rat. Digestion of the immunoprecipitated insulin receptor with 
glycosidases increased the migration of the phosphorylated f3-subunit. 
Treatment with endoglycosidase H enhanced the separation of the phos-
phorylated fj-subunit that co-migrated with control and the one that 
appeared in the diabetic derived insulin receptor preparation. Neuramini-
dase, on the other hand, appeared to reduce or eliminate the differences 
in migration of the control and diabetic derived insulin receptor popula-
tions, suggesting that the differences in migration were due to an 
excessive sialidation of the f3-subunit of the insulin receptor in dia-
betes. We were however unable to completely eliminate the second, 
slower migrating band of the diabeticf3-subunit by sequential digestion 
with neuraminidase and endoglycosidase H, which suggests that other 
carbohydrate components contribute to the alteration in insulin receptor 
migratory behavior on electrophoresis gels. Whether this alteration in 
structural properties is the cause of the chang~ in kinase activity 
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observed in the insulin receptor or is coincidental is unknown. It is 
interesting that both the structural change and the alteration in kinase 
activity are reversed by insulin treatment and when one is observed, so 
is the other. 
In conclusion, the work presented in this dissertation does point 
out that some, but not all, insulin resistant states may show a concor-
dant change in the properties of the insulin receptor. The exact role 
of the alteration in the kinase activity and structural changes play in 
the insulin resistance associated with insulinopenic diabetes ~waits the 
direct demonstration of the role the kinase activity plays ip initiating 
insulin's action in the cell. In the case of skeletal muscle, one must 
look past the receptor to discover the reason for the insulin resistance 
seen so soon after denervation. 
56 
experiments we established that 2-deoxyglucose uptake of muscles incu-
bated with or without insulin was linear with time under these condi-
tions. 
The correlation coefficients (r) of 2-deoxyglucose uptake (0.1 mM) 
VS. time (10,15,20 and 30 min.) were 0.996 in the absence and in the 
presence of 1 mU/ml of insulin; with 5 roM 2-deoxyglucose the respective 
r values were 0.972 without and 0.989 with insulin, (n = 4 muscles/time 
point). With 5 roM 2-deoxyglucose in the presence of insulin initial 
rates of 2-deoxyglucose uptake decreased after 15 min., and only the 
first two time points were used in the calculation of the r value. In 
subsequent experiments, all incubations with 5 mM 2-deoxyglucose were 
limited to 15 min. 
The degree of phosphorylation of intracellular 2-deoxyglucose was 
determined after separating 2-deoxyglucose from 2-deoxyglucose-6-P04 by 
chromatography on Dowex l-X8 columns (11). It was assumed that 
[14CJsucrose and extracellular free 2-deoxyglucose were distributed 
identically, and that 2-deoxyglucose-6-P04 was only found intra-
cellularly. 
Glucose-6-phosphate (G-6-P) content. Muscles were preincubated and 
incubated as described for the glycogen synthesis experiments except 
that [14C]glucose was omitted. Immediately after incubation the muscles 
were frozen between two blocks of dry ice, placed into 1 ml of ice cold 
6% perchloric acid and homogenized for 1 min. with an ice-cooled 
Polytron tissue homogenizer (Brinkman, Ill.). The precipitated protein 
was pelleted by centrifugation at 5000 x gfor 15 min. The supernate 
was neutralized with KHC0
3 
and G-6-P assayed by the method of Lowry and 
Passoneau (12) in an Aminco-Bowman spectrofluorometer. 
